<SEC-DOCUMENT>0001193125-22-123712.txt : 20220427
<SEC-HEADER>0001193125-22-123712.hdr.sgml : 20220427
<ACCEPTANCE-DATETIME>20220427163203
ACCESSION NUMBER:		0001193125-22-123712
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20220609
FILED AS OF DATE:		20220427
DATE AS OF CHANGE:		20220427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Ikena Oncology, Inc.
		CENTRAL INDEX KEY:			0001835579
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40287
		FILM NUMBER:		22860169

	BUSINESS ADDRESS:	
		STREET 1:		50 NORTHERN AVE.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
		BUSINESS PHONE:		857-343-8292

	MAIL ADDRESS:	
		STREET 1:		50 NORTHERN AVE.
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02210
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d288879ddef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML><HEAD>
<TITLE>DEF 14A</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A
</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>(Rule <FONT STYLE="white-space:nowrap">14a-101)</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SCHEDULE 14A INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Securities Exchange Act of 1934 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by the
Registrant&nbsp;&nbsp;&#9746; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Filed by a Party other than the Registrant&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B></B>&#9744;<B></B><B></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>Confidential, for Use of the Commission Only (as permitted by Rule
<FONT STYLE="white-space:nowrap">14a-6(e)(2))</FONT> </B></P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Proxy Statement </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Definitive Additional Materials </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Soliciting Material under <FONT STYLE="white-space:nowrap">&#167;240.14a-12</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>IKENA ONCOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of registrant as specified in its charter) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Name of Person(s) Filing Proxy Statement, if other than the Registrant) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Payment of Filing Fee (Check all boxes that apply): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9746;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">No fee required. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee paid previously with preliminary materials. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules
<FONT STYLE="white-space:nowrap">14a-6(i)(1)</FONT> and <FONT STYLE="white-space:nowrap">0-11.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g288879g01a01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>IKENA ONCOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>645 Summer Street, Suite 101 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Boston, MA 02210 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE
OF 2022 ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>To be held June&nbsp;9, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Notice is hereby given that the 2022 Annual Meeting of Stockholders, or Annual Meeting, of Ikena Oncology, Inc., will be held online on June 9, 2022 at 4:15
p.m. Eastern Time. The safety of our stockholders is important to us, and given the continuing concerns resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, this year&#146;s Annual Meeting will be held virtually. You may
attend the meeting virtually via the Internet at www.virutalshareholdermeeting.com/IKNA2022, where you will be able to vote electronically and submit questions. You will need the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number
included with the Notice of Internet Availability of Proxy Materials being mailed to you separately in order to attend the Annual Meeting. The purpose of the Annual Meeting is the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To elect three class I directors to our board of directors, to serve until the 2025 annual meeting of
stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To ratify the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for
the fiscal year ending December&nbsp;31, 2022; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman; " ALIGN="left">To transact any other business properly brought before the Annual Meeting or any adjournment or postponement of
the Annual Meeting. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">The proposal for the election of directors relates solely to the election of three class I directors nominated by
the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Only Ikena Oncology, Inc. stockholders of record at the close of business on April&nbsp;14, 2022, will be entitled to vote at the
Annual Meeting and any adjournment or postponement thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Ikena Oncology, Inc. is following the Securities and Exchange Commission&#146;s &#147;Notice
and Access&#148; rule that allows companies to furnish their proxy materials by posting them on the Internet. As a result, we are mailing to our stockholders a Notice of Internet Availability of Proxy Materials, or the Notice, instead of a paper
copy of the accompanying proxy statement and our Annual Report for the fiscal year ended December&nbsp;31, 2021, or 2021 Annual Report. We plan to mail the Notice on or about April&nbsp;27, 2022, and it contains instructions on how to access both
the 2021 Annual Report and accompanying proxy statement over the Internet. This method provides our stockholders with expedited access to proxy materials and not only lowers the cost of printing and distribution but also reduces the environmental
impact of the Annual Meeting. If you would like to receive a print version of the proxy materials, free of charge, please follow the instructions on the Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Please see the &#147;General Information&#148; section of the proxy statement that accompanies this notice for more details regarding the logistics of the
virtual Annual Meeting, including the ability of stockholders to submit questions during the Annual Meeting, and technical details and support related to accessing the virtual platform. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Your vote is important. Whether or not you expect to attend the virtual meeting, it is important that your shares be represented. To ensure that your vote is
recorded promptly, please vote as soon as possible, even if you plan to attend the meeting, by submitting your proxy via the Internet at the website provided on the proxy card or by signing, dating and returning the proxy card. Even if you have
voted by proxy, you may still vote at the virtual meeting. Please note, however, that if your shares are held through a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record
holder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">By order of the Board of Directors,</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">/s/ Mark Manfredi</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Mark Manfredi, Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman"><I>President and Chief Executive Officer</I></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">Boston, MA </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman">April&nbsp;27,
2022 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_1">PROXY STATEMENT FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS</A></P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_2">GENERAL INFORMATION</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_3">PROPOSAL NO. 1 &#150; ELECTION OF CLASS I DIRECTORS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_4">PROPOSAL NO. 2 &#150; RATIFICATION OF THE APPOINTMENT OF ERNST&nbsp;
&amp; YOUNG LLP AS IKENA ONCOLOGY, INC.&#146;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER&nbsp;31, 2022</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_5">CORPORATE GOVERNANCE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_6">CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_7">PRINCIPAL STOCKHOLDERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_9">REPORT OF THE AUDIT COMMITTEE</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_10">HOUSEHOLDING</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_11">STOCKHOLDER PROPOSALS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc288879_12">OTHER MATTERS</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:18pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g288879g02a02.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>IKENA ONCOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>645 Summer Street, Suite 101 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Boston, MA 02210 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_1">
</A>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE 2022 ANNUAL MEETING OF STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO BE HELD June&nbsp;9, 2022 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy
statement contains information about the 2022 Annual Meeting of Stockholders, or the Annual Meeting, of Ikena Oncology, Inc., which will be held virtually on June&nbsp;9, 2022 at 4:15 p.m. Eastern Time. This year&#146;s Annual Meeting will be held
virtually, both to increase accessibility and encourage participation from our stockholders and due to continuing safety concerns resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. You may attend the Annual Meeting
virtually at www.virutalshareholdermeeting.com/IKNA2022, where you will be able to vote electronically and submit questions. You will need the <FONT STYLE="white-space:nowrap">16-digit</FONT> control number included with the Notice of Internet
Availability of Proxy Materials being mailed to you separately in order to attend the Annual Meeting. The board of directors of Ikena Oncology, Inc. is using this proxy statement to solicit proxies for use at the Annual Meeting. In this proxy
statement, the terms &#147;Ikena,&#148; &#147;Ikena Oncology,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148; refer to Ikena Oncology, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified, the proxies
will be voted in accordance with the recommendation of our board of directors with respect to each of the matters set forth in this proxy statement and the accompanying proxy card. You may revoke your proxy at any time before it is exercised at the
meeting by giving our corporate secretary written notice to that effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This proxy statement and our 2021 Annual Report to Stockholders on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> for the fiscal year ended December&nbsp;31, 2021, or the 2021 Annual Report, are first being mailed to stockholders on or about April&nbsp;27, 2022. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; under applicable federal securities laws and therefore permitted to conform with certain reduced public company
reporting requirements. As an emerging growth company, we provide in this proxy statement the scaled disclosure permitted under the Jumpstart Our Business Startups Act of 2012, the JOBS Act, including the compensation disclosures required of a
&#147;smaller reporting company,&#148; as that term is defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> promulgated under the Securities Exchange Act of 1934, as amended, the Exchange Act. In addition, as an emerging growth company, we
are not required to conduct votes seeking approval, on an advisory basis, of the compensation of our named executive officers or the frequency with which such votes must be conducted. We will remain an &#147;emerging growth company&#148; until the
earliest of (i)&nbsp;the last day of the fiscal year following the fifth anniversary of our initial public offering in March 2021; (ii)&nbsp;the last day of the fiscal year in which our total annual gross revenue is equal to or more than
$1.07&nbsp;billion; (iii)&nbsp;the date on which we have issued more than $1&nbsp;billion in nonconvertible debt during the previous three years; or (iv)&nbsp;the date on which we are deemed to be a large accelerated filer under the rules of the
Securities and Exchange Commission, or the SEC. Even after we are no longer an &#147;emerging growth company,&#148; we may remain a &#147;smaller reporting company.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Important Notice Regarding the Availability of Proxy Materials for </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>the Annual Meeting of Stockholders to be Held on June&nbsp;9, 2022: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>This proxy statement and our 2021 Annual Report to Stockholders are </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>available for viewing, printing and downloading at </B><B><I>www.ProxyVote.com</I></B><B>. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>A copy of this proxy statement and our 2021 Annual Report, as filed with the SEC, except for exhibits, will be furnished without charge to any stockholder
upon written request to Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, Massachusetts 02210, Attention: Corporate Secretary. This proxy statement and our 2021 Annual Report are also available on the SEC&#146;s website at</B><B><I>
www.sec.gov</I></B><B>. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_2"></A>IKENA ONCOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROXY STATEMENT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOR THE
2022 ANNUAL MEETING OF STOCKHOLDERS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL INFORMATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Why are you holding a&nbsp;virtual&nbsp;Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This year&#146;s Annual Meeting will be held virtually, both to increase accessibility and encourage participation from our stockholders and due to continuing
safety concerns resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. We have implemented the virtual format in order to facilitate stockholder attendance at our Annual Meeting. We have designed our virtual format to enhance,
rather than constrain, stockholder access, participation and communication. For example, the virtual format allows stockholders to communicate with us during the Annual Meeting so they can ask questions of our board of directors or management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I attend and participate in the Annual Meeting online? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To attend and participate in the Annual Meeting, stockholders will need to access the live audio webcast of the meeting. To do so, stockholders of record will
need to visit www.virutalshareholdermeeting.com/IKNA2022 and use their control number provided in the proxy card to preregister to this website, and beneficial owners of shares held in street name will need to follow the same instructions.
Registration will open 15 minutes prior to the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The live audio webcast of the Annual Meeting will begin promptly at 4:15 p.m. Eastern Time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I get help if I have trouble checking in or listening to the meeting online? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There will be a support number available on the login page of the virtual meeting 15 minutes before the meeting begins for any shareholders having technical
difficulties. The technical support line will not be able to provide control numbers, but will be able to assist with any technical issues. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When are
this proxy statement and the accompanying materials scheduled to be sent to stockholders? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On or about April&nbsp;27, 2022, we will mail this proxy
statement and the accompanying proxy card or, for shares held in street name (i.e. held for your account by a broker or other nominee), a voting instruction form, and the 2021 Annual Report. These materials are also available for viewing, printing
and downloading on the Internet at <B><I>www.ProxyVote.com</I></B>. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is soliciting my vote? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Board of Directors, or the board of directors, is soliciting your vote for the Annual Meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>When is the record date for the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
record date for determination of stockholders entitled to vote at the Annual Meeting is the close of business on April&nbsp;14, 2022. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How many votes
can be cast by all stockholders? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There were 29,947,826 shares of our voting common stock, par value $0.001 per share, outstanding on April&nbsp;14,
2022, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record is entitled to one vote for each share of our common stock held by such stockholder. As the stockholder of record,
you have the right to grant your voting proxy directly to the individuals listed on the proxy card or vote on your </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
own behalf at our virtual Annual Meeting. None of our shares of preferred stock were outstanding as of April&nbsp;14, 2022. As of April&nbsp;14, 2022, there were 6,215,465 shares of <FONT
STYLE="white-space:nowrap">non-voting</FONT> common stock, par value $0.001 per share, outstanding. The shares of <FONT STYLE="white-space:nowrap">non-voting</FONT> stock are not entitled to vote on the proposals presented at the Annual Meeting.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who is entitled to vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Registered
Stockholders</I>.&nbsp;If shares of our voting common stock are registered directly in your name with our transfer agent, you are considered the stockholder of record with respect to those shares. As the stockholder of record, you have the right to
grant your voting proxy directly to the individuals listed on the proxy card or vote on your own behalf at our virtual Annual Meeting. Throughout this proxy statement, we refer to these registered stockholders as &#147;stockholders of record.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Street Name Stockholders</I>.&nbsp;If shares of our voting common stock are held on your behalf in a brokerage account or by a bank or other nominee,
you are considered to be the beneficial owner of shares that are held in &#147;street name,&#148; and the proxy materials were forwarded to you by your broker or nominee, who is considered the stockholder of record with respect to those shares. As
the beneficial owner, you have the right to direct your broker, bank or other nominee as to how to vote your shares. Beneficial owners are also invited to attend our virtual Annual Meeting. However, since a beneficial owner is not the stockholder of
record, you may not vote your shares of our common stock on your own behalf at the Annual Meeting unless you follow your broker&#146;s procedures for obtaining a legal proxy. Note you should also be receiving a voting instruction form for you to use
from your broker. Throughout this proxy statement, we refer to stockholders who hold their shares through a broker, bank or other nominee as &#147;street name stockholders.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I vote? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a stockholder of record, there
are four ways to vote: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Internet. </I></B>You may vote at www.ProxyVote.com, 24 hours a day, seven days a week. Use the Internet
to transmit your voting instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the meeting date. You will need the control number included on your proxy card. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>During the Annual Meeting. </I></B>You may vote during the Annual Meeting by going to
www.virutalshareholdermeeting.com/IKNA2022. You will need the control number included on your proxy card. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Telephone. </I></B>You may vote using a touch-tone telephone by calling
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903,</FONT></FONT></FONT> 24 hours a day, seven days a week. Use any touch-tone telephone to transmit your voting instructions up until
11:59 p.m. Eastern Time the day before the meeting date. You will need the control number included on your proxy card. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B><I>By Mail</I></B>. You may vote by completing and mailing your proxy card. Mark, sign and date your proxy
card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Even if you plan to participate in our virtual Annual Meeting, we recommend that you also vote by proxy so that your vote will be counted if you later decide
not to participate in the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you are a street name stockholder, you will receive voting instructions from your broker, bank or other
nominee. You must follow the voting instructions provided by your broker, bank or other nominee in order to instruct your broker, bank or other nominee on how to vote your shares. Street name stockholders should generally be able to vote by
returning an instruction card, or by telephone or on the Internet. However, the availability of telephone and Internet voting will depend on the voting process of your broker, bank or other nominee. As discussed above, if you are a street name
stockholder, you may not vote your shares on your own behalf at the Annual Meeting unless you obtain a legal proxy from your broker, bank or other nominee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>By Proxy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you will not be attending the Annual Meeting, you may vote by proxy. You can vote by proxy over the Internet by following the instructions provided in the
enclosed proxy card. Proxies submitted by mail must be received before the start of the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you complete and submit your proxy before the
Annual Meeting, the persons named as proxies will vote the shares represented by your proxy in accordance with your instructions. If you submit a proxy without giving voting instructions, your shares will be voted in the manner recommended by the
board of directors on all matters presented in this proxy statement, and as the persons named as proxies may determine in their discretion with respect to any other matters properly presented at the Annual Meeting. You may also authorize another
person or persons to act for you as proxy in a writing, signed by you or your authorized representative, specifying the details of those proxies&#146; authority. The original writing must be given to each of the named proxies, although it may be
sent to them by electronic transmission if, from that transmission, it can be determined that the transmission was authorized by you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If any other
matters are properly presented for consideration at the Annual Meeting, including, among other things, consideration of a motion to adjourn the Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting
additional proxies), the persons named in your proxy and acting thereunder will have discretion to vote on those matters in accordance with their best judgment. We do not currently anticipate that any other matters will be raised at the Annual
Meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How do I revoke my proxy? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may revoke
your proxy by (1)&nbsp;entering a new vote by mail that we receive before the start of the Annual Meeting or over the Internet or via telephone, (2)&nbsp;attending and voting at the Annual Meeting online (although attendance at the Annual Meeting
will not in and of itself revoke a proxy), or (3)&nbsp;by filing an instrument in writing revoking the proxy or another duly executed proxy bearing a later date with our Corporate Secretary. Any written notice of revocation or subsequent proxy card
must be received by our Corporate Secretary prior to the taking of the vote at the Annual Meeting. Such written notice of revocation or subsequent proxy card should be sent to our principal executive offices at Ikena Oncology, Inc., 645 Summer
Street, Suite 101, Boston, Massachusetts 02210, Attention: Corporate Secretary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a broker, bank, or other nominee holds your shares, you must contact
such broker, bank, or nominee in order to find out how to change your vote. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How is a quorum reached? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Amended and Restated Bylaws, or bylaws, provide that a majority of the shares entitled to vote, present or represented by proxy, will constitute a quorum
for the transaction of business at the Annual Meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under the Delaware General Corporation Law, shares that are voted &#147;abstain&#148; or
&#147;withheld&#148; and broker <FONT STYLE="white-space:nowrap">&#147;non-votes&#148;</FONT> are counted as present for purposes of determining whether a quorum is present at the Annual Meeting. If a quorum is not present, the meeting may be
adjourned until a quorum is obtained. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How is the vote counted? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Under our bylaws, any proposal other than an election of directors is decided by a majority of the votes properly cast for and against such proposal, except
where a larger vote is required by law or by our Fifth Amended and Restated Certificate of Incorporation, or certificate of incorporation, or bylaws. Abstentions and broker <FONT STYLE="white-space:nowrap">&#147;non-votes&#148;</FONT> are not
included in the tabulation of the voting results on any such proposal and, therefore, do not have an impact on such proposals. A broker <FONT STYLE="white-space:nowrap">&#147;non-vote&#148;</FONT> occurs when a nominee holding shares for a
beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item, and has not received instructions from the beneficial owner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If your shares are held in &#147;street name&#148; by a brokerage firm, your brokerage firm is required to
vote your shares according to your instructions. If you do not give instructions to your brokerage firm, the brokerage firm will still be able to vote your shares with respect to certain &#147;discretionary&#148; items, but will not be allowed to
vote your shares with respect to <FONT STYLE="white-space:nowrap">&#147;non-discretionary&#148;</FONT> items. Proposal No.&nbsp;1 is a <FONT STYLE="white-space:nowrap">&#147;non-discretionary&#148;</FONT> item. If you do not instruct your broker how
to vote with respect to this proposal, your broker may not vote for this proposal, and those votes will be counted as broker <FONT STYLE="white-space:nowrap">&#147;non-votes.&#148;</FONT> Proposal No.&nbsp;2 is considered to be a discretionary item,
and your brokerage firm will be able to vote on this proposal even if it does not receive instructions from you. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To be elected, the directors nominated
via Proposal No.&nbsp;1 must receive a plurality of the votes cast and entitled to vote on the proposal, meaning that the director nominees receiving the most votes will be elected. Shares voting &#147;withheld&#148; have no effect on the election
of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Who pays the cost for soliciting proxies? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We are making this solicitation and will pay the entire cost of preparing and distributing our proxy materials and soliciting votes. If you choose to access
the proxy materials or vote over the Internet, you are responsible for any Internet access charges that you may incur. Our officers and employees may, without compensation other than their regular compensation, solicit proxies through further
mailings, personal conversations, facsimile transmissions, <FONT STYLE="white-space:nowrap">e-mails,</FONT> or otherwise. Proxy solicitation expenses that we will pay include those for preparation, mailing, returning, and tabulating the proxies.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How may stockholders submit matters for consideration at an Annual Meeting? </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The required notice must be in writing and received by our corporate secretary at our principal executive offices not less than 90 days nor more than 120 days
prior to the first anniversary of the preceding year&#146;s annual meeting. However, in the event that the date of the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding
year&#146;s annual meeting, or if no annual meeting were held in the preceding year, a stockholder&#146;s notice must be so received no earlier than the 120th day prior to such annual meeting and not later than the close of business on the later of
(A)&nbsp;the 90th day prior to such annual meeting and (B)&nbsp;the tenth day following the day on which notice of the date of such annual meeting was mailed or public disclosure of the date of such annual meeting was made, whichever first occurs.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, any stockholder proposal intended to be included in the proxy statement for the next annual meeting of our stockholders in 2023 must also
satisfy the requirements of SEC Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and be received not later than December&nbsp;28, 2022. If the date of the annual meeting
is moved by more than 30 days from the date contemplated at the time of the previous year&#146;s proxy statement, then notice must be received within a reasonable time before we begin to print and send proxy materials. If that happens, we will
publicly announce the deadline for submitting a proposal in a press release or in a document filed with the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>How can I find out the results of the
voting at the Annual Meeting? </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We plan to announce preliminary voting results at the Annual Meeting. Final voting results will be published in a
Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> or Form <FONT STYLE="white-space:nowrap">8-K,</FONT> that we expect to file with the SEC within four business days after the Annual Meeting. If final voting results are not
available to us in time to file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> within four business days after the Annual Meeting, we intend to file a Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish preliminary results and, within
four business days after the final results are known to us, file an additional Form <FONT STYLE="white-space:nowrap">8-K</FONT> to publish the final results. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_3"></A>PROPOSAL NO. 1 &#150; ELECTION OF CLASS I DIRECTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors currently consists of eight members. In accordance with the terms of our certificate of incorporation and bylaws, our board of
directors is divided into three classes, Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, with members of each class serving staggered three-year terms. The members of the classes are divided as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;I directors are Iain Dukes, D.Phil, Maria Koehler, M.D., and Otello Stampacchia, Ph.D., and their
terms will expire at the Annual Meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;II directors are David Bonita, Jean-Francois Formela, M.D., and Richard Wooster, Ph.D., and their
terms will expire at the annual meeting of stockholders to be held in 2023; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;III directors are Mark Manfredi, Ph.D. and Ronald C. Renaud, Jr., and their terms will expire at
the annual meeting of stockholders to be held in 2024. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the expiration of the term of a class of directors, directors in that class
will be eligible to be elected for a new three-year term at the annual meeting of stockholders in the year in which their term expires. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our certificate
of incorporation and bylaws provide that the authorized number of directors may be changed only by resolution of our board of directors. Our certificate of incorporation also provides that our directors may be removed only for cause by the
affirmative vote of the holders of at least two thirds (2/3) or more of the outstanding shares then entitled to vote in an annual election of directors, and that any vacancy on our board of directors, including a vacancy resulting from an
enlargement of our board of directors, may be filled only by vote of a majority of our directors then in office. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has nominated
Iain Dukes, D.Phil, Maria Koehler, M.D., and Otello Stampacchia, Ph.D. for <FONT STYLE="white-space:nowrap">re-election</FONT> as a Class&nbsp;I director at the Annual Meeting. The nominees are presently directors, and have indicated a willingness
to continue to serve as directors, if elected. If the nominees become unable or unwilling to serve, however, the proxies may be voted for substitute nominees selected by our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our Nominating and Corporate Governance Committee Policies and Procedures for Director Candidates, or the Director Guidelines, provide that the value of
diversity should be considered in determining director candidates as well as other factors such as a candidate&#146;s character, judgment, skills, education, expertise and absence of conflicts of interest. However, we do not have a formal policy
concerning the diversity of the board of directors. Our priority in selection of board members is identification of members who will further the interests of our stockholders through their established records of professional accomplishment, their
ability to contribute positively to the collaborative culture among board members, and their knowledge of our business and understanding of the competitive landscape in which we operate and adherence to high ethical standards. Although the
nominating and corporate governance committee does not have a formal diversity policy and does not follow any ratio or formula with respect to diversity in order to determine the appropriate composition of the board of directors, the nominating and
corporate governance committee and the full board of directors are committed to creating a board of directors with diversity, including diversity of expertise, experience, background, race and gender, and are committed to identifying, recruiting and
advancing candidates offering such diversity in future searches. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Diversity Matrix </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="99%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9" ALIGN="right"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="right">As of April&nbsp;14, 2022</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total
Number of Directors</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>8</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Female</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Male</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B><FONT STYLE="white-space:nowrap">Non-</FONT><BR>Binary</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><B>Did Not<BR>Disclose<BR>Gender</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" COLSPAN="9" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Part I: Gender Identity</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directors</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">7</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" COLSPAN="9" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="9" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt; padding-right:2pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Part II: Demographic Background</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">African
American or Black</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alaskan
Native or Native American</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Asian</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hispanic
or Latinx</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Native
Hawaiian or Pacific Islander</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">White</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">7</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Two or
More Races or Ethnicities</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="8" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>LGBTQ+</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="2" COLSPAN="8" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Did Not Disclose Demographic Background</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="7" NOWRAP ALIGN="center" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition to the information presented below regarding each of the nominees and continuing directors&#146; specific
experience, qualifications, attributes and skills that our board of directors and our nominating and corporate governance committee considered in determining that he or she should serve as a director, we also believe that each of our directors has
demonstrated business acumen, integrity and an ability to exercise sound judgment, as well as a commitment of service to our company and our board of directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nominee for Election as Class&nbsp;I Director </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
following table identifies our director nominees, and sets forth their principal occupation and business experience during the last five years and age as of April&nbsp;14, 2022. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"><B>Positions&nbsp;and&nbsp;Offices&nbsp;Held&nbsp;with&nbsp;Ikena<BR>Oncology, Inc.</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director<BR>Since</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Iain Dukes, D.Phil.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2016</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">63</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Koehler, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">65</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Otello Stampacchia, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">52</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Iain D. Dukes, D.Phil</I></B><B>.</B>&nbsp;has served as a member of our board of directors since November 2016.
Dr.&nbsp;Dukes is a Venture Partner at OrbiMed Advisors LLC, which he joined in August 2016. Dr.&nbsp;Dukes has served as the Chief Executive Officer of Viriom Inc. since February 2019 and has also served as the Executive Chairman of Angiex Inc.
since February 2020. In June 2018, <FONT STYLE="white-space:nowrap">Dr.&nbsp;Dukes&nbsp;co-founded&nbsp;Theseus</FONT> Pharmaceuticals, Inc. and currently serves as the Chief Executive Officer. In September 2017, Dr,
<FONT STYLE="white-space:nowrap">Dukes&nbsp;co-founded&nbsp;Kartos</FONT> Therapeutics, Inc. and currently serves as President. Dr.&nbsp;Dukes previously served as Senior Vice President and Head of Business Development and Licensing for Merck
Research Laboratories from August 2013 through May 2016. Prior to joining Merck, Dr.&nbsp;Dukes was Vice President of External Research&nbsp;&amp; Development at Amgen, Inc. from August 2010 to August 2013. From October 2017 to July 2020,
Dr.&nbsp;Dukes was a board member and Chairman of KaNDy Therapeutics, which was acquired by Bayer AG in September 2020. From January 2020 to June 2020, Dr.&nbsp;Dukes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
served as supervisory board member of Themis BioScience GmbH, until it was acquired by Merck&nbsp;&amp; Co. Dr.&nbsp;Dukes <FONT STYLE="white-space:nowrap">also&nbsp;co-founded&nbsp;Telios</FONT>
Pharmaceuticals, Inc., where he serves as President. Dr.&nbsp;Dukes currently serves on the boards of directors of NeRRe Therapeutics, ReViral Limited, and ENYO Therapeutics. Since August 2016, Dr.&nbsp;Dukes has also served as chairman of the board
of directors of Iovance Biotherapeutics Inc. (Nasdaq: IOVA). Dr.&nbsp;Dukes holds Master of Jurisprudence and Doctor of Philosophy degrees from the University of Oxford, a Master of Science degree in Cardiovascular Studies from the University of
Leeds and a Bachelor of Science degree in Pharmacology from the University of Bath. We believe that Dr.&nbsp;Dukes is qualified to serve as a member of our board of directors because of his extensive experience in the pharmaceutical industry,
including his service in senior management roles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Maria Koehler, M.D., Ph.D.</I></B>, has served on our Board of Directors since April 2021.
Dr.&nbsp;Koehler is a board-certified hematologist/oncologist and has more than 20 years of pharmaceutical and biotechnology experience. Since May 2019, Dr.&nbsp;Koehler has been Chief Medical Officer at Repare Therapeutics, Inc., a public precision
oncology company. Prior to joining Repare, Dr.&nbsp;Koehler was Chief Medical Officer at Bicycle Therapeutics Limited, a public biopharmaceutical company, from September 2017 to April 2019, and before that had roles of increasing responsibility at
Pfizer Inc. from 2009 through 2017, most recently as Vice President of Oncology Strategy, Innovation and Collaborations. Prior to joining Pfizer, Dr.&nbsp;Koehler was the group leader for the Medicine Development Center of GlaxoSmithKline Oncology.
Prior to that, Dr.&nbsp;Koehler was a Senior Medical Director for oncology research and development at AstraZeneca plc. She has also served as the clinical director of Bone Marrow Transplantation at University Hospital in Pittsburgh as well as the
director of the Bone Marrow Transplant Program and associate professor at St. Christopher&#146;s Hospital in Philadelphia. Dr.&nbsp;Koehler earned an M.D., and a Ph.D. in Toxicology from Silesian School of Medicine, Katowice, Poland. She received
her initial training in immunology/oncology at the University of Heidelberg in Heidelberg, Germany, and additional training at St. Jude Children&#146;s Research Hospital in the department of virology and molecular biology. Dr.&nbsp;Koehler currently
serves on the board of directors of Silverback Therapeutics, Inc.&nbsp;We believe Dr.&nbsp;Koehler is qualified to serve on our board of directors because of her management experience in the biopharmaceuticals industry and her biotech oncology
experience in clinical drug development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Otello Stampacchia, Ph.D</I></B><B>.</B>&nbsp;has served as a member of our board of directors since
December 2020. Dr.&nbsp;Stampacchia is founder, Managing Director, and member of the investment committee at Omega Funds. Dr.&nbsp;Stampacchia currently serves on the board of directors of Kronos Bio, Inc. (Nasdaq: KRON), Morphic Holding, Inc.
(Nasdaq: MORF), and Replimune Group, Inc. (Nasdaq: REPL), and private companies: Amunix Pharmaceuticals, Inc. and Scorpion Therapeutics, Inc. Prior to founding Omega in January 2004, Dr.&nbsp;Stampacchia was a Partner at AlpInvest Partners (now part
of The Carlyle Group). Before AlpInvest Partners, he was the portfolio manager of the Lombard Odier Immunology Fund, an investment vehicle in Geneva, Switzerland, investing in public and private healthcare companies worldwide. Previously,
Dr.&nbsp;Stampacchia was a member of the HealthCare corporate finance and M&amp;A team at Goldman Sachs. Before Goldman, he <FONT STYLE="white-space:nowrap">helped&nbsp;co-found&nbsp;the</FONT> healthcare investment activities at Index Securities
(now Index Ventures). Dr.&nbsp;Stampacchia received a Masters of Science in Plant Genetics from the University of Pavia, a Masters of Science in Molecular Biology and a Doctorate of Philosophy in Molecular Biology from the University of Geneva and a
Doctorate of Philosophy in Biotechnology from European Union Strasbourg. We believe Dr.&nbsp;Stampacchia is qualified to serve on our board of directors because of his venture capital experience in the life sciences industry and his service on the
boards of other public and private life sciences companies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The proxies will be voted in favor of the above nominees unless a contrary specification is
made in the proxy. The nominees have consented to serve as our directors if elected. However, if the nominees are unable to serve or for good cause will not serve as a director, the proxies will be voted for the election of such substitute nominee
as our board of directors may designate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The board of directors recommends voting &#147;FOR&#148; the election of Iain Dukes, D.Phil, Maria Koehler,
M.D., and Otello Stampacchia, Ph.D. as Class&nbsp;I directors, to serve for a three-year term ending at the annual meeting of stockholders to be held in 2025. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directors Continuing in Office </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table identifies our directors, and sets forth their principal occupation and business experience during the last five years and their ages as of
April&nbsp;14, 2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Positions&nbsp;and&nbsp;Offices&nbsp;Held&nbsp;with Ikena<BR>Oncology, Inc.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Director<BR>Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Class&nbsp;and&nbsp;Year<BR>in&nbsp;Which&nbsp;Term<BR>Will Expire</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald C. Renaud, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chairman of the Board of Directors and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Class&nbsp;III&#151;2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Manfredi, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Class&nbsp;III&#151;2024</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Bonita, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Class&nbsp;II&#151;2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jean-Fran&ccedil;ois Formela, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2016</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Class&nbsp;II&#151;2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Wooster, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center">Class&nbsp;II&#151;2023</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;II Directors (Term Expires at 2023 Annual Meeting) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>David Bonita, M.D.</I></B>&nbsp;has served as a member of our board of directors since March 2016. Dr.&nbsp;Bonita is a member of OrbiMed Advisors LLC,
an investment firm. Dr.&nbsp;Bonita currently serves on the boards of directors of Acutus Medical Inc. (Nasdaq: AFIB), IMARA Inc. (Nasdaq: IMRA), Prelude Therapeutics, Inc. (Nasdaq: PRLD), Repare Therapeutics Inc. (Nasdaq: RPTX), and Tricida, Inc.
(Nasdaq: TCDA), as well as several private companies. Dr.&nbsp;Bonita also previously served on the boards of directors of Clementia Pharmaceuticals Inc., Loxo Oncology, <FONT STYLE="white-space:nowrap">Inc.,&nbsp;SI-BONE,&nbsp;Inc.,</FONT> and
ViewRay Inc. Prior to OrbiMed, Dr.&nbsp;Bonita worked as a corporate finance analyst in the healthcare investment banking groups of Morgan Stanley and UBS. He has published scientific articles in peer-reviewed journals based on signal transduction
research performed at Harvard Medical School. He received his B.A. in biology from Harvard University and his joint M.D./M.B.A. from Columbia University. We believe that Dr.&nbsp;Bonita is qualified to serve on our board of directors based on his
roles on several public and private boards of directors as well as his extensive experience in investing in healthcare companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jean-Fran&ccedil;ois Formela, M.D.</I></B><I></I>&nbsp;has served as a member of our board of directors and as a member of our audit committee since
March 2016. Dr.&nbsp;Formela is currently a Partner at Atlas Venture and focuses on novel drug discovery approaches and therapeutics. Dr.&nbsp;Formela joined Atlas Venture in 1993 to build the U.S. life sciences<B><I> </I></B>franchise.
Dr.&nbsp;Formela is a director <FONT STYLE="white-space:nowrap">and&nbsp;co-founder&nbsp;of</FONT> IFM Therapeutics, Inc., Intellia Therapeutics, Inc. (Nasdaq: NTLA), Korro Bio, Inc., Triplet Therapeutics, Inc. and Translate Bio, Inc. (Nasdaq:
TBIO). Dr.&nbsp;Formela also serves on the board of Spero Therapeutics, Inc. (Nasdaq: SPRO). Dr.&nbsp;Formela is a member of the Partners Healthcare Innovation Growth Board and a former trustee of the Boston Institute of Contemporary Art.
Dr.&nbsp;Formela received his Doctor of Medicine from Paris University School of Medicine and his Master of Business Administration from Columbia University. We believe Dr.&nbsp;Formela&#146;s experience in the life sciences industry, as well as his
practice of medicine, provides him with the qualifications and skills to serve as a director of our Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Richard Wooster, Ph.D.</I></B>, has
served as a member of our board of directors since January 2022. From April 2019 to October 2021, Dr.&nbsp;Wooster served as the Chief Scientific Officer of Translate Bio, Inc. Prior to that, from March 2015 to April 2019, Dr.&nbsp;Wooster served as
the President of Research and Development and Chief Scientific Officer at Tarveda Therapeutics, Inc., a biopharmaceutical company (formerly known as Blend Therapeutics, Inc.). From May 2013 until March 2015, he acted as the Chief Scientific Officer
of Tarveda Therapeutics and as its President from January 2014 to March 2015. Prior to joining Tarveda Therapeutics, Dr.&nbsp;Wooster was Vice President and Discovery Performance Unit Head in Oncology at GlaxoSmithKline plc, a pharmaceutical
company. During his academic career, Dr.&nbsp;Wooster discovered the breast cancer susceptibility gene BRCA2, was one of the founders of the Cancer Genome Project at the Welcome Trust Sanger Institute where mutations in BRAF were first discovered
and developed the COSMIC mutation database and website. Dr.&nbsp;Wooster received a BSc in Biochemistry and a Ph.D. in drug metabolizing enzymes from the University of Dundee, Scotland. We believe Dr.&nbsp;Wooster is qualified to serve on our board
of directors based on his experience in drug discovery and development and his management experience in the life sciences industry. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Class&nbsp;III Directors (Term Expires at 2024 Annual Meeting) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ronald C. Renaud, Jr.</I></B>&nbsp;has served as Chairman of our board of directors and as a member of our audit and compensation committees since March
2018. From November 2014, Mr.&nbsp;Renaud served as President and Chief Executive Officer and as a member of the board of directors of Translate Bio, Inc. until it was acquired by Sanofi in September 2021. Mr.&nbsp;Renaud currently serves as a
member of the board of directors of Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Axial Biotherapeutics, Inc. Formerly, Mr.&nbsp;Renaud served as President and Chief Executive Officer of Idenix Pharmaceuticals, Inc., a biopharmaceutical company,
from October 2010 until Idenix was acquired by Merck&nbsp;&amp; Co., a pharmaceutical company, in August 2014. He was previously Chief Financial Officer and Chief Business Officer of Idenix Pharmaceuticals, Inc. from May 2007 until October 2010.
Mr.&nbsp;Renaud has also previously served as a member of the boards of directors of Akebia Therapeutics, Inc. (Nasdaq: AKBA), PTC Therapeutics, Inc. (Nasdaq: PTCT), and Chimerix, Inc. (Nasdaq: CMRX). Mr.&nbsp;Renaud received a Bachelor of Arts from
St. Anselm College and a Master of Business Administration from the Marshall School of Business at the University of Southern California. We believe that Mr.&nbsp;Renaud is qualified to serve on our board of directors because of his executive
experience, his service on the boards of other private and public life sciences companies and his extensive knowledge of the life sciences industry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Mark Manfredi, Ph.D.</I></B>&nbsp;is a founding member of Ikena Oncology and has served as our President and Chief Executive Officer, and as a member of
our board of directors since December 2017. Previously, Dr.&nbsp;Manfredi served as our Chief Scientific Officer from March 2016 until December 2017. Prior to that, from April 2015 to September 2017, Dr.&nbsp;Manfredi was <FONT
STYLE="white-space:nowrap">an&nbsp;in-house&nbsp;oncology</FONT> expert at Atlas Venture, a company that has founded multiple biotechnology companies and Dr.&nbsp;Manfredi currently serves as an advisor to Atlas Venture. Concurrently, from April
2015 to April 2016, Dr.&nbsp;Manfredi was the Chief Scientific Officer of Raze Therapeutics, Inc., a biotechnology company focused on oncology therapeutics that target key metabolic pathways. He also previously held roles of increasing
responsibility at Millennium Pharmaceuticals, Inc., as well as its parent company, Takeda Pharmaceutical Company from April 2001 to April 2015. Dr.&nbsp;Manfredi holds a Bachelor of Science in Zoology from the University of Rhode Island, and a
Doctorate of Philosophy from Boston College. We believe that Dr.&nbsp;Manfredi is qualified to serve as our President and Chief Executive Officer and as a member of our board of directors because of his significant scientific and industry knowledge,
as well as valuable experience gained from prior service as President and Chief Executive Officer.<B><I> </I></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no family relationships
between or among any of our directors or executive officers. The principal occupation and employment during the past five years of each of our directors was carried on, in each case except as specifically identified above, with a corporation or
organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement or understanding between any of our directors and any other person or persons pursuant to which he or she is to be selected as a director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no material legal proceedings to which any of our directors is a party adverse to us or any of our subsidiaries or in which any such person has a
material interest adverse to us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_4"></A>PROPOSAL NO. 2 &#150; RATIFICATION OF THE APPOINTMENT OF
ERNST&nbsp;&amp; YOUNG LLP AS IKENA ONCOLOGY, INC.&#146;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER&nbsp;31, 2022 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ikena&#146;s stockholders are being asked to ratify the appointment by the audit committee of the board of directors of Ernst&nbsp;&amp; Young LLP as
Ikena&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2022. Ernst&nbsp;&amp; Young LLP has served as Ikena&#146;s independent registered public accounting firm since 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee is solely responsible for selecting Ikena&#146;s independent registered public accounting firm for the fiscal year ending
December&nbsp;31, 2022. Stockholder approval is not required to appoint Ernst&nbsp;&amp; Young LLP as Ikena&#146;s independent registered public accounting firm. However, the board of directors believes that submitting the appointment of
Ernst&nbsp;&amp; Young LLP to the stockholders for ratification is good corporate governance. If the stockholders do not ratify this appointment, the audit committee will reconsider whether to retain Ernst&nbsp;&amp; Young LLP. If the selection of
Ernst&nbsp;&amp; Young LLP is ratified, the audit committee, at its discretion, may direct the appointment of a different independent registered public accounting firm at any time it decides that such a change would be in the best interest of Ikena
and its stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A representative of Ernst&nbsp;&amp; Young LLP is expected to be present at the Annual Meeting and will have an opportunity to make
a statement if he or she desires to do so and to respond to appropriate questions from our stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ikena incurred the following fees from
Ernst&nbsp;&amp; Young LLP for the audit of the financial statements and for other services provided during the years ended December&nbsp;31, 2021 and 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2021</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit fees (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,313,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">596,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit-Related fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax fees (2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All other fees (3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,319,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">607,850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Audit fees consist of fees billed for the audit of our annual financial statements, the review of our interim
financial statements included in our quarterly reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> and services in connection with the Company&#146;s initial public offering, securities offerings, including registration statements,
responding to SEC comment letters, comfort letters and consents. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Tax fees consist of fees for tax compliance, advice and tax planning and includes fees for tax return
preparation. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Other fees consist of the annual subscription fee for Ernst&nbsp;&amp; Young&#146;s online accounting research
tool. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Audit Committee <FONT STYLE="white-space:nowrap">Pre-approval</FONT> Policy and Procedures </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our audit committee has adopted policies and procedures relating to the approval of all audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services
that are to be performed by our independent registered public accounting firm. This policy provides that we will not engage our independent registered public accounting firm to render audit or <FONT STYLE="white-space:nowrap">non-audit</FONT>
services unless the service is specifically approved in advance by our audit committee or the engagement is entered into pursuant to the <FONT STYLE="white-space:nowrap">pre-approval</FONT> procedure described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">From time to time, our audit committee may <FONT STYLE="white-space:nowrap">pre-approve</FONT> specified types of services that are expected to be provided to
us by our independent registered public accounting firm during the next 12 months. Any such <FONT STYLE="white-space:nowrap">pre-approval</FONT> details the particular service or type of services to be provided and is also generally subject to a
maximum dollar amount. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During our 2021 and 2020 fiscal years, no services were provided to us by Ernst&nbsp;&amp; Young LLP other
than in accordance with the <FONT STYLE="white-space:nowrap">pre-approval</FONT> policies and procedures described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>The board of directors
recommends voting &#147;FOR&#148; Proposal No.&nbsp;2 to ratify the appointment of Ernst&nbsp;&amp; Young LLP as Ikena Oncology, Inc.&#146;s independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2022. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_5"></A>CORPORATE GOVERNANCE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Nomination Process </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our nominating and corporate
governance committee is responsible for identifying individuals qualified to serve as directors, consistent with criteria approved by our board of directors, and recommending such persons to be nominated for election as directors, except where we
are legally required by contract, law or otherwise to provide third parties with the right to nominate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The process followed by our nominating and
corporate governance committee to identify and evaluate director candidates includes requests to board members and others for recommendations, meetings from time to time to evaluate biographical information and background material relating to
potential candidates, and interviews of selected candidates by management, recruiters, members of the committee and our board of directors. The qualifications, qualities and skills that our nominating and corporate governance committee believes must
be met by a committee-recommended nominee for a position on our board of directors are as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominees should demonstrate high standards of personal and professional ethics and integrity.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominees should have proven achievement and competence in the nominee&#146;s field and the ability to exercise
sound business judgment. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominees should have skills that are complementary to those of the existing board. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominees should have the ability to assist and support management and make significant contributions to the
Company&#146;s success. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Nominees should have an understanding of the fiduciary responsibilities that are required of a member of the
board of directors and the commitment of time and energy necessary to diligently carry out those responsibilities. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Stockholders may
recommend individuals to the nominating and corporate governance committee for consideration as potential director candidates. Any such proposals should be submitted to our corporate secretary at our principal executive offices no later than the
close of business on the 90th day nor earlier than the close of business on the 120th day prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the date of the preceding year&#146;s annual meeting and should include
appropriate biographical and background material to allow the nominating and corporate governance committee to properly evaluate the potential director candidate and the number of shares of our stock beneficially owned by the stockholder proposing
the candidate. Stockholder proposals should be addressed to Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, MA 02210, Attention: Corporate Secretary. Assuming that biographical and background material has been provided on a timely basis
in accordance with our bylaws, any recommendations received from stockholders will be evaluated in the same manner as potential nominees proposed by the nominating and corporate governance committee. If our board of directors determines to nominate
a stockholder-recommended candidate and recommends his or her election, then his or her name will be included on our proxy card for the next annual meeting of stockholders. See &#147;Stockholder Proposals&#148; for a discussion of submitting
stockholder proposals. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
common stock is listed on The Nasdaq Global Market. Under the Nasdaq listing rules, independent directors must comprise a majority of a listed company&#146;s board of directors within twelve months from the date of listing. In addition, the Nasdaq
listing rules require that, subject to specified exceptions, each member of a listed company&#146;s audit, compensation and nominating and corporate governance committees be independent within twelve months from the date of listing. Audit committee
members must also satisfy additional independence criteria, including those set forth in Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Securities Exchange Act of 1934, as amended, or the Exchange Act, and compensation committee
members must also satisfy the independence criteria set forth in Rule <FONT STYLE="white-space:nowrap">10C-1</FONT> under the Exchange Act. Under Nasdaq listing rules, a director will only qualify as an &#147;independent
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
director&#148; if, in the opinion of that company&#146;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying
out the responsibilities of a director. In order to be considered independent for purposes of Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> under the Exchange Act, a member of an audit committee of a listed company may not, other than in his or
her capacity as a member of the audit committee, the board of directors, or any other board committee: (1)&nbsp;accept, directly or indirectly, any consulting, advisory, or other compensatory fee from the listed company or any of its subsidiaries,
other than compensation for board service; or (2)&nbsp;be an affiliated person of the listed company or any of its subsidiaries. In order to be considered independent for purposes of Rule <FONT STYLE="white-space:nowrap">10C-1,</FONT> the board of
directors must consider, for each member of a compensation committee of a listed company, all factors specifically relevant to determining whether a director has a relationship to such company which is material to that director&#146;s ability to be
independent from management in connection with the duties of a compensation committee member, including, but not limited to: the source of compensation of the director, including any consulting advisory or other compensatory fee paid by such company
to the director, and whether the director is affiliated with the company or any of its subsidiaries or affiliates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In April 2022, our board of directors
undertook a review of the composition of our board of directors and its committees and the independence of each director. Based upon information requested from and provided by each director concerning his or her background, employment and
affiliations, including family relationships, our board of directors has determined that all members of the board of directors, except Mark Manfredi, Ph.D., are independent directors, including for purposes of Nasdaq and the SEC rules. In making
that determination, our board of directors considered the relationships that each director has with us and all other facts and circumstances the board of directors deemed relevant in determining independence, including the potential deemed
beneficial ownership of our capital stock by each director and respective affiliations, including <FONT STYLE="white-space:nowrap">non-employee</FONT> directors that are affiliated with certain of our major stockholders. We expect that the
composition and functioning of our board of directors and each of our committees will continue to comply with all applicable requirements of Nasdaq and the rules and regulations of the SEC. There are no family relationships among any of our
directors or executive officers. Mark Manfredi, Ph.D. is not an independent director under these rules because he is currently employed as the chief executive officer and president of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors has established
an audit committee, a compensation committee, and a nominating and corporate governance committee, each of which operate pursuant to a charter adopted by our board of directors. We believe that the composition and functioning of all of our
committees comply with the applicable requirements of Nasdaq, the Sarbanes-Oxley Act of 2002 and SEC rules and regulations that are applicable to us. We intend to comply with future requirements to the extent they become applicable to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full text of our audit committee charter, compensation committee charter and nominating and corporate governance charter is posted on the investor
relations portion of our website at <I>www.ikenaoncology.com</I>. We do not incorporate the information contained on, or accessible through, our corporate website into this prospectus, and you should not consider it a part of this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Jean-Francois Formela, M.D.,
Ronald C. Renaud, Jr., and Otello Stampacchia, Ph.D. serve on the audit committee, which is chaired by Mr.&nbsp;Renaud. Our board of directors has determined that each member of the audit committee is &#147;independent&#148; for audit committee
purposes as that term is defined in the rules of the SEC and the applicable Nasdaq rules, and each has sufficient knowledge in financial and auditing matters to serve on the audit committee. Our board of directors has designated Mr.&nbsp;Renaud as
an &#147;audit committee financial expert,&#148; as defined under the applicable rules of the SEC. During the fiscal year ended December&nbsp;31, 2021, the audit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
committee met four times. The report of the audit committee is included in this proxy statement under &#147;Report of the Audit Committee.&#148; The audit committee&#146;s responsibilities
include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, approving the compensation of, and assessing the independence of our independent registered public
accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> auditing and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services, and the terms of such services, to be provided by our independent registered public accounting firm; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the overall audit plan with our independent registered public accounting firm and members of management
responsible for preparing our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and discussing with management and our independent registered public accounting firm our annual and
quarterly financial statements and related disclosures as well as critical accounting policies and practices used by us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">coordinating the oversight and reviewing the adequacy of our internal control over financial reporting;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing policies and procedures for the receipt and retention of accounting-related complaints and concerns;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending, based upon the audit committee&#146;s review and discussions with management and our independent
registered public accounting firm, whether our audited financial statements shall be included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K;</FONT> </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">monitoring the integrity of our financial statements and our compliance with legal and regulatory requirements as
they relate to our financial statements and accounting matters; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing the audit committee report required by SEC rules to be included in our annual proxy statement;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing all related person transactions for potential conflict of interest situations and approving all such
transactions; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing quarterly earnings releases. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All audit and <FONT STYLE="white-space:nowrap">non-audit</FONT> services, other than <I>de minimis </I><FONT STYLE="white-space:nowrap">non-audit</FONT>
services, to be provided to us by our independent registered public accounting firm must be approved in advance by our audit committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Bonita, M.D.,
Jean-Fran&ccedil;ois Formela, M.D., and Ronald C. Renaud, Jr. serve on the compensation committee, which is chaired by Dr.&nbsp;Bonita. Our board of directors has determined that each member of the compensation committee is &#147;independent&#148;
as defined in the applicable Nasdaq rules. During the fiscal year ended December&nbsp;31, 2021, the compensation committee met four times. The compensation committee&#146;s responsibilities include: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">annually reviewing and approving the corporate goals and objectives relevant to the compensation of our Chief
Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the performance of our Chief Executive Officer in light of such corporate goals and objectives and
based on such evaluation, recommending to the board of directors the cash compensation of our Chief Executive Officer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">determining the compensation of our other executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing and administering our compensation and similar plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the retention or termination of any consulting firm or outside advisor to assist in the
evaluation of compensation matters and evaluating and assessing potential and current compensation advisors in accordance with the independence standards identified in the applicable Nasdaq rules; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retaining and approving the compensation of any compensation advisors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and approving the grant of equity-based awards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors the compensation of our directors; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparing our compensation committee report if and when required by SEC rules,&nbsp;if and when required, to be
included in our annual proxy statement. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">David Bonita, M.D., Iain D. Dukes, D.Phil., and Otello Stampacchia, Ph.D. serve on the nominating and corporate governance committee, which is chaired by
Dr.&nbsp;Stampacchia. Our board of directors has determined that each member of the nominating and corporate governance committee is &#147;independent&#148; as defined in the applicable Nasdaq rules. During the fiscal year ended December&nbsp;31,
2021, the nominating and corporate governance committee met zero times. The nominating and corporate governance committee&#146;s responsibilities include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending to the board of directors criteria for board and committee membership;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for identifying and evaluating board of director candidates, including nominees
recommended by stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing the composition of the board of directors to ensure that it is composed of members containing the
appropriate skills and expertise to advise us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying individuals qualified to become members of the board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recommending to the board of directors the persons to be nominated for election as directors and to each of the
board&#146;s committees; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to the board of directors appropriate corporate governance guidelines; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the evaluation of our board of directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The nominating and corporate governance committee considers candidates for board of directors membership suggested by its members and the chief executive
officer. Additionally, in selecting nominees for directors, the nominating and corporate governance committee will review candidates recommended by stockholders in the same manner and using the same general criteria as candidates recruited by the
committee and/or recommended by our board of directors. Any stockholder who wishes to recommend a candidate for consideration by the committee as a nominee for director should follow the procedures described later in this proxy statement under the
heading &#147;Stockholder Proposals.&#148; The nominating and corporate governance committee will also consider whether to nominate any person proposed by a stockholder in accordance with the provisions of our bylaws relating to stockholder
nominations as described later in this proxy statement under the heading &#147;Stockholder Proposals.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Identifying and Evaluating Director
Nominees.</I> Our board of directors is responsible for filling vacancies on our board of directors and for nominating candidates for election by our stockholders each year in the class of directors whose term expires at the relevant annual meeting.
The board of directors delegates the selection and nomination process to the nominating and corporate governance committee, with the expectation that other members of the board of directors, and of management, will be requested to take part in the
process as appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Generally, the nominating and corporate governance committee identifies candidates for director nominees in consultation with
management, through the recommendations submitted by stockholders or through such other methods as the nominating and corporate governance committee deems to be helpful to identify candidates. Once </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates have been identified, the nominating and corporate governance committee confirms that the candidates meet all of the minimum qualifications for director nominees established by the
nominating and corporate governance committee. The nominating and corporate governance committee may gather information about the candidates through interviews, detailed questionnaires, comprehensive background checks or any other means that the
nominating and corporate governance committee deems to be appropriate in the evaluation process. The nominating and corporate governance committee then meets as a group to discuss and evaluate the qualities and skills of each candidate, both on an
individual basis and taking into account the overall composition and needs of our board of directors. Based on the results of the evaluation process, the nominating and corporate governance committee recommends candidates for the board of
directors&#146; approval to fill a vacancy or as director nominees for election to the board of directors by our stockholders each year in the class of directors whose term expires at the relevant annual meeting. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board and Committee Meetings Attendance </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The full board
of directors met four times during 2021. During 2021, each member of the board of directors attended in person or participated in 75% or more of the aggregate of (i)&nbsp;the total number of meetings of the board of directors (held during the period
for which such person has been a director) and (ii)&nbsp;the total number of meetings held by all committees of the board of directors on which such person served (during the periods that such person served). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Attendance at Annual Meeting of Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Directors are responsible for attending the annual meeting of stockholders to the extent practicable. We did not hold an annual meeting of stockholders in
2021. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policy on Trading, Pledging and Hedging of Company Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain transactions in our securities (such as purchases and sales of publicly traded put and call options, and short sales) create a heightened compliance
risk or could create the appearance of misalignment between management and stockholders. In addition, securities held in a margin account or pledged as collateral may be sold without consent if the owner fails to meet a margin call or defaults on
the loan, thus creating the risk that a sale may occur at a time when an officer or director is aware of material, <FONT STYLE="white-space:nowrap">non-public</FONT> information or otherwise is not permitted to trade in Company securities. Our
insider trading policy expressly prohibits derivative transactions of our stock by our executive officers, directors, employees, consultants and designated contractors. Our insider trading policy expressly prohibits purchases of any derivative
securities that provide the economic equivalent of ownership. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">During fiscal 2021, David Bonita, M.D., Jean-Fran&ccedil;ois Formela, M.D., and Ronald C. Renaud, Jr. were the only members of our compensation committee. None
of the members of our compensation committee is, or has at any time during the prior three years been, one of our officers or employees. None of our executive officers currently serve, or have in the past fiscal year served, as a member of the board
of directors or compensation committee of any entity that has one or more of its executive officers serving as a member of our board of directors or our compensation committee. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of
directors adopted a Code of Business Conduct and Ethics in connection with our initial public offering in March 2021. The Code of Business Conduct and Ethics will apply to our directors, officers, and employees, including our principal executive
officer, principal financial officer, principal accounting officer, or controller, or persons performing similar functions. The full text of our Code of Business Conduct and Ethics is </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
posted on our website at <I>www.ikenaoncology.com</I>. If we make any substantive amendments to, or grant any waivers from, our Code of Business Conduct and Ethics for any officer or director, we
will disclose the nature of such amendment or waiver on our website or in a current report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K.</FONT> </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Leadership Structure and Board&#146;s Role in Risk Oversight </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ronald C. Renaud, Jr. is the current chairman of our board of directors. We believe that separating the positions of chief executive officer and chairperson of
the board of directors allows our chief executive officer to focus on our <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> business, while allowing a chairperson of the board to lead the board of directors
in its fundamental role of providing advice to and independent oversight of management. Our board of directors recognizes the time, effort and energy that the chief executive officer is required to devote to his position in the current business
environment, as well as the commitment required to serve as our chairperson, particularly as the board of directors&#146; oversight responsibilities continue to grow. While our amended and restated bylaws and corporate governance guidelines do not
require that our chairperson and chief executive officer positions be separate, our board of directors believes that having separate positions is the appropriate leadership structure for us at this time and demonstrates our commitment to good
corporate governance. Risk is inherent to every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including risks relating to our financial condition, development and commercialization
activities, operations, strategic direction and intellectual property. Management is responsible for the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> management of risks we face, while our board of
directors, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, our board of directors has the responsibility to satisfy itself that the risk management processes designed and
implemented by management are adequate and functioning as designed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The role of the board of directors in overseeing the management of our risks is
conducted primarily through committees of the board of directors, as disclosed in the descriptions of each of the committees above and in the charters of each of the committees. The full board of directors (or the appropriate board committee in the
case of risks that are under the purview of a particular committee) discusses with management our major risk exposures, their potential impact on us, and the steps we take to manage them. When a board committee is responsible for evaluating and
overseeing the management of a particular risk or risks, the chairman of the relevant committee reports on the discussion to the full board of directors during the committee reports portion of the next board meeting. This enables the board of
directors and its committees to coordinate the risk oversight role, particularly with respect to risk interrelationships.</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Communication with the
Directors of Ikena Oncology, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Any interested party with concerns about our company may report such concerns to the board of directors or the
chairman of our board of directors or the chairman of our nominating and corporate governance committee, by submitting a written communication to the attention of such director at the following address: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">c/o Ikena Oncology, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">645
Summer Street, Suite 101 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Boston, Massachusetts 02210 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">United States </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You may submit your concern
anonymously or confidentially by postal mail. You may also indicate whether you are a stockholder, customer, supplier, or other interested party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A copy
of any such written communication may also be forwarded to Ikena&#146;s legal counsel and a copy of such communication may be retained for a reasonable period of time. The director may discuss the matter with Ikena&#146;s legal counsel, with
independent advisors, with <FONT STYLE="white-space:nowrap">non-management</FONT> directors, or with Ikena&#146;s management, or may take other action or no action as the director determines in good faith, using reasonable judgment, and applying his
or her own discretion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Communications may be forwarded to other directors if they relate to important substantive matters and
include suggestions or comments that may be important for other directors to know. In general, communications relating to corporate governance and long-term corporate strategy are more likely to be forwarded than communications relating to ordinary
business affairs, personal grievances, and matters as to which we tend to receive repetitive or duplicative communications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee oversees
the procedures for the receipt, retention, and treatment of complaints received by Ikena Oncology regarding accounting, internal accounting controls, or audit matters, and the confidential, anonymous submission by employees of concerns regarding
questionable accounting, internal accounting controls or auditing matters. Ikena Oncology has also established a toll-free telephone number for the reporting of such activity, which is <FONT STYLE="white-space:nowrap">877-</FONT> <FONT
STYLE="white-space:nowrap">900-2988.</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the total compensation for each person who served as a <FONT STYLE="white-space:nowrap">non-employee</FONT> member of our board
of directors and received compensation for such service during fiscal year 2021. Other than as set forth in the table below, we did not pay any compensation, make any additional equity awards or <FONT STYLE="white-space:nowrap">non-equity</FONT>
awards to, or pay any other compensation to any of the <FONT STYLE="white-space:nowrap">non-employee</FONT> members of our board of directors in fiscal year 2021. Directors who also serve as employees received no additional compensation for their
service as directors. During fiscal year 2021, Mark Manfredi, Ph.D., our President and Chief Executive Officer, was a member of our board of directors, as well as an employee, and received no additional compensation for his services as a director.
See the section titled &#147;<I>2021 Summary Compensation Table</I>&#148; for more information about his compensation in fiscal year 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>NAME</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>FEES<BR>EARNED<BR>OR<BR>PAID&nbsp;IN<BR>CASH&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION<BR>AWARDS<BR>($) (1)(2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Bonita, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">37,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">161,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Iain Dukes, D.Phil.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,891</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">215,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">270,606</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jean-Francois Formela, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">36,406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">160,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald C. Renaud, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">65,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">619,140</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">684,287</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Otello Stampacchia, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,705</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">162,309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Koehler, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">431,020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">455,736</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reflect the grant date fair value of stock options granted in 2021 in accordance with Financial
Accounting Standards Board, or FASB Accounting Standards Codification, or ASC Topic 718. Such grant date fair values do not take into account any estimated forfeitures related to service-based vesting conditions. The assumptions used in calculating
the grant date fair value of the stock options reported in this column are set forth in Note 10 to the financial statements included in our Annual Report on <FONT STYLE="white-space:nowrap">Form&nbsp;10-K.</FONT> The amounts reported in this column
reflect the accounting cost for these stock options and do not correspond to the actual economic value that may be received by our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors upon the exercise of such options.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><FONT STYLE="white-space:nowrap">Non-employee</FONT> directors who served on the Board of Directors during 2021
held the following unexercised stock as of December&nbsp;31, 2021 and held no shares of restricted stock: </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="39%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>NAME</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>AGGREGATE&nbsp;NUMBER&nbsp;OF&nbsp;SHARES<BR>SUBJECT TO STOCK OPTIONS</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Bonita, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Iain Dukes, D.Phil.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">259,839</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jean-Francois Formela, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald C. Renaud, Jr.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">237,259</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Otello Stampacchia, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Koehler, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Policy </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our initial public offering, we implemented a formal policy, pursuant to which our <FONT STYLE="white-space:nowrap">non-employee</FONT>
directors are eligible to receive the following cash retainers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Annual Retainer for Board Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service on the board of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">35,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Additional Annual Retainer for Committee Membership</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the audit committee (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as chair of the audit committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the compensation committee (other than chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as chair of the compensation committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as member of the nominating and corporate governance committee (other than
chair)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as chair of the nominating and corporate governance committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Additional Annual Retainer for <FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chairman
of the Board</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Annual service as chairman of the board of directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our policy in effect following our initial public offering provided that, upon initial election to our board of directors,
each <FONT STYLE="white-space:nowrap">non-employee</FONT> director will be granted an option to purchase 26,838 shares of our common stock, referred to herein as the Initial Grant. In February 2022, we amended our policy to increase the number of
shares of our common stock underlying the Initial Grants to 29,200 shares. Furthermore, our policy provides that, on the date of each of our annual meeting of stockholders, each <FONT STYLE="white-space:nowrap">non-employee</FONT> director who will
continue as a non-employee director following such meeting will be granted an annual option to purchase 13,419 shares of our common stock, referred to herein as the Annual Award. Each Annual Award will vest in full on the earlier of (i)&nbsp;the
first anniversary of the grant date or (ii)&nbsp;our next annual meeting of stockholders, subject to such director&#146;s continued service to us through the applicable vesting date. With respect to the Initial Grants, the shares subject to each
Initial Grant will vest in equal annual installments over three years from the date of grant, subject to such director&#146;s continued service to us through the applicable vesting dates. Such awards are subject to full accelerated vesting upon the
sale of the Company, subject to such director&#146;s continued service to us through the date of such sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Employee directors receive no additional
compensation for their service as a director. We reimburse all reasonable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred by directors for their attendance at meetings of our board of
directors or any committee thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE OFFICERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table identifies our executive officers, and sets forth their current positions at Ikena Oncology, Inc. and their ages as of April&nbsp;25,
2022. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Position Held with Ikena Oncology, Inc.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Officer<BR>Since</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Manfredi, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>President, Chief Executive Officer and Director</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2017</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jeffrey Ecsedy, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Development Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">52</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sergio Santillana, M.D., M.Sc., MBA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Medical Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jotin Marango, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Financial Officer and Head of Corporate Development</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">2022</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">43</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michelle Zhang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chief Scientific Officer</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">You should refer to &#147;<I>Class</I><I></I><I>&nbsp;III Directors</I>&#148; above for information about our Chief Executive
Officer and President, Mark Manfredi, Ph.D. Biographical information for our other executive officers, as of April&nbsp;25, 2022, is set forth below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jeffrey Ecsedy, Ph.D.</I></B>&nbsp;has served as our Chief Development Officer since November 2021. Before that Dr.&nbsp;Ecsedy served as our Chief
Scientific Officer from March 2019 to December 2021. Prior to this, Dr.&nbsp;Ecsedy served as our Senior Vice President of Research and Development from October 2017 to February 2019. Previously, from June 2013 to October 2017, Dr.&nbsp;Ecsedy
served as the Senior Director and Head of Oncology Translational Medicine at Takeda Pharmaceuticals Company Limited. Dr.&nbsp;Ecsedy holds a Bachelor of Science in Biological Sciences from the University of Connecticut and a Doctorate of Philosophy
from Boston College. We believe that Dr.&nbsp;Ecsedy is qualified to serve as our Chief Scientific Officer because of his significant scientific and industry knowledge, and his prior service in senior management roles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sergio Santillana, M.D., M.Sc., MBA</I></B>&nbsp;has served as our Chief Medical Officer since July 2020. Prior to this, he served as Senior Clinical
Consultant for Ikena from September 2019 to June 2020. Dr.&nbsp;Santillana is also founder and President of his own oncology consulting firm, SLSS Consulting LLC, where he provides strategic consultancy services since April 2019. From June 2017 to
April 2019 Dr.&nbsp;Santillana served as Senior Vice President and Chief Medical Officer at Merrimack Pharmaceuticals, Inc., a company focused on developing biologics and nanotherapeutics for solid tumors. Before joining Merrimack Pharmaceuticals,
Inc., from March 2016 to June 2017, he was Head of Clinical Research and then Chief Medical Officer for ARIAD Pharmaceuticals, a commercial-stage biotechnology company focused on developing targeted therapies for cancer, that was acquired by Takeda
Pharmaceutical Company. From August 2014 to March 2016, Dr.&nbsp;Santillana served as the Senior Medical Director of Oncology and Clinical Research at Takeda Pharmaceuticals International Limited, where he was the Global Clinical Lead of early
development programs. Prior to joining Takeda Oncology, he served in various oncology clinical development roles at GlaxoSmithKline and Eli Lilly Oncology. Before joining the biopharmaceutical industry, Dr.&nbsp;Santillana was a practicing medical
oncologist for more than a decade. Dr.&nbsp;Santillana holds a Bachelor of Science, Medical Degree (MD)&nbsp;and specialty/residence in Medical Oncology from the Universidad Nacional Federico Villarreal, a Master of Science from Kellogg College at
Oxford University, and Master of Business Administration from Sloan School of Management at the Massachusetts Institute of Technology. We believe that Dr.&nbsp;Santillana is qualified to serve as our Chief Medical Officer because of his executive
experience in the life sciences industry and his extensive medical knowledge. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Jotin Marango, M.D., Ph.D.</I></B>&nbsp;has served as our Chief
Financial Officer and Head of Corporate Development since April 2022. Prior to this, he served as Senior Vice President, Chief Business Officer at Aptose Biosciences Inc. (NASDAQ: APTO) from June 2019 to April 2022, and also as their Chief Financial
Officer from May 2021 to April 2022. Before that, Dr.&nbsp;Marango worked as an equity research analyst at Roth Capital Partners covering small and <FONT STYLE="white-space:nowrap">mid-cap</FONT> biotechnology companies focused on hematology,
oncology, and rare diseases. Dr.&nbsp;Marango </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
also served as Chief Operating Officer at the Samuel Waxman Cancer Research Foundation from 2012 to 2015, where he oversaw venture philanthropy initiatives in therapeutic development. Through his
education and career, Dr.&nbsp;Marango has solidified a passion for working in oncology and facilitating growth for businesses looking to make a difference in cancer research. Dr.&nbsp;Marango holds a B.A. in Chemistry with Honors from Harvard
University and earned his M.D. and Ph.D. from the Mount Sinai School of Medicine of New York University. We believe that Dr.&nbsp;Marango is qualified to serve as our Chief Financial Officer and Head of Corporate Development because of his extensive
experience in oncology biopharma business, finance, and corporate relations&nbsp;&amp; development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Michelle Zhang, Ph.D.</I></B> has served as our
Chief Scientific Officer since December 2021. Prior to this, Dr.&nbsp;Zhang served as our Senior Vice President, Translational Research and Early Development from September 2019 to December 2021. Prior to that, Dr.&nbsp;Zhang served as our Vice
President, Research and Development from April 2016 to September 2019. Dr.&nbsp;Zhang holds a Bachelor of Science in Biology from Fudan University and a Doctorate of Philosophy in Biochemistry from Harvard University. We believe that Dr.&nbsp;Zhang
is qualified to serve as our Chief Scientific Officer because of her extensive industry knowledge and experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The principal occupation and employment
during the past five years of each of our executive officers was carried on, in each case except as specifically identified above, with a corporation or organization that is not a parent, subsidiary or other affiliate of us. There is no arrangement
or understanding between any of our executive officers and any other person or persons pursuant to which he or she was or is to be selected as an executive officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">There are no material legal proceedings to which any of our executive officers is a party adverse to us or in which any such person has a material interest
adverse to us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers for the year ended December&nbsp;31, 2021 are: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mark Manfredi, Ph.D., our President and Chief Executive Officer; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Sergio Santillana, M.D., M.Sc., MBA, our Chief Medical Officer; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Douglas R. Carlson, our former Chief Operating Officer and Executive Vice President of Finance.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2021 Summary Compensation Table </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table presents the compensation awarded to, earned by or paid to each of our named executive officers for the years indicated. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Manfredi, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">530,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">265,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,654,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,449,179</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>President and Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">409,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">196,560</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">606,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sergio Santillana, M.D., M.Sc., MBA (1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">440,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">176,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,096,022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,712,022</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">137,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,521</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">586,700</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">54,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">826,970</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas R. Carlson</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">410,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">164,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,308,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,882,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Former Chief Operating Officer and EVP of Finance</I>(4)<I> </I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">330,372</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">138,756</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">469,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amounts represent bonuses earned in 2021 and 2020 and paid in 2022 and 2021, respectively, pursuant to the
Company&#146;s cash incentive plan based on the achievement of certain corporate and individual performance milestones. For Dr.&nbsp;Santillana, his 2020 base salary reflects that he devoted approximately 50% of his full working time to our company
during the time that he served as our Chief Medical Officer in 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the aggregate grant date fair value of the stock options award to the named
executive officers during fiscal year 2021 and 2020, calculated in accordance with ASC Topic 718. Such grant date fair value does not take into account any estimated forfeitures. The assumptions used in calculating the grant date fair value of the
awards reported in this column are set forth in Note 10 to the financial statements included in our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K.</FONT> The amounts reported in this column reflect the accounting cost for the stock
options and does not correspond to the actual economic value that may be received upon exercise of the stock option or any sale of any of the underlying shares of common stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount reported for Dr.&nbsp;Santillana represents fees paid to Dr.&nbsp;Santillana for his services as a
consultant in 2020 prior to becoming our Chief Medical Officer in July 2020. Pursuant to the consulting agreement between us and Dr.&nbsp;Santillana, he was paid $500 per hour for consulting services. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Carlson resigned as our Chief Operating Officer and Executive Vice President of Finance, effective
February&nbsp;18, 2022. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Narrative to 2021 Summary Compensation Table </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Base salaries </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our named executive officers each receive a
base salary to compensate them for services rendered to our company. The base salary payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#146;s skill set, experience, role and
responsibilities. Base salaries are reviewed annually, typically in connection with our annual performance review process, approved by our board of directors or the compensation committee, and may be adjusted from time to time to realign salaries
with market levels after taking into account individual responsibilities, performance, and experience. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For fiscal year 2021, the annual base salary for each of Dr.&nbsp;Manfredi, Dr.&nbsp;Santillana, and
Mr.&nbsp;Carlson were $530,000, $440,000 and $410,000, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Bonuses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For the fiscal year 2021, each named executive officer was eligible to earn an annual cash bonus based on the achievement of certain corporate and individual
performance milestones. The target annual bonus for each of Dr.&nbsp;Manfredi, Dr.&nbsp;Santillana, and Mr.&nbsp;Carlson for the fiscal year ended December&nbsp;31, 2021 were 50%, 40% and 40% of annual base salary, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Equity Compensation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our equity grant program is intended
to align the interests of our named executive officers with those of our stockholders and to motivate them to make important contributions to our performance. In 2021, we granted stock options to each of our named executive officers, as reflected in
the &#147;Outstanding Equity Awards at 2021 Fiscal Year End Table&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Perquisites </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We generally do not provide perquisites to our executive officers, including our named executive officers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Ikena Oncology, Inc. 401(k) Plan </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We maintain a 401(k)
retirement savings plan for our employees, including our named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms as other full-time
employees. Our 401(k) plan is intended to qualify for favorable tax treatment under Section&nbsp;401(a) of the Code and contains a cash or deferred feature that is intended to meet the requirements of Section&nbsp;401(k) of the Code. We believe that
providing a vehicle <FONT STYLE="white-space:nowrap">for&nbsp;tax-deferred&nbsp;retirement</FONT> savings though our 401(k) plan adds to the overall desirability of our executive compensation package and further incentivizes our employees, including
our named executive officers, in accordance with our compensation policies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Employment Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2021, we entered into new employment agreements with each of Dr.&nbsp;Manfredi, Dr.&nbsp;Santillana, and Mr.&nbsp;Carlson, which superseded each such
named executive officer&#146;s existing offer letter, change in control and severance agreement and change in control severance agreement, as applicable, and which became effective upon our initial public offering. The new employment agreements
contain substantially similar terms that provide for each of the named executive officer&#146;s continued employment and annual base salary, and set forth the terms of their discretionary annual bonus,
<FONT STYLE="white-space:nowrap">the&nbsp;at-will&nbsp;nature</FONT> of their employment, certain expense reimbursements, the terms of severance payments payable upon certain terminations of employment and their eligibility to participate in our
benefit plans generally. Mr.&nbsp;Carlson resigned in February 2022. Prior to his resignation he was eligible to receive severance payments and benefits on substantially similar terms as Dr.&nbsp;Santillana as described below. Mr.&nbsp;Carlson did
not receive any severance benefits in connection with his resignation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that Dr.&nbsp;Manfredi&#146;s or Dr.&nbsp;Santillana&#146;s service
with the Company is terminated without &#147;cause&#148; or for &#147;good reason&#148; (in each case, as defined in his employment agreement), on or within twelve months after the closing of a &#147;change in control&#148; (as defined in his
employment agreement), such named executive officer will be entitled to the following severance benefits, subject to the executive executing a separation agreement and it becoming effective,
<FONT STYLE="white-space:nowrap">(i)&nbsp;a&nbsp;lump-sum&nbsp;payment</FONT> equal to equal to 1&nbsp;times (or in the case of Dr.&nbsp;Manfredi, 1.5&nbsp;times) the sum of (a)&nbsp;such named executive officer&#146;s then-current base salary or
the base salary in effect immediately prior to the change in control, if higher, plus (b)&nbsp;such named executive officer&#146;s annual target bonus for the then-</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
current year; (iii)&nbsp;immediate acceleration of all time-based stock options and other stock-based awards subject to time-based vesting held by such named executive officer, effective as of
the later of the date of termination or the effective date of the separation agreement and release; and (iv)&nbsp;up to 12 months (or in the case of Dr.&nbsp;Manfredi, 18 months) of the employer portion of COBRA premium payments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In the event that Dr.&nbsp;Manfredi&#146;s or Dr.&nbsp;Santillana&#146;s service with the Company is terminated without &#147;cause&#148; or for &#147;good
reason,&#148; in each case, other than in connection with a change in control, such named executive officer will be entitled to the following severance benefits, subject to such executive executing a separation agreement and release and it becoming
effective: (i)&nbsp;payments equal to nine months of such named executive officer&#146;s then-current base salary (or in the case of Dr.&nbsp;Manfredi, 12 months) and (ii)&nbsp;up to nine months (or in the case of Dr.&nbsp;Manfredi, 12 months) of
the employer portion of COBRA premium payments. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon the occurrence of a change of control, all payments and benefits received by Dr.&nbsp;Manfredi and
Dr.&nbsp;Santillana in connection with a change of control that constitute &#147;excess parachute payments&#148; under Section&nbsp;280G of the Code will be subject to a modified economic cutback treatment such that the &#147;excess parachute
payments&#148; to be received by each such affected named executive officer will either be (i)&nbsp;paid in full or (ii)&nbsp;reduced below such named executive officer&#146;s threshold amount under Code Section&nbsp;280G in order to avoid
triggering the excise tax that would otherwise be payable on such &#147;excess parachute payment&#148; amounts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In addition, each of our named executive
officers previously entered into our standard confidential information, <FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation,</FONT> and invention assignment agreement with us which continues to
remain in effect and contains protections of confidential information, requires the assignment of inventions and contains other restrictive covenants. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Risk Assessment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We believe that although a
portion of the compensation provided to our executive officers and other employees is performance-based, our executive compensation program does not encourage excessive or unnecessary risk taking. This is primarily due to the fact that our
compensation programs are designed to encourage our executive officers and other employees to remain focused on both short-term and long-term strategic goals, in particular in connection with our <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">pay-for-performance</FONT></FONT> compensation philosophy. As a result, we do not believe that our compensation programs are reasonably likely to have a material adverse effect on us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal 2021 <FONT STYLE="white-space:nowrap">Year-End</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding outstanding equity awards held by our named executive officers as of fiscal year 2021: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>OPTION AWARDS&nbsp;(1)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>NAME</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Exercise&nbsp;Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Expiration&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Manfredi</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">95,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8/23/2026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">158,843</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/19/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">151,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12/17/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/20/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">140,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">63,917&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/19/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/12/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">929,386&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/11/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sergio Santillana</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/23/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">55,852</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">101,859&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(4)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.51</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7/22/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/12/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">218,862&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/11/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas R. Carlson&nbsp;(5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/20/2019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">129,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,189&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(2)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3/19/2029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/12/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">261,344&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">(3)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2/11/2031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the outstanding equity awards in the table above that was granted prior to our initial public offering
in March 2021 was granted pursuant to our 2016 Stock Incentive Plan, as amended, or the 2016 Plan. Each of the outstanding equity awards listed in the table above is subject to accelerated vesting in the event of certain terminations following a
change in control, as described above in the &#147;Executive Employment Arrangements&#148; section. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an option to purchase shares of our common stock granted on March&nbsp;20, 2019. The shares
underlying this option vest as follows: 25% of the shares vested on March&nbsp;20, 2020 and the remainder vest over the next three years in equal monthly installments on the last day of each succeeding calendar month (with the option becoming fully
vested on the fourth anniversary of the vesting commencement date), subject to continued service to us through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an option to purchase shares of our common stock granted on February&nbsp;12, 2021. The shares
underlying this option vest as follows: 25% of the shares vested on February&nbsp;12, 2022 and the remainder vest over the next three years in equal monthly installments on the last day of each succeeding calendar month (with the option becoming
fully vested on the fourth anniversary of the vesting commencement date), subject to continued service to us through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents an option to purchase shares of our common stock granted on July&nbsp;23, 2020. The shares
underlying this option vest as follows: 25% of the shares vested on July&nbsp;1, 2021 and the remainder vest over the next three years in equal monthly installments on the last day of each succeeding calendar month thereafter (with the option
becoming fully vested on the fourth anniversary of the vesting commencement date), subject to continued service to us through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Mr.&nbsp;Carlson resigned effective February&nbsp;18, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Compensation Plan Information </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table provides information as of December&nbsp;31, 2021 with respect to the shares of our common stock that may be issued under our existing
equity compensation plans. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Equity Compensation Plan Information</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Plan Category</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities</B><br><B>to be issued</B><br><B>upon<BR>exercise</B><br><B>of<BR>outstanding</B><br><B>options,<BR>warrants</B><br><B>and
rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted</B><br><B>average</B><br><B>exercise</B><br><B>price of</B><br><B>outstanding</B><br><B>options,</B><br><B>warrants</B><br><B>and rights</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of</B><br><B>securities</B><br><B>remaining</B><br><B>available</B><br><B>for future</B><br><B>issuance</B><br><B>under
equity</B><br><B>compensation</B><br><B>plans</B><br><B>(excluding</B><br><B>securities in</B><br><B>first column)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans approved by security holders<SUP
STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,822,373</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,250,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equity compensation plans not approved by security holders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,822,373</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7.17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,250,479</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes the following plans: our 2016 Stock Incentive Plan (the &#147;2016 Plan&#148;), our 2021 Stock Option
and Incentive Plan (the &#147;2021 Plan&#148;) and our 2021 Employee Stock Purchase Plan (the &#147;2021 ESPP&#148;). </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">As of December&nbsp;31, 2021, a total of 3,263,664 shares of our common stock have been reserved for issuance
pursuant to the 2021 Plan. The 2021 Plan provides that the number of shares reserved and available for issuance under the plan will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2022, by 4% of the outstanding number of
shares of our common stock on the immediately preceding December&nbsp;31 or such lesser number of shares as determined by the Compensation Committee. This number will be subject to adjustment in the event of a stock split, stock dividend or other
change in our capitalization. The shares of common stock underlying any awards that are forfeited, cancelled, held back upon exercise or settlement of an award to satisfy the exercise price or tax withholding, reacquired by us prior to vesting,
satisfied without the issuance of stock, expire or are otherwise terminated, other than by exercise, under the 2021 Plan and the 2016 Plan will be added back to the shares of common stock available for issuance under the 2021 Plan. Following our
initial public offering the Company no longer makes grants under the 2016 Plan. As of December&nbsp;31, 2021, a total of 346,613 shares of our common stock have been reserved for issuance pursuant to the 2021 ESPP. The 2021 ESPP provides that the
number of shares reserved and available for issuance under the plan will automatically increase each January&nbsp;1, beginning on January&nbsp;1, 2021, by the lesser of (i) 346,613 shares of our common stock, (ii) 1% of the outstanding number of
shares of our common stock on the immediately preceding December&nbsp;31 or (iii)&nbsp;such lesser number of shares as determined by the Compensation Committee. This number will be subject to adjustment in the event of a stock split, stock dividend
or other change in our capitalization. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Includes 1,841,894 shares of common stock issuable upon the exercise of outstanding options.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_6"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Relationships and Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Other than the
compensation agreements and other arrangements described under &#147;Executive Compensation&#148; and <FONT STYLE="white-space:nowrap">&#147;Non-Employee</FONT> Director Compensation Policy&#148; in this proxy statement and the transactions
described below, since January&nbsp;1, 2020, there has not been and there is not currently proposed, any transaction or series of similar transactions to which we were, or will be, a party in which the amount involved exceeded, or will exceed,
$120,000 (or, if less, 1% of the average of our total assets amounts at December&nbsp;31, 2020 and 2021) and in which any director, executive officer, holder of five percent or more of any class of our capital stock or any member of the immediate
family of, or entities affiliated with, any of the foregoing persons, had, or will have, a direct or indirect material interest. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Series B Convertible
Preferred Stock Financing </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In December 2020, we sold an aggregate of 85,806,214 shares of our Series B preferred stock at a purchase price of $1.3985
per share for aggregate proceeds of $120.0&nbsp;million. The following table summarizes purchases of our Series B preferred stock by related persons: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participant</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares of<BR>Series B<BR>Preferred<BR>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total<BR>Purchase<BR>Price<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with FMR LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,876,296</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">24,999,999.96</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with OrbiMed Advisors
LLC<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">16,088,665</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">22,499,998.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omega Fund VI, L.P.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">12,870,933</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17,999,999.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Atlas Venture Opportunity Fund I,
L.P.<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,362,888</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,499,998.87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Celgene Corporation (BMS)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">715,051</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">999,998.82</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with FMR LLC collectively beneficially own more than five percent of our outstanding
capital stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with OrbiMed Advisors LLC, or OrbiMed Advisors, collectively beneficially own more than
five percent of our outstanding capital stock. Dr.&nbsp;Bonita is a member of OrbiMed Advisors and a member of our board of directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Omega Fund VI, L.P. is a holder of five percent or more of our capital stock. Mr.&nbsp;Stampacchia is a
Managing Director <FONT STYLE="white-space:nowrap">and&nbsp;co-founder&nbsp;of</FONT> Omega Fund Management, LLC, is one of three directors of Omega Fund VI GP Manager, Ltd., the sole general partner of Omega Fund VI GP, L.P., which is the sole
General Partner of Omega Fund VI, L.P. and is a member of our board of directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Atlas Venture Opportunity Fund I, L.P. is an affiliate of Atlas Venture. Entities affiliated with Atlas Venture
collectively beneficially own more than five percent of our outstanding capital stock. Dr.&nbsp;Formela is a partner at Atlas Venture and a member of our board of directors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Initial Public Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In March 2021, in connection with our initial public offering, we sold an aggregate of 8,984,375 shares of common stock, including the exercise in full by the
underwriters of their option to purchase up to 1,171,875 additional shares of common stock at a public offering price of $16.00 per share. The aggregate gross proceeds to us from the offering were approximately $143.8&nbsp;million, before deducting
underwriting discounts and commissions and other offering expenses. The following table summarizes purchases of our shares of common stock by related persons in connection with our initial public offering: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="76%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"><B>STOCKHOLDER</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>SHARES<BR>OF<BR>COMMON<BR>STOCK</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>TOTAL<BR>PURCHASE<BR>PRICE</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OrbiMed Private Investments VI, LP(1)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OrbiMed Genesis Master Fund, L.P.(2)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">48,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">774,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omega Fund VI, L.P.(3)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">450,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The securities are held of record by OrbiMed Private Investments VI, LP (&#147;OPI VI&#148;). OrbiMed Capital
GP VI LLC (&#147;GP VI&#148;) is the general partner of OPI VI. OrbiMed Advisors LLC (&#147;OrbiMed Advisors&#148;), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP VI. The
Reporting Person is a member of OrbiMed Advisors. By virtue of such relationship, OrbiMed Advisors and GP VI may be deemed to have voting power and investment power over the securities held by OPI VI and as a result, may be deemed to have beneficial
ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares
held by OPI VI. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The securities are held of record by OrbiMed Genesis Master Fund, L.P. (&#147;OrbiMed Genesis&#148;). OrbiMed
Genesis GP LLC (&#147;Genesis GP&#148;) is the general partner of OrbiMed Genesis. OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationship, OrbiMed Advisors and Genesis GP may be deemed to have voting power and
investment power over the securities held by Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon,
Sven H. Borho, and Jonathan T. Silverstein, each of whom disclaims beneficial ownership of the shares held by OrbiMed Genesis. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Shares held directly by Omega Fund VI, L.P. (&#147;Omega VI&#148;). Omega Fund VI GP, L.P. (&#147;Omega VI
GP&#148;) is the sole general partner of Omega VI. Omega Fund VI GP Manager, Ltd. (&#147;Omega VI Manager&#148;) is the sole general partner of Omega VI GP. The Reporting Person is a director of Omega VI Manager and disclaims beneficial ownership of
the shares held by Omega VI except to the extent of his pecuniary interest therein, if any. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Agreements with Stockholders </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our Series B convertible preferred stock financing, we entered into investors&#146; rights, voting and right of first <FONT
STYLE="white-space:nowrap">refusal&nbsp;and&nbsp;co-sale&nbsp;agreements&nbsp;containing</FONT> registration rights, information rights, voting rights and rights of first refusal, among other things, with certain holders of our preferred stock and
certain holders of our common stock. These stockholder agreements terminated upon the closing of our initial public offering in March 2021, except for the registration rights granted under our investors&#146; rights agreement, as more fully
described in our Description of Securities, filed as Exhibit 4.2 to our Annual Report on Form <FONT STYLE="white-space:nowrap">10-K,</FONT> filed March&nbsp;17, 2022. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our
initial public offering in March 2021, we entered into agreements to indemnify our directors and executive officers. These agreements, among other things, require us to indemnify these individuals </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
for certain expenses (including attorneys&#146; fees), judgments, fines and settlement amounts reasonably incurred by such person in any action or proceeding, including any action by or in our
right, on account of any services undertaken by such person on our behalf or that person&#146;s status as a member of our board of directors to the maximum extent allowed under Delaware law. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies for Approval of Related Party Transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our
board of directors reviews and approves transactions with directors, officers and holders of five percent or more of our voting securities and their affiliates, each a related party. Prior to our initial public offering in March 2021, the material
facts as to the related party&#146;s relationship or interest in the transaction were disclosed to our board of directors prior to their consideration of such transaction, and the transaction was not considered approved by our board of directors
unless a majority of the directors who are not interested in the transaction approved the transaction. Further, when stockholders are entitled to vote on a transaction with a related party, the material facts of the related party&#146;s relationship
or interest in the transaction were disclosed to the stockholders, who must approve the transaction in good faith. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with our initial public
offering in March 2021, we adopted a written related party transactions policy that provides that such transactions must be approved by our audit committee. This policy became effective on the date on which the registration statement related to our
initial public offering was declared effective by the SEC. Pursuant to this policy, the audit committee has the primary responsibility for reviewing and approving or disapproving &#147;related party transactions,&#148; which are transactions between
us and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person has or will have a direct or indirect material interest. For purposes of this policy, a related person will be
defined as a director, executive officer, nominee for director, or greater than 5% beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their immediate family members. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_7"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following table sets forth information, to the extent known by us or ascertainable from public filings, with respect to the beneficial ownership of our
common stock as of April&nbsp;25, 2022 by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our directors and executive officers as a group; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person, or group of affiliated persons, who is known by us to beneficially own <FONT
STYLE="white-space:nowrap">greater-than-5.0%</FONT> of our common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The column entitled &#147;Shares Beneficially Owned&#148; is
based on a total of 36,163,291 shares of our common stock outstanding as of April&nbsp;25, 2022. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Beneficial ownership is determined in accordance with
the rules and regulations of the SEC and includes voting or investment power with respect to our common stock. Shares of our common stock subject to options that are currently exercisable or exercisable within 60 days of April&nbsp;25, 2022 are
considered outstanding and beneficially owned by the person holding the options for the purpose of calculating the percentage ownership of that person but not for the purpose of calculating the percentage ownership of any other person. Except as
otherwise noted, the persons and entities in this table have sole voting and investing power with respect to all of the shares of our common stock beneficially owned by them, subject to community property laws, where applicable. Except as otherwise
indicated in the table below, addresses of named beneficial owners are in care of Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, Massachusetts 02210. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="84%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares beneficially owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and address of beneficial owner (1)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Voting<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR><FONT STYLE="white-space:nowrap">Non-Voting</FONT><BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B></B><B><I>&gt; 5% Stockholders</I></B><B>:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with OrbiMed Advisors LLC (2)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,933,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6,215,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">25.30</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Atlas Venture (3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5,018,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.88</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with FMR LLC (4)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4,723,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13.06</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Omega Fund VI, L.P. (5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,249,123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">6.22</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Citadel LLC (6)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,128,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5.88</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Named Executive Officers and Directors</I></B>:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mark Manfredi, Ph.D. (7)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">881,397</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sergio Santillana, M.D., M.Sc., MBA (8)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">148,513</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ronald C. Renaud, Jr. (9)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">143,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Bonita, M.D. (2)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Iain D. Dukes, D.Phil. (10)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">204,585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Jean-Fran&ccedil;ois Formela, M.D. (3)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Maria Koehler, M.D. (11)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,946</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Otello Stampacchia, Ph.D. (5)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Wooster, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All executive officers and directors as a group (12 persons)&nbsp;(12)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,738,728</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">4.81</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than one percent. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Unless otherwise indicated, the address for each beneficial owner is c/o Ikena Oncology, Inc., 645 Summer
Street, Suite 101, Boston, Massachusetts 02210. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information herein is based on the Schedule 13D/A filed with the SEC on August&nbsp;16, 2021 by OrbiMed
Advisors LLC (&#147;OrbiMed Advisors&#148;), OrbiMed Capital GP VI LLC (&#147;OrbiMed GP&#148;), OrbiMed Genesis GP </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
LLC (&#147;OrbiMed Genesis GP&#148;), and OrbiMed Capital LLC (&#147;OrbiMed Capital&#148;) (collectively, the &#147;Reporting Persons&#148;). OrbiMed Private Investments VI, LP, (&#147;OPI
VI&#148;) holds 1,845,872 shares of common stock and 5,429,023 shares of <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock. OrbiMed GP is the general partner of OPI VI, pursuant to the terms of the limited partnership agreement of OPI
VI, and OrbiMed Advisors is the managing member of OrbiMed GP, pursuant to the terms of the limited liability company agreement of OrbiMed GP. As a result, OrbiMed Advisors and OrbiMed GP share power to direct the vote and disposition of the Shares
held by OPI VI and may be deemed directly or indirectly, including by reason of their mutual affiliation, to be the beneficial owners of the Shares held by OPI VI.&nbsp;OrbiMed Advisors exercises this investment and voting power through a management
committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI VI. OrbiMed Genesis Master Fund, L.P. (&#147;OrbiMed Genesis&#148;) holds 91,014 shares of common stock
and 157,288 shares of <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock. OrbiMed Genesis GP is the general partner of OrbiMed Genesis, pursuant to the terms of the limited partnership agreement of OrbiMed Genesis, and OrbiMed Advisors
is the managing member of OrbiMed Genesis GP, pursuant to the terms of the limited liability company agreement of OrbiMed Genesis GP. As a result, OrbiMed Advisors and OrbiMed Genesis GP share power to direct the vote and disposition of the Shares
held by OrbiMed Genesis and may be deemed, directly or indirectly, including by reason of their mutual affiliation, to be the beneficial owners of the Shares held by OrbiMed Genesis.&nbsp;OrbiMed Advisors exercises this investment and voting power
through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OrbiMed Genesis. Worldwide Healthcare Trust PLC (&#147;WWH&#148;) holds 997,055 shares
of common stock and 629,155 shares of <FONT STYLE="white-space:nowrap">non-voting</FONT> common stock. OrbiMed Capital is the investment advisor of WWH. As a result, OrbiMed Capital has the power to direct the vote and disposition of the Shares held
by WWH and may be deemed directly or indirectly, including by reason of mutual affiliation, to be the beneficial owner of the Shares held by WWH. OrbiMed Capital disclaims any beneficial ownership over the shares of the other Reporting
Persons.&nbsp;OrbiMed Capital exercises this investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by WWH. The
principal business address of&nbsp;the Reporting Persons is c/o&nbsp;OrbiMed Advisors, 601 Lexington Avenue 54th Floor, New York, NY 10022. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information herein is based on the Schedule 13D filed with the SEC on February&nbsp;11, 2022 by (i)&nbsp;Atlas
Venture Fund X, L.P., a Delaware limited partnership (&#147;Atlas X&#148;), (ii) Atlas Venture Associates X, L.P., a Delaware limited partnership (&#147;AVA X LP&#148;), (iii) Atlas Venture Associates X, LLC, a Delaware limited liability company
(&#147;AVA X LLC&#148; and together with Atlas X and AVA X LP, the &#147;Fund X Reporting Persons&#148;), (iv) Atlas Venture Fund XI, L.P., a Delaware limited partnership (&#147;Atlas XI&#148;), (v) Atlas Venture Associates XI, L.P., a Delaware
limited partnership (&#147;AVA XI LP&#148;), (vi) Atlas Venture Associates XI, LLC, a Delaware limited liability company (&#147;AVA XI LLC&#148; and together with Atlas XI and AVA XI LP, the &#147;Fund XI Reporting Persons&#148;) (vii) Atlas Venture
Opportunity Fund I, L.P., a Delaware limited partnership (&#147;AVOF&#148;), (viii) Atlas Venture Associates Opportunity I, L.P., a Delaware limited partnership (&#147;AVAO LP&#148;) and (ix)&nbsp;Atlas Venture Associates Opportunity I, LLC, a
Delaware limited liability company (&#147;AVAO LLC&#148; and together with AVOF and AVAO LP, the &#147;Opportunity Fund Reporting Persons&#148; and together with the Fund X Reporting Persons and Fund XI Reporting Persons, the &#147;Reporting
Persons&#148;). Atlas X is the record owner of 2,901,609 shares of common stock. AVA X LP is the general partner of Atlas X and AVA X LLC is the general partner of AVA X LP. Each of Atlas X, AVA X LP and AVA X LLC has shared voting and dispositive
power over the shares held by Atlas X. As such, each of Atlas X, AVA X LP and AVA X LLC may be deemed to beneficially own the shares held by Atlas X. Atlas XI is the record owner of 1,241,935 shares of Common Stock. AVA XI LP is the general partner
of Atlas XI and AVA XI LLC is the general partner of AVA XI LP. Each of Atlas XI, AVA XI LP and AVA XI LLC has shared voting and dispositive power over the shares held by Atlas XI. As such, each of Atlas XI, AVA XI LP and AVA XI LLC may be deemed to
beneficially own the shares held by Atlas XI. AVOF is the record owner of 874,634 shares of Common Stock. AVAO LP is the general partner of AVOF and AVAO LLC is the general partner of AVAO LP. Each of AVOF, AVAO LP and AVAO LLC has shared voting and
dispositive power over the shares held by AVOF. As such, each of AVOF, AVAO LP and AVAO LLC may be deemed to beneficially </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
own the shares held by AVOF. The address of the principal place of business of each of the Reporting Persons is c/o 300 Technology Square, 8th Floor, Cambridge, Massachusetts 02139.
</TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information herein is based on the Schedule 13G/A filed with the SEC on February&nbsp;9, 2022 by FMR LLC.
Fidelity Management&nbsp;&amp; Research Company LLC, or FMR Co. LLC, beneficially own shares reported in this filing. FMR Co. LLC beneficially owns five percent or greater of the outstanding shares reported in this filing. Abigail P. Johnson is a
Director, the Chairman, and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of
the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders&#146; voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of
Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#146; voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form
a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act, or the
Fidelity Funds, advised by FMR Co. LLC, a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds&#146; Boards of Trustees. FMR Co. LLC carries out the voting of the shares under written guidelines established by the Fidelity
Funds&#146; Boards of Trustees. This information reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies, collectively referred to as the
FMR Reporters. This information does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange
Commission Release <FONT STYLE="white-space:nowrap">No.&nbsp;34-39538</FONT> (January&nbsp;12, 1998). The address of the entities and individuals listed above is 245 Summer Street, Boston, Massachusetts 02210. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information herein is based on the Schedule 13G filed with the SEC on February&nbsp;14, 2022 by Omega Fund VI,
L.P. (&#147;Omega Fund&#148;), Omega Fund VI GP, L.P. (&#147;Omega GP&#148;), Omega Fund VI GP Manager, Ltd. (&#147;Omega Ltd&#148;), Claudio Nessi (&#147;Nessi&#148;), Otello Stampacchia (&#147;Stampacchia&#148;), and Anne-Mari Paster
(&#147;Paster&#148;) (together, the &#147;Reporting Persons&#148;). Omega Fund owns 2,249,123 shares of common stock. Omega Ltd serves as the general partner of Omega GP, which serves as the general partner of Omega Fund, and each of Omega GP and
Omega Ltd may be deemed to own beneficially the shares held by Omega Fund. Nessi, Stampacchia, and Paster are the directors of Omega Ltd and may be deemed to beneficially own the shares held by Omega Fund. Each of the Reporting Persons disclaims
beneficial ownership of the shares of the Issuer&#146;s Common Stock held by Omega Fund except to the extent of his, her or its pecuniary interest therein. The address of the principal business office of Omega Fund, Omega GP, Omega Ltd, Nessi,
Stampacchia, and Paster, is c/o Omega Fund Management, LLC, 888 Boylston Street, Suite 1111, Boston, MA 02199. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Information herein is based on the Schedule 13G/A filed with the SEC on February&nbsp;14, 2022 by Citadel
Advisors LLC (&#147;Citadel Advisors&#148;), Citadel Advisors Holdings LP (&#147;CAH&#148;), Citadel GP LLC (&#147;CGP&#148;), Citadel Securities LLC (&#147;Citadel Securities&#148;), Citadel Securities Group LP (&#147;CALC4&#148;), Citadel
Securities GP LLC (&#147;CSGP&#148;) and Mr.&nbsp;Kenneth Griffin (collectively with Citadel Advisors, CAH, CGP, Citadel Securities, CALC4 and CSGP, the &#147;Reporting Persons&#148;) with respect to the shares of common stock owned by Citadel
Multi-Strategy Equities Master Fund Ltd. (&#147;CM&#148;), and Citadel Securities. Citadel Advisors is the portfolio manager for CM. CAH is the sole member of Citadel Advisors. CGP is the general partner of CAH. CALC4 is the <FONT
STYLE="white-space:nowrap">non-member</FONT> manager of Citadel Securities. CSGP is the general partner of CALC4. Mr.&nbsp;Griffin is the President and Chief Executive Officer of CGP, and owns a controlling interest in CGP and CSGP. The address of
the principal business office of each of the Reporting Persons is 131 S. Dearborn Street, 32nd Floor, Chicago, Illinois 60603. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 881,397 shares of our common stock that are exercisable within 60 days of
April&nbsp;25, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 148,513 shares of our common stock that are exercisable within 60 days of
April&nbsp;25, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 143,071 shares of our common stock that are exercisable within 60 days of
April&nbsp;25, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 204,585 shares of our common stock that are exercisable within 60 days of
April&nbsp;25, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of options to purchase 8,946 shares of our common stock that are exercisable within 60 days of
April&nbsp;25, 2022. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 44,475 shares of our common stock and options to purchase 1,694,253 shares of our common stock that
are exercisable within 60 days of April&nbsp;25, 2022. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_9"></A>REPORT OF THE AUDIT COMMITTEE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The audit committee is appointed by the board of directors to assist the board of directors in fulfilling its oversight responsibilities with respect to
(1)&nbsp;the integrity of Ikena&#146;s financial statements and financial reporting process and systems of internal controls regarding finance, accounting, and compliance with legal and regulatory requirements, (2)&nbsp;the qualifications,
independence, and performance of Ikena&#146;s independent registered public accounting firm, (3)&nbsp;the performance of Ikena&#146;s internal audit function, if any, and (4)&nbsp;other matters as set forth in the charter of the audit committee
approved by the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management is responsible for the preparation of Ikena&#146;s financial statements and the financial reporting
process, including its system of internal control over financial reporting and its disclosure controls and procedures. The independent registered public accounting firm is responsible for performing an audit of Ikena&#146;s financial statements in
accordance with the standards of the Public Company Accounting Oversight Board (PCAOB) and issuing a report thereon. The audit committee&#146;s responsibility is to monitor and oversee these processes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with these responsibilities, the audit committee reviewed and discussed with management and the independent registered public accounting firm
the audited financial statements of Ikena Oncology, Inc. for the fiscal year ended December&nbsp;31, 2021. The audit committee also discussed with the independent registered public accounting firm the matters required to be discussed by the
PCAOB&#146;s Auditing Standard No.&nbsp;1301, <I>Communication with Audit Committees</I>. In addition, the audit committee received written communications from the independent registered public accounting firm confirming their independence as
required by the applicable requirements of the PCAOB and has discussed with the independent registered public accounting firm their independence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Based
on the reviews and discussions referred to above, the audit committee recommended to the board of directors that the audited financial statements of Ikena Oncology be included in Ikena&#146;s 2021 Annual Report, that was filed with the SEC. The
information contained in this report shall not be deemed to be (1) &#147;soliciting material,&#148; (2) &#147;filed&#148; with the SEC, (3)&nbsp;subject to Regulations 14A or 14C of the Exchange Act, or (4)&nbsp;subject to the liabilities of
Section&nbsp;18 of the Exchange Act. This report shall not be deemed incorporated by reference into any of our other filings under the Exchange Act or the Securities Act, except to the extent that we specifically incorporate it by reference into
such filing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">THE AUDIT COMMITTEE OF THE BOARD OF <BR>DIRECTORS OF IKENA ONCOLOGY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Ronald C. Renaud, Jr., Chairperson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jean-Francois Formela, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Otello Stampacchia, Ph.D.</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">April&nbsp;27, 2022 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_10"></A>HOUSEHOLDING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Some banks, brokers and other nominee record holders may be participating in the practice of &#147;householding&#148; proxy statements and annual reports.
This means that only one copy of our documents, including the Annual Report to stockholders and proxy statement, may have been sent to multiple stockholders in your household. We will promptly deliver a separate copy of either document to you upon
written or oral request to Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, Massachusetts 02210, Attention: Corporate Secretary, telephone: <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">857-273-8343.</FONT></FONT> If
you want to receive separate copies of the proxy statement or Annual Report to stockholders in the future, or if you are receiving multiple copies and would like to receive only one copy per household, you should contact your bank, broker or other
nominee record holder, or you may contact us at the above address and phone number. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_11"></A>STOCKHOLDER PROPOSALS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">A stockholder who would like to have a proposal considered for inclusion in our 2023 proxy statement must submit the proposal in accordance with the
procedures outlined in Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> of the Exchange Act so that it is received by us no later than December&nbsp;28, 2022. However, if the date of the 2023 Annual Meeting of Stockholders is changed by more than
30 days from the date of the previous year&#146;s meeting, then the deadline is a reasonable time before we begin to print and send our proxy statement for the 2023 Annual Meeting of Stockholders. SEC rules set standards for eligibility and specify
the types of stockholder proposals that may be excluded from a proxy statement. Stockholder proposals should be addressed to Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, Massachusetts 02210, Attention: Corporate Secretary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To comply with the universal proxy rules (once effective), stockholders who intend to solicit proxies in support of director nominees other than the
Company&#146;s nominees must provide notice that sets forth the information required by Rule <FONT STYLE="white-space:nowrap">14a-19</FONT> under the Securities Exchange Act of 1934 no later than April&nbsp;10, 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If a stockholder wishes to propose a nomination of persons for election to our board of directors or present a proposal at an annual meeting but does not wish
to have the proposal considered for inclusion in our proxy statement and proxy card, our bylaws establish an advance notice procedure for such nominations and proposals. Stockholders at an annual meeting may only consider proposals or nominations
specified in the notice of meeting or brought before the meeting by or at the direction of the board of directors or by a stockholder of record on the record date for the meeting, who is entitled to vote at the meeting and who has delivered timely
notice in proper form to our corporate secretary of the stockholder&#146;s intention to bring such business before the meeting. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The required notice must
be in writing and received by our corporate secretary at our principal executive offices not less than 90 days nor more than 120 days prior to the first anniversary of the preceding year&#146;s annual meeting. However, in the event that the date of
the annual meeting is advanced by more than 30 days, or delayed by more than 60 days, from the first anniversary of the preceding year&#146;s annual meeting, a stockholder&#146;s notice must be so received no earlier than the 120th day prior to such
annual meeting and not later than the close of business on the later of (A)&nbsp;the 90th day prior to such annual meeting and (B)&nbsp;the tenth day following the day on which notice of the date of such annual meeting was mailed or public
disclosure of the date of such annual meeting was made, whichever first occurs. For stockholder proposals to be brought before the 2023 Annual Meeting of Stockholders, the required notice must be received by our corporate secretary at our principal
executive offices no earlier than February&nbsp;9, 2023 and no later than March&nbsp;11, 2023. Stockholder proposals and the required notice should be addressed to Ikena Oncology, Inc., 645 Summer Street, Suite 101, Boston, Massachusetts 02210,
Attention: Corporate Secretary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc288879_12"></A>OTHER MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Our board of directors does not know of any other matters to be brought before the Annual Meeting. If any other matters not mentioned in this proxy statement
are properly brought before the meeting, the individuals named in the enclosed proxy intend to use their discretionary voting authority under the proxy to vote the proxy in accordance with their best judgment on those matters. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g288879g27k39.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">VOTE BY INTERNET Before The Meeting - Go to www.proxyvote.com or scan the QR Barcode above Use the Internet to transmit your voting
instructions and for electronic delivery of information up until 11:59 p.m. Eastern Time the day before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you access the web site and follow
the instructions to obtain your records and to create an electronic voting instruction form. During The Meeting - Go to www.virtualshareholdermeeting.com/IKNA2022 You may attend the meeting via the Internet and vote during the meeting. Have the
information that is printed in the box marked by the arrow available and follow the instructions. VOTE BY PHONE - <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-800-690-6903</FONT></FONT></FONT>
Use any touch-tone telephone to transmit your voting instructions up until 11:59 p.m. Eastern Time the day before the <FONT STYLE="white-space:nowrap">cut-off</FONT> date or meeting date. Have your proxy card in hand when you call and then follow
the instructions. VOTE BY MAIL Mark, sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. TO VOTE, MARK BLOCKS BELOW IN BLUE
OR BLACK INK AS FOLLOWS: D84214-P70373 KEEP THIS PORTION FOR YOUR RECORDS THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. DETACH AND RETURN THIS PORTION ONLY IKENA ONCOLOGY, INC. For Withhold For All To withhold authority to vote for any
individual All All Except nominee(s), mark &#147;For All Except&#148; and write the The Board of Directors recommends you vote FOR the number(s) of the nominee(s) on the line below. following: ! ! ! 1. To elect three class I directors to our board
of directors, to serve until the 2025 annual meeting of stockholders and until their successor has been duly elected and qualified, or until their earlier death, resignation or removal. Nominees: 01) Iain Dukes, D. Phil 02) Maria Koehler, MD 03)
Otello Stampacchia, PhD The Board of Directors recommends you vote FOR the following proposal: For Against Abstain 2. To ratify the appointment of Ernst&nbsp;&amp; Young LLP as our independent registered public accounting firm for the fiscal year
ending December&nbsp;31, 2022. ! ! ! To transact any other business that may properly come before the meeting or any adjournment of the meeting. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator,
or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer. Signature [PLEASE SIGN
WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g288879g27k40.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting: The Notice and Proxy Statement, Annual Report and
Form <FONT STYLE="white-space:nowrap">10-K</FONT> are available at www.proxyvote.com. D84215-P70373 IKENA ONCOLOGY, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS ANNUAL MEETING OF SHAREHOLDERS JUNE&nbsp;9, 2022 The shareholder(s)
hereby appoint(s) Mark Manfredi, PhD and Jotin Marango, MD, PhD, or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot,
all of the shares of Common Stock of Ikena Oncology, Inc. that the shareholder(s) is/are entitled to vote at the Annual Meeting of Shareholders to be held online at 4:15 p.m., Eastern Time on Thursday, June&nbsp;9, 2022, and any adjournment or
postponement thereof. THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER(S). IF NO SUCH DIRECTIONS ARE MADE, THIS PROXY WILL BE VOTED FOR THE ELECTION OF THE NOMINEES LISTED ON THE REVERSE SIDE FOR THE BOARD OF
DIRECTORS AND FOR PROPOSAL 2. PLEASE MARK, SIGN, DATE AND RETURN THIS PROXY CARD PROMPTLY USING THE ENCLOSED REPLY ENVELOPE CONTINUED AND TO BE SIGNED ON REVERSE SIDE </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g288879g01a01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g288879g01a01.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1RN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ')*^<Q0X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 W
M-34U' (% $!-:6-R;W-O9G0@5V]R9" M($EK96YA("T@1ED@,C R,2!0<F]X
M>2!3=&%T96UE;G1?1U @1')A9G0@-"XR-BXR #A"24T$)0      $! ]^'QV
M33*+VX_=LH=:D\ X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q :Z            IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              "T   !-0         !
M      $              34   "T                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     (X0DE-! P     $A$    !    H
M %T   '@  "N8   $?4 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( %T H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MUT%5P#\?"#@&'C]&&N_]N;$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( $X A@,!$0 "$0$#$0'_Q  >   !! (# 0              !@<("0,%
M 0(*!/_$ #\0  $$ @$# P(#!04$"P    ,! @0%!@<1  @2"1,A%#$505$6
M%R)QD2,R88&V&'>QP1DI,S8W.4)48I;1_\0 '0$  00# 0$
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M^)!C?&8KOEJ=,&R]Z1[@N5^M,Y6*MM"6>H\ECAWIKI::2L24*<,0)GFC. ,
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M:Z#8I!FOL%EQ6RA<N:&0@1M*UORY$:U51.4=+=DT%)<KX*6MA$\'N=5*8V.
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MZ>^M,P=<.$ D#P*Q_DU\N3Y>+F(K53GI]NFW'I+);[C421RP7A)D%/CXA&%
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M3W)]==^6^W4-JI(*"W4D%%1TL20P4U-&D,,4:#I54CC"J, #D#/UTW?<!HK
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MUAD6OLTJ(1I$J!+-C60.BB):XMD#8Y&UMS52E1#A?'.K/J(["L#.C>[#E->
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M:WRF6,C9<:'1M8LH;Y46&Q6&:IN6Y*@5%3+4334UIAY:1))&9&D*\>N2'*8
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6K,5IH(858XR5CC5%)..Y"Y/U)U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g288879g02a02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g288879g02a02.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1RN4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ')*^<Q0X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 W
M-34U' (% $!-:6-R;W-O9G0@5V]R9" M($EK96YA("T@1ED@,C R,2!0<F]X
M>2!3=&%T96UE;G1?1U @1')A9G0@-"XR-BXR #A"24T$)0      $! ]^'QV
M33*+VX_=LH=:D\ X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q :Z            IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              "T   !-0         !
M      $              34   "T                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     (X0DE-! P     $A$    !    H
M %T   '@  "N8   $?4 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( %T H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MUT%5P#\?"#@&'C]&&N_]N;$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( $X A@,!$0 "$0$#$0'_Q  >   !! (# 0              !@<("0,%
M 0(*!/_$ #\0  $$ @$# P(#!04$"P    ,! @0%!@<1  @2"1,A%#$505$6
M%R)QD2,R88&V&'>QP1DI,S8W.4)48I;1_\0 '0$  00# 0$
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M^)!C?&8KOEJ=,&R]Z1[@N5^M,Y6*MM"6>H\ECAWIKI::2L24*<,0)GFC. ,
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M:Z#8I!FOL%EQ6RA<N:&0@1M*UORY$:U51.4=+=DT%)<KX*6MA$\'N=5*8V.
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MZ>^M,P=<.$ D#P*Q_DU\N3Y>+F(K53GI]NFW'I+);[C421RP7A)D%/CXA&%
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M3W)]==^6^W4-JI(*"W4D%%1TL20P4U-&D,,4:#I54CC"J, #D#/UTW?<!HK
M>X+661ZWSRGB6%==P9(H<X@!DL**T^G,E?=U,I['DA6%=(<TP2C5$(U'QS-+
M&,8)%=KN=5:*N&KI9'C:.1"RJQ"NG4.I& X*D<$8Q^&,Z8]Y;1LV]K!<+!>J
M6*HIJVFEB1W0&2GE:-A%40OCJ26)B&5U*MD8)*D@UU^D-L7*CZNVKH+,9AIM
MWV][$G8I!(<SBE!1SY-D,5>UQ$<[Z:NN:FZ%#;[I&!B%CQA^V$(F]2_?]'"M
M=176F18XKO21U)1<X63I0MG_ #F#<_4'CC5%^S%?;C)MS<6R;O/)/7; OU59
M1),W5*:+S9U@4C)/3&T$BIR0$95!P  T6P\?;WS>I=.U/F;S66D>UK&P6=EC
MC2D=69'DA1U,F6&>,;A-19]Q:Q:R8QRJ0M5C4J&Q6),D*Q;13R;6V:M?3$"Z
M7QGBBG..N.%#TL4R, D X8<J6!R"-1J^4*^,/C]4;7NV9]F^&]!3UM50!SY%
M?=IA!,HJ8P<%&>98G5Q\45,Z@ ,V;R:6DJ*.L@U=/60:JM@1A1(5?710PH,.
M*!O@&/%B1V#!' )B(P0A#8P;$\6M1/CJMI)'E=I)':1V)9G=BS,Q[DDDDD_,
M\ZZ[IZ:GI(8Z>E@BIJ>%%BB@@C6**.-.$1(T"HB*. J@ #@<#3 ]S/;=K_N9
MUAD6OLTJ(1I$J!+-C60.BB):XMD#8Y&UMS52E1#A?'.K/J(["L#.C>[#E->
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M:WRF6,C9<:'1M8LH;Y46&Q6&:IN6Y*@5%3+4334UIAY:1))&9&D*\>N2'*8
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6K,5IH(858XR5CC5%)..Y"Y/U)U__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g288879g27k39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g288879g27k39.jpg
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M(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X #D%D;V)E &3
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M 0    $1 B$Q$D%1\&&A Q,B,E)Q@9$SL<'1X?%"@D-B_]H # ,!  (1 Q$
M/P#^_C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8%
MGL5A!U*OG;79BL(%6ZR')V&P&R;Z(HX.#"PGR18J0DN;TW'A#X$9QYUQ6])0
MVC>]_1K XG^F?ZK[/FAV,+S*V:'@R/9O#*I>;/%@ZD1H$Q^@FO)SR1XZ?"::
M7IN5/FUJM4NG2'O_ #KTY/?7O2=:W@=R,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"*IO=.*CNP!_'PA
MUKF\+N]AJ4J_ >-2[K78_4#-'A294.9;Q=%=()LTZMQI<%]M<UN,J.E;*];7
M[4*]@<U?,DEZZ\0O;?[CE8],PE2/B2TU)SM=A\B?PK*A_'<^4>ECA(T1SALK
MN+[GO(<G+C:<][^-M/L]H?QB^K&9_:6GZY-3ZFT+K=<]/UPI7HOD%OP8C<CE
MTW\%CIF$U;'"KM,*R+0XQ)@R-MM-7B6R!=F?!0_K3>!MWZW6O&$1ROT8Y/I'
MD_(MKSNUQ&J0? Y'C/'FO6XOXE.B8BU;ZNH3\"Q_6KA-9!3+;#;B7ICEB26:
MU'^)M(;X^$YW]L+2'K#77:AX23A&F])>F>7LRN#+<_!VG>VEF=^*!5PC'F)3
MO6M?&@[D[WK_ $R?;[=X']07C.[Y:O4)2O,:!XZC^GZE-Z0UXTE>E%J(J#\!
M.W%..]1#AS[4SYGVZTG2%H]S_P"E[<#8O 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8$5=%[OP_D$H9"ZUV3E7+IIIA^4&B=%Z'4:3*+
M1HKB&I4@9'LI@8[/8C.N)2XMK2TH4K6M[UO>L+$3.R./[['AG_BW\8_S]\K^
M^O!QR[2?WV/#/_%OXQ_G[Y7]]>#CEVEF%&\E?'+J!]NJ<T[_ ,3Z):7HLF<S
M6J-U6BVT^["A)TN9,;# #Q BN+$0K6W7--[0WK?M5O6"8F-X39A# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# B&D^0/"^D]$Z9R+GO8.:W?J?&) F)USG55NE?.W7F<DZW(="Q[U6AL^27J
M[Q5N*ZJ.F8TSMW3:O=]OLW@?S:]?_P#PO#Q5_P#E=VK[I_(# _JHP+%:*Q7[
MM6;%3+:'@6&JVX$7K%F %&$2AAROGA\@49#D8KGM1)@$QLMQEYO?T+;7O6_X
M<#B#Z9'I0+\..U5_J%X:A&R7"_"NH^$G$C;ZHL^4S31/D]Y,=:L]ACJ6MZ0-
MFV6HVZF,.*UI#F]QY+6][3M6MAVY-W"I5I^#%L=HKH"237\(;'-FQ@I\@Y[?
M=^'!9G26'):_>^CV-Z5OVX&0I5I6M*3O2DJUI25)WK>E:WKVZWK>OHWK>L#]
MP/)]]B*P[)E/-1HT=M;S\A]Q#+#+3:=J<===<VEMMM"=;WM6]ZUK7\.!9@%J
MJ]K8?E5>R ;)&C._ DR !@>88COZ]OM9?>'2)+;3NO9O^*K>M_1@7[ 8&.)N
M-16=55D6JN+LR$[6NN).#%'4(UKWMK4(U*V02G2?I]NV_9[,#(\!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?PB^OAX'=[]1GUEZGPCQYATHI>Z_
MX&T[H:X_0K.JL XU8#]=Z )*?)$-BS/NSG"5DB[TREE.G-;4K:M>[],>CV\H
MP]NY[M1>;_LSOJ9T.?6YAWQE\"NM,@3M@,3AW2>R=%7"MD0W7XH2'6[)]B9%
M+D* U>;'44'ZA+AR]$7G-R'Y$?W(Z+2S[N,]9A4=F_9I/4PZL;#EZMXM^ 7
M(@L2L9)KO%^R=*;"'I*YKLO1PSKILOI)/99MIS4=/RLF-'^"A/M:VOVKVHCW
M<8ZS*J\#_2<\M?3']6WTR#?DJ,YB(8['UCK8.G.\VO"K7)?=J7%+7+L+!?20
M(-4&(Y$L$?2->\ZE[VJUO6O=^F4LYXYX3$=G^C%E>4P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P.$?IX^2O
M#>J>JIZNW%>?>('/N)]0X99N.Q.L>0]:L;A2W^2DDY%M'U7/N8557$M@G:U\
MB[IC2)T_XFI"M[VG>OI#3/K_ /\ A>'BK_\ *[M7W3^0&!_51@?RB],[9OU%
M?VCGQ'YMXRVDM;.'>EQSKK=U\K.@4TS.US_\*G1!1&OA.92B8V8H#928@^,#
ML*9W[ZM/I+LZUO<"3[@;"^M!YU>6K7?/&;TE_38,CZEYE^7PTI<KUV>>RQ*C
M^./CP,=*PB]ZCK<:G)&'2J0)9UN;\N]+AQ1:TPF]D)L%UD(DK/[)?Z>!X0@S
MY3]4\MO+3MQ9C<FZ]HZ-VXR,+'+!)WMT@3%BQ[4J0.ANR5;4TP0GF)"-?_6R
M7E>U6PU*[_PORK_9H+)S_P K_&3R"[5Y->E++Z#6*3Y1^*G<K#N\V3A@&ZF8
MX>)T7E9Q$6!$A,1ITI#$9<2,.<V25$BD4D&)6Y$0.P'K^=!9*^AOYF=,YK:I
M6AUAX]S&TT^WUDC,'/30-EZIRZ:-*BR,1R+,:C%0Q%*M;UM.ULN[2K7LWO6!
MP;]-+TO_ "@]<'QQY/Y0>JCY,]TKWBK!HE6YUXK^(7&K;.Y_7+!0N: 8M UU
MCHSA!DVLC*N<P$\\W+>:?-EO:N5\^P/7#B[#?GIO[*]XY<IKA#H_IB>0WDYX
M3^5U4BN&.:W85V:PFZ.;L ]AQZ#7NA#W8NK"JNFWTZCR'HDS:&&W5+=AS6M*
MBN!T,]#;U#>E^>_BM;1GDD(AUKS'\3>LVGQG\J 42)&&MS.@T=WX$6Z-"(*$
M0!:;5#0M$MF-I,1)B!.U&0W&TTVD.;WEITGS&]9GU$>V^FCXB]]MWB?X+^&#
M0(+YT>1/+WG8/4>F=0L:9RU\3HE@C+BRQS$!0V6,D1T/L1=/02<@CJ:RB! ?
M"1F_V1OTFFA:=MR/*M%\2GXVNMH\@)J.@_6WPO<V<TZFM:J^B>WM_%]NAGN>
M_P#1[ON_1@< _43JOJ8^G'Y8^GIZ?W8?*7HWDKX9V[SC\?.Q^*W=+F7-M]@A
M#*M>15&NO"[]:HI!$DY#!Q;W$>?@379T%;'R,F!\FAV3 8#_ $>\!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#^?;7_P"$VJ_^4C__ #%IR=73_P#+
M_P"G]!.5S,#@YZGGZT/T%O\ ^(/RT_\ O?A^273#[<OT=X\KF8# XI>NCZFG
M2_3$\6*9T?CE&K=LZ;UOJL#D]8-7M@E)Y_0U2*U8;.0L]CA"9HV86E(A %,P
M8?S49MQU:G7%J0PIETZ>WA&<Z[(M].GO/J[VBXUR]>6'1/3M\B?">QT:WVJP
M^0GBM=GI17FQ8-7E' PZ0E$D8$-"77D*CSMLPY3T3V>^MQ&M;]L,HPVBXR:;
M<_\ 4W]8+U6K[U$YZ3W,/';B?B)S"Y3J2)[_ .4$<T4,],,0&697M@C!R2C<
M%V:-D,35#X@B7]61IC"99#4AS3"34X88???)VW]/:T^HY.HO3 OJ7T7A55Z#
M2K;#AT.^\',2)%(Z=0WP3$Z79IH\F7G3Z\3%F=/QGFWXX[2FTI7IC2=^^JN>
M7#_TM_.]R;]HW\B+5Z@5;1;Z+S<=Z7'3/+N\^)O/.QMU,V.M&C P8+B54^1N
M\BWR@COMGV(.;(M?53:$!2:M(7[\=:\CK/M1Q_\ [JW1#U]?51\FO3$:\."7
MCE5^;7'\,]VZ<,O5;O\ 6[">EFQE%B\ZG#0M6E5VP!Y00D7U99;"G_@3U:4M
MM2&5;1M*ZS[>$9W:V^6OK@0R/HY&?4C\%9E+EW<7;N7TVPT/J(N19G.8V^QV
MT$#NM%NX((=KLI1@5#*;<@RFY#<>;&<8F,Z6RZG6#'V_KXY.TO >B= [%XB\
M4ZRO[.,=3ZGXX<XZ(K6XDR)46>@7CF0:R[]L%,F:0BUQNQ$__JM///(BZ]WW
MUJU[VSG,5E,=+?RZ^9OJ#_M W@C>?%7G7:27ILF;%Y=]*3R?FS_/*7V@N*&6
MG1BD@G)-O?.'JY)&AMSKY#5IR*U-=^$AW?P_:E*5S5VQP]O*ZO1M?Y%^IOZC
M_I@\%)D?/&J^*7?/*/R Z/6>9^#G)_%=GIXL(=*(A247PWU1VWQ6B[PL05,
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M /R]@03Y->G%^U ^7O!^E^-G>/-WTWK9R3K0)JO70#&HI\)+F0(Y0>:B.0C
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MR3793FG;0B(G>_C;A+)PP^Y&TZ]W3B6?>^G:<#^JC 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# _GVU_\ A-JO_E(__P Q:<G5T_\ R_\ I_03E<S
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M"QV>TW$8%/\ NS-/2F/?UKWG/A#C*M;\LA^K(1I!'GYD#<ZR>K8>\C3UII4
M+46KK*JT*D.OVM)J0&,$K=/M\:)#@PE//?.LOM.[;U\NN2./7HR!GR@JJ^1V
MSM4NJW 53:G(ABI&RT*% )$;"DQ&J]C##X;\U/Q-5.WR%B9,M2DQ)$R*_N*X
M^PA#SA*UIC_./+<-ULT/K-!YS=)UC;"@#UU$F9-9!.<\CDU,1C(FR.OFGT.V
MBLDWE19$")I_:W6'=I7\/3;CA9QK=MSADP& P& P& P& P& P& P& P& P&
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M_.<CR%)2Y'6M@5DRH#U7Q<ND--- 5,I;Z_T6R?(CJZY3BDRM&"=/"B#I;ZI
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ME^L9:3%F3[69(5ZQ_7?09$R(@:J&)A2H[,EF(F:G<S#7);'/3Y2@&_5QO1(
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M90=+E+'1"Z(T:;&?D*$SUO-P2B66G5N*'37(SB6G]:^$XIM6DJWM._8'KHA
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MWV8L2*R[)E2I+J&(\:.PA3KS[[SJDMLLLMIVI2E;TE*=;WO?LP*,87&F679
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M*1*;VZPMB8U[T64AQ"=_QFUKUK>MZW[-ZWK N^ P& P& P& P& P& P& P&
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M6%-G0)#;4.BP&"GU/6+[W^ZUBFPBK-DA(W3JT"[<D<S!VRMJ.U7HCC.F6_\
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M0E/^DC[ENJV7E7Z)JMGC["[#RSIW*97DS49=CM?5BMXZ,8J]9&-CQ[]MYHF
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M#*9$>>D:Q(<FJAR6%I6VYI'N+2K6T[WK>L(C"E^1/*K[8X]2!F2D4_,^UR8
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MDIUC3CZV1T!E@S.43%.CV&3 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M1!@V'N4>VDC Z-?0M9L?DV2[%+=W9+ %GU@M2U]VMZTM "D6? E?$:9=B/\
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M=6(Z"LH@H(":B04DY*RA&'+=B06F1J]2-K<6E/P=^_[?=^G"U*UE>Y\:!E&
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M/M2D?%BS(JW&'DI<0I*O9OVI6G:=^S>MZPB]8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MCMH?6G"6MCWA-PW[*IIHR%900-$ P):;%6!W<M@:?URY)9B'.)QR4J!,?UR
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M>N P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M5O3&X^F_F-_"T*FZZL>-^3'%ZV3C@[!:"86P2PU:/0ZV3H]_AV:= M]KK='
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M!TFZ238TA=B<,..E&!<@#$FCA@@D1CL&'EH_]S/R&F9J677$-J'&61EO*S@
M2-"ED.AQDQI]0D7]AZ(!M1-"*3%I*>BRK1,V,!2_J\-'ICB)JWY'PD)TXVUO
MV/.(;4*EEB>T4690BG1!!-4D"&-*KI318>;K! 4<8L$6MS!!D*?$0[ &)12,
MM&O@2(;;J]+0I*=H<0O8J;I;@7>:19>5!>PCOK<=43E@%UZ-NW!BM0*LRB70
MX_-D[F""\%LE&VHZ_P#[NE;6M24;1M*M)<TK0K6GD'\B>4V3E=P[)5S12QTB
MCU^=9CC@^JVB.>^JX=-@=!87 JQ<0,L,]9JG%H9 =\.-M!"+,8<84M#B5;%3
M==49B_-SA#NK4JSG"U%U734(3";M%6MD.59]$J]SBPPVZ]%2 4Z4L6FNHBVY
M ./\<Q$V[[[T=#>_>T7C*7;-WCE%2I-.Z*7MB7J9T),)=)-5\-8K<FSL$:B8
MOL26(@U,0;)2H*Z77YI-3^F?@MPXRW%J2G6$J;IBJ?*_Q_=+AP<;H+4\C93.
MP%20,KEO*1;N3:F/#IZ*&1'U^2-O44)/CK9)21#LV,,=U[LMQG>]:V.,K7 \
MP>"2  &Q%[43IT.S,="E!(UUJ-LK9">SS M8A%J2Q%FAM>_.2Y59CT.'I6YI
M".WI<9ESVZU@XRKP_EOXZ&SHVL1NH"(%@)_:%+8BQCK!4IH^552%Q&'AE@9M
M0@-NKFH$KGIS?R)+Y28ZR*DO-MK9:4O0XRJY'E-P>*B]NO7O26.;,%I5MDHK
M-Q>BQH@ W$KEAF!Y+-><8MD.N&R$>.1>$JG-P%R&OF%-I<1M0J6/2?+;EFK%
M4*H)FN68W<>B"Z'#;KC1 J-&L&UV5(>PG#\<9L &CET5*>J%&DR6I$],9W<7
M3VFE[T*ED]T\H."\]M92C6[HPP7;PT$?/GUYH>>*DD:*O"VAHV,P&%$/K"PS
MDFHCS0N/MTDJ+(1(TQ\#?Q,$8S.JA?\ ++Q[BB5FI72($6(V^J(Y&DAK-',M
MD$N@HNQ3E>>"(/H,?6EF@C]0]QM2ME'_ )'3?SB%L)'&5CK'F-PJRO3MMVZ-
M'%_78T> /L1R1<&<"&J[03(6W2RHD=+@5$ ;*=!BAX3IAR%J66;7%9VM_P#T
M6AQE7#_,7QL)(JBV>HCHJKL4&"*W&+A+4!GRY!MBFR0<N6.-@A\\.#.,]$ [
MA$IK<<?+^N(>F7E[D-Z4.,LXN'?N/4 _JKW.]B:Z?4XEI TBT1;>7M=0N-\0
MXVM$);+D9=6H!B0EU*MM;<A*CZ5\RMME8J95/-^Y<GZZ0M KG%U&6HA3'HK-
MDBPF2$=P?J;.-BHLA'S\.(F= >+5HC#U)C;>C_-CY+'O_%8=0D3$QNE?"& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P
M& P& P& P& P& P& P& P.6X*7X'&*/;NBVRI2Z3&&R':A>D'$]/:7 &*M??
M:&/,[(MLQF"5;.O&K:A9F!MV&IMA#+TG>Q41,8W]2\3F_3JIXI',3I$0B%<+
M#7M3@Y^?T*<[*L53['<R(N><E3%.+"2*]V0Z0<>??7&1"ERXFW-MM+@^T?5.
MK92Q6KEG-GOP+7WI5_EE.F*=EC'R;EP)2P  ^: \_"0';\$$KBU44JP$X R)
M)+3T2II&;[7'GWGEJV9BYUAI1( >#TF%RR=2[O9J!S6NJ 7\HQ$J_;([%W&C
MD >M4>O6NT&=,1XD.>.YLS8H88C&?FS1F]S(+;")>GWS7U):N75?%+GW*NVT
MD:$FVFLSQLRFG:;5U] +D[?#IG.ZCRXJE1&*+ER*Q7P-;$"A;IWYA(OW]LOJ
ME?%DI4X2LI83:K9Z?54YMU$2-C:Z"WS^+:TGJ*(?Z38C%D*51WR%Z 44VN*R
M3>F!7;$>O6Y)QO2P\1]3J77T(C1D-EK*VRED$^.''>7R^=7AT^S5.L/6JX6!
MHP5Z)T"QS77]C"]TOIZTL/'[)7Q%6D2X3\HZ[)B0 BU1EZ>C_P"BPFLS<(SB
M<2\*%TSHG9W8%EF5*E#NY5J_78^<['+>DMQ'NGANT&4J+2UF;=+1*NMGB_6<
M%N7I;KKJ8+BE,M>X+RV55%[-XC<KO1ZO<WFV>??+]T:K@+;71X2]&B0NX] L
MCC!(X<'FXS2@+35TL*G+8\GW5#B\S:9R&I*]HP3&4[L#  ?!ZC5.BLG;$Z?^
M [8NBO$AH/HL(/:HMPFGO*<A/M]6KD.0+ET$&H4\9'0"Z9$(.Q#8B)WI2M,O
M%^KQ_"8N2U_QGY_3;IW#EL6P::YZ MT4W-O1;J$4Q7AH.E4=Z372 ?H:9!VO
MBHE)HE?W";^0VEL<VT^PA>I"UO$FYTEAP*O^/6J_Y ^59<+U.Q1ZETKJ5S,P
MS@FZPR8$MPFQ4U-C;YM1%38\25'(6?Q[&2F9D:.VX83'2U)5[BGVL&ND*RE<
MU\-[5<Q51!#[&]<:ZR#L%3&6 GU:(U3'Z*P.L@.LTJ>;EL! I;DS71$N:!#9
M&I->29>:6PRE;J$B\F+52P>/O/.<$_'2T5VPR8)KH?;T="B0!!#Z[U=W>J#3
M<0H!KU'=)6R-*O!_H0DA28@A+DT>)2RII321KBFAK=L>W<O (#=RW2[*5LT8
MV+F\O7&Z7="'3YPFX29U3YOUX)9@9&3+E,'FPP#E=>E6"<XRE [8M+<W;>G7
M=/%K+HE&X2N*>)=OIE&"4&QEU>34QFA2H:+X2GZ&5JLE8(076Z=7+*>D/[&A
M'.MR'V0P!$?<86B;(TGW(B4X36?V8-0Y'I\5( /377I(^LE X:XH+V>%UUL)
M)&@7!O3JMLL6M<) ^/(*B>.QRPL=)4V^8##DNL,2(DC6WVE+/*=U\'= \'>/
M5V_<AEV$_7H_0ZNU+NU,NVNP2K<X"G4H9SX15W(5I8D6FLD$<\"1&8 1KY6:
MT,93,0QI"E2%$K*9>Y$IX=UPM>[(E)0,S%Z&Y<>C$4M=-#HKW0N5UY[L)0F(
M&,B5.S;&U&KR7S4&!K2I>UK1(:><>4T\/J4%4$>#4(E!I =%LE$^HBB_*TC3
M2>XD%A19^&?Y?KFQR2::>8Y9K43CY(.-'$'!;C2@KZ8^M.>\IP?5NV>O8CC-
M)K\RMVD:1W!Z_P!%^L]UX)#N%E/6R^/;9M<F0,%5EHH>TW"C5+<^5MA#<.)$
MAN..^XUI>]DUG]D-U#H'C2>"IXBN.:@5U_JDU->'D7+:4"2#L#L!\S4YWVU'
M*G":P-MG2J3/761L\C&40BQ&FXS"HS\=IPLWO+#[!V7QUX-T:\^-AFFR M-G
M\G&VCH!O1Z8<]VG!..V2O_&>J3,DC=)-=#\TXDV,D3H*''5$9$-K33CTAQ](
MJ9BULL8SP4(A)D&T,V5;?.OKFZM&3,+L;1J$;K&N9U*VF )R?$1(/7*C2:]7
MX!IF(Y*FB)*7&9C32US$[+]3][%U;QEZ!+Y3S^?:KSNA\]AD^CKM'/F>E0XD
MMANDT_D &BC[)41;9FTD;4/\JA>G8025)FM+4AB6TG3R]))$3'CQV8395>$H
M9^OUJ>%/PPYBP7($9$";-U*#SOD]0!O=9Z):6G=MM1*I1QMG/>/\N?.K\7<&
M9-F0V7VVW41V5J+]2N*A/ 6XV$0-T5FANE7<K>J+3QEXC]C%SJ[<BY^[BG&2
M-(L;];DUU<*X]@*L!$ROJ]I4LCIL<[IQEA3 ^J/T95:N4<A\0JM6+V7JQ'JM
MKL]D,4Z]W6X6.6/KQ9-UG]1Z6:MO5Y!I5E$QJR$EGRT.+*GMRUQFY\>.](4C
M6G4"YRTZ+A6O'/A%YZ-V[F%JI]V./1]UKL,6T$KM.8J[@;NEOOEA^I.50*W:
ME?9@*)*T)44BM$0=]:+88<WI[X2'=$N=)A$?VV\1Z9;9A./RR]5^S\C\K^?<
M-8%QKL5@BRT^:1='5_MAF!NXMA#W-^?MVVQJ2Z40](A.P9K2&/BJC^\7ZOYA
M+2NE^!][LY3J\6Q;,FKFS%(GI@87TI4<H_R*9R<X -F!(P5IJ&90NR4V.'<<
M;9D'VR<"'%3,^,AK9*RC1;#V_3_(VNVUPY\5B_SP->A' #D/JS=T8D$>N@.P
M A0>O-17"[?1A_5>LAR2H,&,HY%V0A-/-)BMM--CZD> N@> MVK\:PE)TVGV
MJ=405O.UE9'H)(C(;93S@=48%L"0&OJJZ&ZW+?JQ9D'+C/OCI4UN6[&:W(DK
M67ZMD@V7F'CUXOUWCMB?H%^NUC 5HZJIW%VPF7+K;;/2>8U4F"YR<5:CK<B5
M,Z )Y-!C"1$K>H$2<+;:TAC:U>^(O)\V2^^&/>9%:Z;U:NSX[MM!52FTHV2?
MMBD6.*+&4'R7^SD)BES),)HI7#4F)%>0[I$N9,:FBV_C,O2&'A'*-(;8<)K?
M%A<&Y'N)?"6"LMP-2C#H^25? ?:%PE.-'45QLA_N<<:LX?EO+1 _W-,IUU"/
M=VWM"#,WU3SA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8''^R7/Q)N/(#]GM_%U$4##_1
MZK5J'4KKT,_9BPOFEIZ'6+0_<I=4'QVZ %40[063/5*?DCVX]D9;?D[WMEMD
MZ5E$[I$)]5]/ )=EVF<_*K=VE= F=+9-)#=9 S+*1NWV<!$+F'?3'BL6GFMM
METD2T[N'\P ES&H[NV]O/Z<<)65>3*;CTOP]Z+UBM=%,72QW6Q@((N@USG]9
M$=%(1SYQ3O.^Z Y7V2K(]#EZE#4D@\R.W*9FP(<V,]K26YL&5I@E91"CA6_P
M+40K<P(R1,M("5VJT@8#%]:-UB^OB*@.YP.'U>NQ6Y-?Z3T*E4>YL"IKZ(\T
MX'@O*1)<:U$<^7+]2PVNN^,@+Q(Y9VO?";9+I]AJWCY!A46E7.Y0K?&IG14<
MQH48%-(,6(&6M0JNUE<"45&2%[<.+#)4ZR].VW[2:W,6M@!?C1UHZKCP[B%P
M?&=-OG6CE6G +]:(-2/40;9.B<U[A?P%CK%BAHJ%(DD)RXY&OQ78[)/[6BMI
M86F1M<4NL:VECN%XYQ8H?4TWKB5PL#7CQ>*!SK38VY0*\NT4[M$/G:3Q!UP-
M:QRB'-5Q#S23  DI]15 A.EP7-[9UHD1/\OGH73P?/JWY <G+<$^ON94FO##
MMBA5/HT:8LX&[UTBQ0#+!=@NS79E8*.,2"=@E1(\Z8ZS 4A$?^.]&;4(B];U
M9)6J31"GD!U>@R.1-A=,2:-W<E<*_P!./S1[UP<N1"34B<NI,,AH]*MEC(U2
M=/F-PG'VB$=E?SVW$RO==%Z)-%>*'! T8S#A4=U48]$+C9S$ZUW,DVT'-5&5
M0Y0$6@A89*08"/3IC@^)!A? BP6%?[NAM6M*T2Y22[RVA/5^_P!6=K[*@/4=
M$M7P?\X2TBP:,5492"7QGM3=28?S57#1HF_EEL^ZEK2T^QS:E[)9&Y=1XM8N
MM,0&6[5NAD+F2M@243+2X4^1T-R8_<T1DR9SJQ,,]+(R7W8\-3#"7Y+KB$I6
MXI6RW.ZPU7A/,*9;=WD$!F-V?8YT<D@1LEF-MM*F#J\*+F&!QDQ/&1K/8X%4
M'-E"K;*2)/Y5*I+SJE+VL7*EL'CUR*S'+G:2=44W:;\[1)-DLPD]9 5@<G\R
M5-W1BH@N%+P)M;, $D74)ECEQ9#[*M-O+<;2E.A<L?<\4N#[D!)4>E.#GZWJ
MKZ K%6:VB_JG[(UZ54A>X6H)UA+2Y57E[@$%>SWBL9ME,S;^V&=H%RF6?4:Z
M3L]=N4X8W(LM3@6$77BBGI27!L&U;$;/L-L-OHB/:(_4,3WE.MK4CX/\3:?>
M5[Q$.3/%/@9!(YB;S^/*'"Z@.H\<(\<LSE?>!!JF5H@5PB!49V)+'PM-.2QD
M,M*9>*QH;ZD-R$ZTCW2\I5"?&7DB99HDF!;?KFRUABHV0]OI715G[&)B-[C1
M7CYM=H43,FXXY6X22,AUR?N![(NWML:2WH7*V1_$?Q]CK?7NAKD_%K ZDM)G
M6FY3D#Z<(JIJEBZN)1+L#J10.!6['.CM1X_PT(W*6YKV.>ZM(N6/V[Q%H]EZ
M#7;T*,G:1]0D+#9GX-3E38LDW>34WHQ>#;#$R81FCB3U9L'53)(:Q)@/HAS9
M'^A4VQM;"Q<[)JLO*ZI< U2$V-5AG2*1+ADJW98EJL8"Y#RT0/,K[Q1NVULF
M'.ZF%@Q&3&G>Q_3<UF2ZAY*TKWK!;%87C?QD87J!D=3M09%&&5$2 A13EC9!
M[8H#,]FC2S=>27T#M!FH)*2%#IY./+FQ77/B(=TXAM2!<EQ\<>.W^VE;K<*K
M(-G#5>:K1-+]FM; 65 CB+57XTO=:AG(]>:/Q:_>"\%HHB*DBU#(OM)?TA>]
M8(F86*S^)?!+C/*$K%2Y4^24,3K$E";==(D,(?+FA]BL!NI#H5ACCZ<5M!P6
MQ**R!;41TD\G:I.W-K<]X<I>HSQ1X(&+0C VCN17A@P*)%P4VJY*!#(P&?S0
MI!?'UURPJ!12CL[CM9<E341]3)NQ+>I#KNEO:=%RI[!XF\,/RI!)^F(01=8M
M?L0X;M,BORB=OA]'@DS!ZI?7[-=L\]$?K5A:97.8>7&8)N-,*:0AG30N6/\
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MI9<6I*=J^CV[^CVX'D\<"QG5L2# MA]I7NN,O$(C3K:O9K?NK;6\E:%>S?\
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M,)?,E?'Z2.V^P+%LB97/]M\_):;<":C6G6F6M+7O;B?8)K5,7CQXX1N'<1E
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MT7HOA]X]W6]W(J\<M=NLO,:P6/V$Q(0VV^3+DY<!R3-FNH93I3BU;5O2=?\
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MT_02YN^K6'_X5/ID_1O^X]XM>S;WRVM_@FIGTR/;M/P-?^[_ /Z[VZ]GN_\
MF]O_ (8:YY]Y;0<[\?N!<HY@0X9S#E?.Z-R0FU9XI+F55KXH14)C-K2\FVL2
MJ_":;A.H.)GKU,2I'^ET[OW_ &^]AF9F9N=VK*?2N],%KX#"?"+Q41MU"-1F
MOP4TG6W4;_BM_ 1\A[7$[]WV:]WV^WV87GGWELMPGQH\;_&<:<#^.W'.8\;%
M7*?&,6"!S:LAZO$L9$;%^1BD)[(EAA!"3"AJ^$EQ6E;0C?L]OLPDS,[RU^+>
MEWZ;1<L6+FO"GQCGFBTT@?-3YW*J>[.G3BDQ^<3+3G78&W77ILY]QQUU7_G<
M5O>]^W>\+SS[RESB/AMXB^,UB)VG@'CWQOC-HM ?5=*F^>TL!52QP&W,8*:$
M290R-'?FP$38S;_PM[4G2T:5[/;K"3EE.\L(Z'Z=W@+UZ[6'I73?$OQYOU^N
M1'4VS7*T<XJQJPV$K'AL0-2"929"=E3IC,& VU[5J4I+;6M?P)PL9Y1I$S2J
MY/X(>!_#+N,ZIQGQD\?>9W^MMD8@F\4FB54!8 S9P=*$DV(I@?&9DQ$DQ<IY
MAU.E:^(TM2=^W6]X)RRF*F9ID/9O!KPX\C+>ST'NWC/Q;KMV:"P:\Q;+]0@%
MF.( CGYLL>);)$H;\C0^)))/N-MZ5[B5/+WK7\;>",LHTB4?U3TT_3MHMEKM
MZIWASXVUBU4^P"[!6+.%YC4AY6OV4(09F""@HC'@H>A%1I-A#C+B%:<;=3K>
MOIU@YY3I,RE_O7BQXM^2ZJV[Y'<2Y-V-5*438JJ^F54'9]UM=@2/66:%*,,/
M_(++)%QMO)1[NW=,(WOV^[K"1E,;2@5?I1^F<VA3CG@SXNH;1K:U+7R*G)0E
M*?IVI2E#M)3K7L]OMWA>>?>6SO7?'W@GD311G/NV<JYYUSG8DH//":K=Z\*L
MU:@%PT*:-&%(<">S(ALRQT"?(9:<3KVH;=6G6_9O>$B9B;C=JPYZ67I@LZ1M
M[PE\4VM.-Z>;VYRNDHTXRK?LTZCWH.O>;WO7T*U]&%YY]Y;/D."^/)7B_P#=
MJ)\QYK.X/&K8ZK?@;E PSU!8JH5^)-&!=U5;>QK8@=(AL.--;;TVVIM.]>SV
M:PES=]6M+7I2^F:\VEUGP;\776EZ]J'&N1TYQM>OX/:E:1VTJU[=?^&%YY]Y
M;1<X\=>$\?YB0XMRSDE Y_R4LFPI)\YJ=:&!:?/3;&W6K-J4#A,-07M'6GEI
ME>\C?QM*WI7M]N$F9F;G=J^CTGO3/0E*$>"OB^E"$Z2E*>04_6DI3K6DIUKZ
MM^C6M:PO//O+8[A?B[XZ>,<"Q"_'GBG-N+CK=.@DK1"YQ5!-5C'R R,[#'S"
MK0J/'1,D0HKZVVU+UO:$*WK7\.$F9G>4!E_2V].0\6+'C7A+XU%#1TH1-F2D
M[DU3D3B9<M,>($R4V0X.4Y(F3YTEQUUQ6]J6XO>]_3O"\\^\I8XAX6>)7C38
MB]N\?O'/C_&[0?"_9PV?YW1@=7*E0/ST8G]43I@N)'>D#_K"&T]\)6]I^(VE
M7L]NM82<LIWEAO1_3J\$>P7BP]+ZGXC\!Z!T"VRF)UGN5LYI6C5B/3(T&*-C
MR2A2;!=E3'F1\%EE*EJWO3;:4_P:UA8SRB*B9IK).X%XA^'W9R%VX)X"^/XB
MS<:X[+[/8NCTN#6J!T0!32TRU52RPN?08](F1CQK5:"$77F)1@,U)97IA+NU
M.?06\LHUF6$]S%>+/DYKIG<.A>&/B-Y$VKDUTC\7T_T.[0"O4&JM ZJ5H 26
M=@/\5L;U.%3S1)90?!<DR-.0Y+R_?2ZGX:Q$S&D3,+$,XMZ:G(NI760UZ??!
M*M;.!@0_0:=>Z%0Z8178^NTB?3'KC3.<$'@-=FQK#S:U=#J,>.2EZA-R)A=6
MU(B[@2?=+><QO+8[R:#>-?1R''!/J">./CD7E2X?6R5#F]%M-?Z!7:>BOU^F
M&BH^$;N]'IJ(]@MGQ?@O1HK2V])%)<2\_I6M-DB9C[9EK7T#Q5]+NC^/O*^Y
M_P#PWO'6Q.]4 TZTP:&*YM0]F(-7*4Q?3N@F-370GP23/-^9"BI1Q#;*=D78
M+<1KX;LIK>BQEG,U<IX\@.K>-/6HO0^!=S\:ZEUOG_*>@<C10 =S;K=CHW08
MAVF4B9]NJ="FC9D.%+YDGJL6#)C*TMW44C%D-N?"F:TV\DBXUB4.<P\+O3LM
MJ9D"\^FEXK4NQ+XU7NZUN'7ZG4KN%L=)/1I'QHK9B70J;/&V6ODV6X\V,\/^
M7VF4P['D2-;=2R6<L^DRR"A][\?>J\'Y5XX)\>?&R#P3I;BN:#N=&>KA7/'W
M[. *)S'IC-,K<ICE[T"SV8//O30F0 T,B-Q#@B4S\PK;>E8T*F)Y7-L,H?AI
MX G[Y&I-O],GQ K?S_:+IQ:"4K@BOV[2BM'YF9Z62.2H1+D],W'&3(0YJ+'0
MAUU[;SRU+TA+>OBS0Y95O++J!Y&>/7$*A8N#<=\6>6T?F3O/>G=")<AJ%KKU
M<FEFTU7MANT%'^<1*6@<N@F=\@T*+6!<O>HQ(]"87$=TK:MTF)G69U6_D7A5
MZ:79H)J+3/3B\7AEC \PH%OE5VV4&I"$A;E:S_4:D>YC9Y0NGG900G0K'RR5
M%FRV8DU#^GDN,-+;]U3BB<LXZRNG ^O^*GB+S2PV&E^-/!O%9WHG"27D<BH<
MYMM<!M])^QTJ6!!U5V5(I%'64N&]RE-H^%%EHC(E(TG;GO[UH91EE.\RLH?Q
M<].OJO;WZV>]/3Q;'$KA:>MR2-WO]8K4(OT.T5'JO4Z=;%\^C)H)"#T"TMSZ
M+]<GH<@H,G#X9EE]")B$O.)ARSB-Y7'E<WQ$\5>Y=:!^.7A1QCGU_@%4<4C'
M>/JK5?M=A,%;)Q2/6ZUU!F%3H#?-:=<['TZ))&RWII3YI@#.?3&VXPAI=2>6
M4:RC_P AZSX.F^L3BWD!Z?7C/=>_V:]&JQTB7:I-4.V:YGJX*X2FJ0>6'"7.
MM%>Q7"YTOL890<7,C@)'O#Y$5Y;.VDKV6.5:3-,HJ?._#GQ+Z/9.JC/3[\<.
M2GN/]&NW. /1N,I$$+]HG$\9RW<)<H+%D\MHOU:BSTV<V!TW]9;W\]-<2XK4
M9'QEB\IBKE>?)\?XLW?I]2F>:O@/QZ_]0V]SFN$[86W6>LHI?#+0%[';9%TW
M8S-*!%I8OEYWG1C1X0W$;U%C253XDB6U[Z<$<HCZ9T5==\4/3Z CN1]&Y3Z>
M?C<SUBS=UL](Y1%9JE-K30:W<@M'0IKM\F7N!52\D .#B.1S#+#T,?.F:?\
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M6?8_>4_1A_Q@M?F:[S_9EC0^+/L?O*?HP_XP6OS-=Y_LRQH?%GV/WE/T8?\
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M^Q^\I^C#_C!:_,UWG^S+&A\6?8_>4_1A_P 8+7YFN\_V98T/BS['[RGZ,/\
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M+HT* +\KNRSN+U:&<AR4ZG1"]..P%OFHZ4N*90E33>W'T*1HO'+77:_1TL_
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M7*QX7IU;.F9965RT0ENDD0E<YC;/JJPQ-TQ$UH=,K?481!)A2&A"!J4R]O\
MRSS;F"I9I:;OX4UXDP(A\ZXL7F,W>+4+ MR@50"-!0FC!(!:K6T:-UN(&L-?
MH1H4[#-/CGY#(V9KX$EQEW>D;%9,LX\WXM]N(])CTSB7,W!G.K'7JX\5G\L
M"72K]AH%4Z"P_H(:JPLT*0V,ML?24R64[>;VEY'M:<1O9)N'U#)>#\R.<D)J
M/%XFZS#LA"Q0R_)Q8,J#A5%RJ(L$DL&,U* 7@-0D7H,ZG;K"?F(Y*.\S\1IQ
M*\%9(OI_6?"FXWH/3&.,4<"W8XI1L 6M7%!]?^>L ;L%GXE,!R1L^H-OA6Y5
MUK>H\&;.7'BSWIL>.SO<ES36%J:99N]^!+S#&QM<XA.FDIC0^OP?P4PV'+$]
M+"62Q#28;7V(>?*4XB%IY66T?B-2 RH@V4\F0I$=W:162FIE\\'KA&LCF^=<
MK!/5*;,'EMF^/0!HXBZ,A\X?)3Z<3)4V FX FI76 ,9F5$;]LET@S[C?L<1M
M0K)F%[=\/.:7:'1+MRKG (C,YU:.H;,/\8$O52'5ZD>J]:((G6:-67A;!R:9
MM\)B$/\ ?W+F.N);:1MUUA#I-99$+ ^(9BI,WF%S[C7V8<LL.FO3YO+P M\;
M;9]JB4ABM'11.M0S%>.(MD]F ]%G1X[T=]S6G4HU].#5&%GZ%X#U8982<FI<
MB*HK8"QGYL:N\='''I&JP*LIR:!'R(-3<&R;?/$5 C*'B/F$D",2,J3':<C>
MQW"UDS6G?W,KW88-0KM Y$Y;)]=AV=JN$.2AA!-N#+"U^Q.0'TDZO%C-V06$
MM0V5/%?$V2'QYS#DAAM#K:E$U1NST#PWAV3K >W<AY=3AW,.A/\ -VR13D:'
MIUE*@Z!7>AW<]"#1^=>\S2::(LT?<PRW(E#V&M;D2G(K#D9;Y:E-M*J7B?T5
MJSR*1S;C]CB4^Q%*F?GC^6@-C8UB!N;:,"XA)ZM-0##PQ].VWU0G)#;;NO<V
MK2OHPDW&Z-TW#P,5,%#EU?CT<D7(2Q;0R;QAN"2&3()X!6)*;./F4AB93V$'
M[6*BI>+(A,K=*0])6K4IC;A:R2%7*QXEW,<2)4_GO$;!&%5L!:Y;T3GM61'C
MA;6$<L5;ERGUUWV1TE0S?S.D;3MYME25+0GWDZ436$6AKYX&E!Q"4Y6N%-R@
M0(>9/QX/,AQ.$R[-^Q[*Q5?)HI$9JXE62/0 D;4,:A^>ITQ 2J.A<R.A9:R6
M3G_2?"J[M6:7,YMP^KP@&^BRF$EJ16TEIH/F%YZ#2[*=E"':=$>$,)_!_(E-
MQ75JG[U\=I;"%Q7/>%2HCO5_">NR:E!G\RXI)F';.4!V!X30@4X'21XBK=)N
M<PJ<L*Z1%&)(1J[S27*=$[4V33'5\9+2V$Z=6*R3,;A>'%>G)'EZ!R"*]JXC
M>?R7T\D%RA8JX&A]4)APAXU$J;X>NO%HEZ$?+.3WX[#[A!EI"U.J]S1-5\Y=
MSS@?3N:\_P"D1N"<M#QK[3*S<6!,OG]*DRAC-D#0S#8^1(9"(:??AHF:;6M.
MM)4I.]ZU[,$W$TSO\ ?"OQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"
MOQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"OQ+<E_-S3O\ DV"Y/P!\
M*_$MR7\W-._Y-@N3\ ?"OQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"
MOQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"OQ+<E_-S3O\ DV"Y/P!\
M*_$MR7\W-._Y-@N3\ ?"OQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"
MOQ+<E_-S3O\ DV"Y/P!\*_$MR7\W-._Y-@N3\ ?"OQ+<E_-S3O\ DV"Y/P!\
M*_$MR7\W-._Y-@N7\^/[1UXQ\5YUX)R?-KE'/JGR7R=\1NI<;Z#R+KO-J\)I
MEO@2)73*Q798$F4K\4>\7 .H+ZDHCR?BI8DQTJ;]W2WDN'3VIGEQG[9?T=T$
M[*M%$I5FG-M-3;%4JX=F-,:WIAN47#PR$AMG2M[5II#TC>D^W>]^S#E.[+<!
M@,!@<*OVE+]3#YA?ZGC7Z>N8Y)=/:^^'3ZJ\YK_8?#FN<DMBR+56ZEXT!^<V
M5P/*;@EVZ_=^6QZR96+FNL2FH9% XFYMAU33B6W?=5M*M:]FZQ=3?FUQ#^EA
MXSURR6*WUPEU4!9;J%Z74+\7$W&!$D7_ )[U+D=,Y";YS=$)KNV#U0!PZ ,.
M VW4?-A;&V]*BR$-2Y<9\O.7XUZ7/!2/.:GR^_WCL_5JW1N+]=X!4W+N>HD0
MF$YIV$+R(,1'Q)5#YS26?KRF+XF$G5XNII10>22[)7(?<VUMD<IWCNP\)Z.'
MAN$B5J4F-T\GT&BN>,^N<]B*WK3W3^=0/$L'2P/'PU1*Q@\0%#$0X]/==GLO
MCI'ST@Z66K:=3-I;+SR_;_E.???3^XIY$W>UW6UV'K%53U*AUGEG>:ASF\_9
M6F>0G-*<8,F:Y2NLC/JJ?.F#A^[*3AJE!Y0<I)%$I,!^4[#<^!HD93$4Q+?I
M@>++G7*CVB8,N!"U5#HWDYT5D?,/05U<^KRTJ9*F=3I5J!MA&FSE B!S$K82
M M:5BW9+VT/*2^\AP<YJE$+],_F(2K\ZK ?NOE+!7PLM!G>-MH5TRN$;EXZ!
MHU7-4:;2.=6$Q02,FP4@]23>Q4^!<=6K3\2)$_CI=BLN)'*;NH>U:],CA-(L
ME&L-*NG:*W'K/-++R6[UO5KK%G ]ZIM[Z;8NP=(8[>N]4BUG[,5Z3?[<4FF9
MPZ>)ER/GW6VW&4>XE Y2L0WTG_&1%5*U"V6#N?2A[/,JMQOEY&^=6)3+'X_<
MVHEVKW2*0 XC9 4"OF:P0JMZI8$E'-SGBE@>= #VY,Y]B,AG"\Y9U5?3IXO7
MJZ:"F+?UJ_E[1Y5\I\R+7=[H?J:[99NS\:7SE-,E%/LO2*O66@.H?*Q$>;&B
MC8STU"'G''MOO./;)RGTI)!SQ3@=&H-/IO;.FWKII.D^0Z?(L-:D[$5:8R="
M=(/WR@4M Z#!G0VZ+119:,$8CZWN3*@P$..O_&6XO8Y5-QV:Q0_1U\,X>]*T
M-Z4M>_%/E7B2\\S?Y8F4[5>)6.AVKEW4VYH"")FCN\U$QR^O+8LL-R,XI :(
MA;"TL-Z2.<^MMV^2<5+\M?\ F"G>.Z=@5]0Z![1UL[2"C&W$FYYA!WX%/Y_2
M64GDQYR8'QM:TVJ#&:TIM3VG'G"3-ITPA@,!@,!@,!@,!@,!@,!@,!@,!@,#
M6;S*YEROL'B[VRA]PL)2J<@FTF:>Z19 [PZ/.#5"CR8MZ,SM.EAI<=J*U$K:
MOF=.QG4JC?$3[-;WK>BXS,3INX)]*HGIG])YQQ/R2V4\IQ'#.A=G[;YW\V\?
M:Q5>:50#R[R'\3:(2ZMV\E8Z98*W O5<L1^L\3*!UUB<7EAD$"DE;#$)<AJ7
M'CK$YQIIRV_E_0%U3F]%\PO&JR<]L,BRAZ/W?FD7X14,_#%76KLV49#-URR@
MI3[!> *N-3(*BD(+JFY34<A%;5M+B4^S=<HGC-]FCPGT=?&<'JXI&V[K["+C
MQ/QOX<^S]?U948.&\;S',C(^V!8WV.TQ'NW3W.-5AJURW$NLD&P['P68R];5
MLUSEKQ?O%GP@Y%Y*TSQ>NO7.\N]"\MV24_F@-$2FRZGS2O4+RW)^=L*J3;A%
MHT>0$8O/;W#40'LX^1GEH3$@>R]\6(TZB+$Y3%Q51_Q3%/$'QU\,_)H]7"OC
MM??*CFW2?#CE_&*E0.B'8G(F"];APN@>8 T0>@B2-9O-.M)RQ)N=U&F6BHMV
M!L;(@NQV6IB5OHJY3E&]5/\ TG.7Z&GBTS6[35Z?TOR!H4&[\_+\FMTH!9Z&
M1(V'F=GY]R2D7&I3Y%LYQ8FVF[:4XJ%/RIL5N,0:+;DHBOQX+_R:"?)EY-[/
M.NV<LHOAOY"R^TN7E'*CO,#7,;DOFD""3Z%]5=<0SR9O5/ADMH&+L*YMS:U&
M7)_W=IS>ENZVA*M;,XWRBMVD@/Q)\,+::Y:8EVFX>.)*6(\7H%L\6+)9.*T(
MUT<OX_\ 1[^6\5C71:<(BV(X.L>^AL&9\'=6,#H]H7'VU+1+3&=80IKEE'GY
M_P"66[X#Z?\ ??'OP^\2)/DO6;7R7@EZIU?YS60/>Z(&-]DZ%P.O/UH!6+";
MH4X$>+V>DV@U /285==%S6;#$@N.Z2C7P7"7E<Y5K+66%X^>E3P<-5^GPO-"
M CFO*.Q<% 4^,.[9SOH%:Y^:F^6-D\E^+\JDDA8JQ69NMS^CW>?'9<+37935
M896X[,0U$>FHFBWG.E:_]._J%H=0AUI:'&W$)6VXA6EH6A>M*0M"T[VE2%)W
M[=;U]&]97-]8&A%WY[XGW&5U:UR>^#J]N;/M8'LI*N]3H,>(T$ZL&H?/[/S>
MTODH19NMB;/OCP]EGX2H9J.0C2M0YC*W'D8:N89/V.-X==1(405T;J_-8[E
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MRJ_G#BOZ;^?8=/:_LAVAXY_5#RO\F]'^Y@7AB=TD80P& P.%7[2E^IA\PO\
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MDV0I#81;KFF8S*E>ZA*EJ]GL3K>]ZUC5>/M_EZ.G'I<^;A;U$O"WF/ED:YS
MY3-Z(5Z! ^Q0RS2+?"'L4N^6&F1Y31Z4$KK\K9-H'J0I*HC?PE.;1[5:3[VZ
MQGCQRXN@^&7!;]ID_4S^57\X<5_3?S[#I[7]D.T/'/ZH>5_DWH_W,"\,3NDC
M"& P&!PJ_:4OU,/F%_J>-?IZYCDET]K[X=>N _U$\4_))SC[C@V5B=TMX1J%
MY6Z\?S9CQ?HG;+)9!5D/>3W-[7PFOU&&9(F;9USE.B?0A48A$" + ZS20PH-
M*FG)<G4.!$@L[4_+8UM.U&HO6NS3#R6\,/3[JHD&'[Y9K_!@WXYYFDZNE)"6
M:UJU=2N\3U!^TEX[8>G%H[!#GQ3QIV7!-3T+BIAP'!SS)!<E+3AJ)RZ>7_#9
M<9XI>.G7_!(;XT5VQ61'!.I4H):1-JK46F4*YSA5SM,3K@>VQ1PF@@*B$*%C
MTIN3MK==895M2FW8WO[7K9FYC*^J ;IZ9/B)2P9.YWBV>05B6=LI+?;BD V_
M93OD'$Z)URBW652NF4WG?/U,:I3/0@(V0N/41-<^0@[F?&>1"D$/BEC/+R9O
M5/2I\7ZE?G.E1;/UHK8(?0><=*^*>NP BE@QRKM%O[S48Y<E]DV#]ABQ[Q<Y
MZ)$HQ-GEI U+,9<S:(S.T$YS5)2\>_ 3B/CCUMWK/.[5U$A-A4?I?.:=1K/<
MAIR@\VHG6.O0^U6VO4H.Q7X)B-#7T0:IV,[/GD)$>,O<33NV&8[; G*9BI8)
M?/2O\9NBE^PD+"2ZQ]5=A@=S0_4(5VBLU7GUA\F-5_\ #S=^;PWP$D@(M72E
MUME<I4^42@PUO2MP(T3YN1\0L9S#9;R1\:*UY*A^9P3=ZZ5S8UR'J@OL5!NG
M*BU;$VD+<Q-1NE&:<VNVU.Z@9@Z17+\29=8>@+]JG$+2I*D:WAF)IKA7/2S\
M7JHH$Z$<Z>U*#O<@)S2)&]NGB]MM?'O*@IYDP;U=31\:4+V6Y7;N)J5,L,Q]
M_P!DV$[\LRB,A#>T%YSX_ACL3TC_ !3#/W";4G+_ $@L>Z+ ZQ3K%4Y="'6S
MCU_'=,(];9-\ZM[W/9=HF15W(O*6H;9YED$ZAOJB)BICZ2VDO/)E-H]-#C]D
MN5FZ+'ZIY!5._P!FN;G0]W"HW6J##(2ZGN) _'SIY\#N502$&(YV3FE5$L'X
MSK#\)F<+C3A+(N6C;JASGRI23_2O\6G>,7G@(1N^U+F5_O'*;P3%5X^&45#/
M\:X_SOA]*#TVSGZR=L=-CPZ7R\6OZS'2H]DCD=/2HA.,XYOV#G-VV6[-XL\F
M[Y;.=6SI<(R8<YK5^S4P4$9+KB@C-<[S14<YZ# LC265$IVY=72IJ.ZS*C.L
M+<6OWE;W[-&8F8BH:Q\X]+/QZY% YBGFMFZC2K1R*Y$K13N@UJ3S,)<5ACM(
MK7.;%SNTN"^7Q*]>*;8:?4!T:6Z8'3CRG(R)""2)24O:-<YE\TCTJO&6A'J-
M8!17KD^1RP_SN7RJ(=O,4G YO1^4:ZNN@\<K#:J^U(WS&OS.SFY"6YSLTR^O
M<5#Q%QF(PT@3G,O #Z4/B_78M2ACR'5MLTSGE"YD'^8N(UU:JYSGQ5Z]X>U]
MR8I-:;^.37R?MAEV0]K2$NF4QI.D)0TIAP<Y6*Q^C[XB6?8V029OCQ42]54P
M2Q&;1[2IL+6?'_E'C8_67@=VH-GJ4L+9^>\6 .D%/#G)J"L9<J'(B;<VC!SR
M9=;/2T\9;? :@S9G3QJX!_R"MM=( [?"&D:G;_(GR$YCY/'[/77DU]QN(5HW
M6N0 Y5:TZAZ-"BQUQI+4QMQ6L$9S"MY_Z9O"^?WOEW1V+IV6R6KE75^O]M&%
M;+9ZJHM9>C]P+60Y?2=PL]?HU?N).NSR=JDNZKD<C$K+BT1U2![ZXT=39)SF
M='GUCP"JG?/,ISR)ZXU7RO.QWB_=/'>)0!DFRQ2=X=Z6BP@S]CZ$ZW-B!TJI
M5"NMG"5Q<)&YS+%R*J6^W_HD;$95C4=V!&?2$\;S];DBBG0_(J1;"2+ )-=9
MUTD.WTTW1K%PIOQNE\V(%$4Q(!-/B\B89@,*8&,%4R6OGE35SG7Y#I><^39+
MOG@]Q'R/\;:OXM=$5=&>=TV/18M=+5:S*KMZ&LT06FMLHCV6+"7\--HIK\X$
M:2EA*9X<M-C>Q"7_ &I)&4Q-PCX_Z:?C=9K_ &RXE5]#56;>;OUSF\9AVUH?
MQ\9TKI_#YOCE=NF@:_!$,'A=M*\>)RA3;:2BA,-<IV7&A,S5[D8.4TI^*^FE
MX_<-Z_5NY5TI>[-T6M5BM5U\Y>]<XL$ZQ3:ARV+Q2NVXH9:YN.L@FSPN5CH8
M9WZDG"!\UF&V]*B/R5O/NB<YF*Z)4MWA)P*_DO*B?> !2T->8E8I]/[".(E5
M,1M!*/3W*6#:ITP9''G*K+;@+3*W(9F*?01:;D,J:6A/L)RG3R0UKTOO'DV6
MB6;K%CZ]Y 7)%PH]F+7'M]N!W$S9P/-^>]7YO3.8'XD6I!:X[S42'[78YCL.
M- C3"!B?N?-ER)&O?V7G,;;)C,^&/,[!XAU_PQ+VGJ$[G%4JG-ZI7+E)M<-_
MJXM/(#]9L_-#^K8^#=@$+'4S=-%OMO3!\AF5N(E,MJ0E;NG!RGERZH&O7I/^
M+72PL0/>)'2[#N#9/(&[1"4VR@]S6KSY(=SYMY%W:WJC-U1 603$=0Y6+DB8
M[L18UF(J1$DQ94=[:-%C.8;L\.XS3_'[E]9Y-1$+36ZOHLN*\\*J@63-F'39
M*Q%R$L;1ZW4:I'ESRQ9YUS4(;$:VI7M]SV[WO9F9F9N4LX0P& P& P& P& P
M& P& P-!8OA"JM3ZO9*'?PH"W5$@7,P)\_G;<\.5,G.@=3M\TA9!8VU II5Q
MH7UXI$9WJ:TXB5[LG:U)6[&6:Y=)8U!].BG1ZRP%FVH65+,U2P5K5HF<\$;*
M+?,^+G./&B(7]OUJM;;PB-S[1=EM+FDZ5+W&3M"6]/*')BLOTVOG4A5R^H!7
MWJ:8MDZM1X5 .58?9H%[N=_M]BA=@73NG 3]ZG0E7]YH3+B$ ZH3[;DIQ$A<
MI]&R\V;/^!P<+!G!*<_4=#K3%Z7!L$@Z%L>U#UV.[<^Z+S\VTL)<A%M/&^>E
M>;1(4:8Z=8F[2J/)6\M43X3L3DSN+XN6LA1)8^R7X<2O^NTTOKS!XU5XIFK6
M$CS*FT_FM=5=J4,F5F!/19J_1V"\R/!>A('')*7(RU)AM;72XORI<^5^( 'F
MM&ZY2E65HLUV*G,U4_-BU8<&;';>"V4:2^JAR)<Z.@ R_:7TBACFUM#![3,3
MXCR4;<4)RN4.%_3RAFZ\W'?Z(.$VM1N'8B)NKT:77!YF:)K'!P(H(3BC+LS8
MG*?N3P:"[*AMEFWG6)6VFGV%LMO8.7\)0M7A;4[5S3G7.7)X<7"Y]2^R5R$E
MJOEK$.:-]CIIRKDK&(;NMPLM@'J"R[%*E1VWR<Q[;;FV-/MH]F]$O6V'+\#8
M,^[TVQG+P(*!:#T^Q]/$07.?1U6>UD;GTH)T\^-ZA:I5DEMW2(*-A&V@:_D8
MJQ[265/?-.QFEX7DLK?IRU!@=2 T>VC8X.J4[F%4)!6>?C&Q=G<YX:)%9A8C
M!093&U(M+$U$:0E:'MH;93[RW=>Q.B\Y6JU^FQ6[24Z$\]T&7&$WN+<7!T>+
M"MPR;SDL;/\ 72@#["LUSI &JLUL<*ZU('D!TX5,^?8;?4P]"5+_ -W)RE?(
M_@Z8$*G,5BT5:LRBI^H=,7;1PF\F"56ZI6RW16S1NC"[ETJQ28?VLJ_1'8ZV
MS!,X);=U-TZ.>9G;;9')(1CQ4-V/G_.!S]FJD"Z54WV.T&(ECI?X0^<22??G
M[@0O,)FK/FJN\^Y6Y=UD,A9RI#:D1$.LO,*:ENH2+K]&0<"\1JUP&=3YH*P.
M&7JO6>QUF>1G@X4>P6]OJG1:9>X12TG(\C;Q4K5X]0^2^(XVKYO<MQ[6H_L^
M$H3E:"'O3@!3Z62J,WHC0V3)!@:? M%1H\:N6$=4*S3NV4D;!:GHL4QY!&:,
M[*\[.=94S'??CN^XPVB5M+0Y:I/)>& \OPIOCN[0-KTR5<;5=SYVOAK80&$S
M=IJ=IJ4QZ,'O?1[F8@:7&L+;[B/K9QA3S"O<;;T[OW1RUM'UE]/ (5CA71%Z
MBC"0>P7.RS&MU<J/"W,C<.IW_H:V[PW3;Q4+&8BB871IT.-MHG'>1+0W+^)[
MOQ(JQ&20.I^%H[H4GF<<5;!M5KE%Y UQ*2.W49-A/1ZBU;>96M@MSVXF+8X;
MI-P'+YC'CQ"$G9E;:GDR7-.R(S2]B,J177_3D'UT556X70AZSU)D"GH!.?6+
M:>&7751.<I,4S\)P&S=2-Q2WP&^9;9*-!U@XT]4U+S349R*SA>3QD^FY&D+D
MRX_89@&=+/.7IINN4B(-#UWH=OM!^-V([3A>[&]]0B+[PNQ.\_AC_BO?5 MM
M$G;TM[WD*'-TBKHR0&#0A+^Q7NCDO0X+006Z&&1 [$EYL$.C#WB!1;6QH9+$
M=Q6GO<>=:4XA#2%I:087O 8# 8# 8# 8# 8# 8# 8# 8# CGL/\ 5)U+\G-W
M^YDGA8W<6?V9K]39XP?SWW'].'0,=&_=^^7>S#FX+?M,GZF?RJ_G#BOZ;^?8
M=/:_LAVAXY_5#RO\F]'^Y@7AB=TD80P& P.%7[2E^IA\PO\ 4\:_3US')+I[
M7WPZ]<!_J)XI^23G'W'!LK$[I;PC2WR8\0AGD5V/Q4ZK*)@PDKQOL_7S[1%V
MMPREQ2KI/%KAS<-+H]@EI<35SE1MQP;8&)"FWDZEB65I2EU#;B#495$QW<W.
M?^CCT2I!P<";W+GK"@4 V 4(IW-[%7JI8G%^$WD9XEI[)914^['9$WO?43'<
MHEANY9+VFRB03+&M./[^<W*:G.)Z>+$>C#:R4FR0+'WBN/""W([#4HUM$T<[
M"ZW+L1;QTYMQ:H4ZQV]5PW")<$XE>^:0[U40;<1N1!-H8_TB%LR),ZGR:;:O
MD1Z./4F7+3/L?DP(L92WB*3T JIZEG(\-GRNMO:N(]3\M^RC6_M6^Y! ]=$<
M(&"@8A._:"1-F[4\^A]2,AS\M&)] ])"]<XHQVT4 Z#Z"=>]A[HO+@'/(1$=
MY*G&//J5Y4@PO7@%KZA00E]I@OG)V35I4.>7:>^5;]D?:XNM#72QG$Z3XT;Q
M^F'XN=0\<N+4Z/UNC\IIMQF4^XQRHZN"%O=&K6[7Y+=^[0&YZ7N$&TV6N2J#
M3*OU6 P.$0WIB1951'29\QEQIS*SG,3.CJ!A@P& P& P& P& P& P& P& P&
M P& P& P& P(C[=W;E'CG0I72^R6UFH5&.5"5]B2D4=L1@U8[*19$UZLU:IU
M46<MENLYPC(2U$&BX,R=(5[?<:WI*MZ+$3,U")^(><7C5Y#W>;S7FERM&N@0
MJU)N2:;T3C_9^*V(K5(!*"'*6&MB^S<^H,JUB0Q0I%CSGAB9:(+LMA,CX>WF
MO?+.,QK.S;3#)@1QUSKO..#\ZLW6.MVN!2N?4^+&E'[$0:FR6XWSY"((&0H@
M\7%G%C!@R8(1X4&##CR)LZ;(:CQVG'G$(46(F9J&OW(?/KQ;[AT07R>CW.YP
M.AGQ9LQ6JOTWAW=^(S;7#K+4>38T5%[M'-*#!MA !"E-R)D,<[)EQHN]ON-)
M:2I>BSC,:SLW(PR8&-W*XU;GE2L]]O-@%52ETL 7M-LLYV8R/#5ZN 8#Y0R9
M*SGU(9B#QH^*X\ZXK>M)0C>\&[3CGGJ3^'O3KI2:#7.@7@78.DE&0= =Z)X_
M>1/(ZS<3LL;+,#0->O'5N44RE$CIL9 >>'PFR&Y)%#:OED.[U[,-<<JMO7AD
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!
M'/8?ZI.I?DYN_P!S)/"QNXL_LS7ZFSQ@_GON/Z<.@8Z-^[]\N]F'-P6_:9/U
M,_E5_.'%?TW\^PZ>U_9#M#QS^J'E?Y-Z/]S O#$[I(PA@,!@<*OVE+]3#YA?
MZGC7Z>N8Y)=/:^^'7K@/]1/%/R2<X^XX-E8G=+>$0]V3IAGE\"@D!51;M46V
M=<YES<Z^\>8!MU81T2VCJA]ITH7!(R3<D>2+QTMP6FV_C;<WM;S*$;5A8BTP
MX0P-/[AY'VOGW<"G.[34*_*IZ05**5:74BMGL73;@7Z 0Z"* U431FZG&%:)
M1%\U(SISZRJ8D88A3ZUITTYO#41<6O1SS,\?J_'YA)(7/X2>M1-D*NAP?,C2
MH<!-F"T=^79!TUN,3!Z@W>Q0Q$EEQG<J/-<7IQI+<>2XR.,H]I?G]P\V+K$&
MPEGA_1"U(I!PC2Z_ (61]=XN%<H)[\&593#8^LCUL8WTH0AMG4=M+J9FM^_[
MS,K3 G&?V947\O!0>D^2%UD<DZRVUXWH *, I047#.V]9ZBUJ]:8K45PLIK3
MPF'9FVIB9"V_A;1M:=K2I.$K;S6T+YJ45$>Z)NM;O%?*UB]7>I!QXREV8]N[
M-UGN(;AD!NH*A#E[/'E6FY5^//C,:4U$DE=:2ZXTR\ZV7C*UR_46\5(40I+?
MOCO_ +KFO,;C-C_B2YXZ"S;Y!BPC&4R-_-! C= ,_,J]J9'M@^QIES<F'\R.
M.20NN>3];H(NVHJ@HE>K'5:2&O)#4"%-U40PNRO/)K"+-:FF7(HR79(\*0[$
MCMI?D;;;2MQ#;;K2UDB+?J_+[C+=\G\SW/.N78;>8M"DA(P94US1";%M4R.1
M^:AR9$% ]Z-22JFV5NH)O;AK0W$6M2$J'&=^B]@O(BN7$;P:Q4X7/)5?NUU-
M58.4)[T)E01XKF_1[^R>T.TB8X^B<J@?*ZC.KC2&/FM[>2VZRMC!2%RGG=SN
M'<U0D1BL+G$2F'KFN_%JO;D,V:%6BEMAE%4:+#$/Z/#U0J22D,2O>2EY,=&T
MH4B7#<>+QT\V51_.KQ]?,D:THO98UJ'QX:$U&152>K60L<R93!Z**/KC*7B[
MEW:F]$"-.0'&F]H7/]FU?[M,^6'&7VGS-HT4Y>:^>Y_UT$5IAYH.T*<I$DL;
ML,&+S"I=5M=A&!P4@C+:$48%<H;1+;WNN?-/,,QTOO26&ECC+)JKY;<AO%V$
MT6INVHU//'; !!FFJL2AU0V]5!00Q8YX.Q$]0AYX6)AV4?MQV$J0I7S.U(2M
M#$I;!.,QJQI7FCS4=-O\&S5OHE?<YW=>CUXRO[)S#;::=RI-8U<>O/*!;G[@
M<V&/6V(C<E[6I*M;4I#"DMN[;+QEFEW\I^1<^L!X#8Y]@;:J[6VK#9(-8,$*
MD)/.4>9TF!3Y-@C1UPU6LO2(?S\6*W[^G4R(S6UID2XK3Q*E>X/D+SLKTH;R
M<3NRE+B0<L.G&(-6,NBA,2K5;FMN,$S9O<9 L4.:&]=K[32W7=*D2Y_P6DK6
MT]IL5-6A/FOG#0KC4*M-.5J[B^AV<>&EA^<B:?8"9FWZ,*N.M3^?I?AP]V0!
M :H)=V5-5\NU&8A_%=]UJ1%6^6<:GR9-.\V^"0WQD9DS8"\BPU*J7*I0P-9)
M&"MN&W&T4BF"(8,#"2X?2819NC!XDB-,BQ%L.2E^]]$>5MDG&5+6?,:@6BXV
MN,Q%*B.94_BICLQ'HMB"'1$*>!!6PO6R1( T\/4V<K[+0&6]I]A2GUZ;;6AI
M3,B.ZZ7C->;U#>5D*Y=IYOR*HTRVPY!Z)T0IT1^Z5<O72=#C4VNTLV$&SA<K
M;*X\ZY,=#&RHLA>W(Z8Z'65:U*]]M@5I;"G?/+G*;"5D+B&1/,A5!K?1(MT-
M5*Y,2[?7C0SO)]9*F"6 SJRPB36N(R"$"3[=;DM+VC;:''HFGQQG]V7L><_
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M^-K1U09G;NW9$%IQH7+\A5SQ757PUD(.0>>TWF_=KNX&'V>Z2J-3?PNTBUD
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MMKYN6B>9DE)<8V<D,,-U]EM$T2M;D&2^[+:5M(F(M&$[M'FM"M-DJ306I/O
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MCW5OM2?=)EY;-TL,F P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MH>.?U0\K_)O1_N8%X8G=)&$,!@,#A5^TI?J8?,+_ %/&OT]<QR2Z>U]\.O7
M?ZB>*?DDYQ]QP;*Q.Z6\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M'#8$9O6U.//.(;0GZ=[UK O6MZWK6];UO6]:WK>M^W6];^G6];U]&];U@?N
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M&4B3*T^9Y1$S6TPTP_N0^I)>]56+V6VQ[O&J/5.<6^PIMG:G[N.N/0P-;\I
MG0.X<O&$ D!CC//;.#Z94Q<&BQ4-,Q%0GG-,,[CJDD37+"-F347PH]2 ;#Y7
MRUOLEBY92 /CERKECEQH7<B<6M<TJU8\'OP.V;F@'D \3'BENM1_+%J/=!O0
M&Y"7V0L=,5#S;:-CI Y8;^?^_P#AC<WQ:]8>\4KIC=[Z\U!.=1\?^H=-75Z_
MV=_ZCH7EN?K)7C=(X73W_JJ-';X"&I+L.Y;D+1J.BYM.N_+J4K3N#EATCKZ,
M@[7P/U'N?5_M?4 G>.F('V"?Y@EK6#5VF['HX_F4GRRXS<O'"K<>"5VMVPKR
MNVS?&2%=@230,:N:!E$V-R%.)C1G(D(G&:BNW^%M%&?,PGZ99X\*WY/Q>F7K
MU :PGEPXMT'HC?;F_%ZS^;])!!:^_P!%. ?M_7ZC+XNY*CK,$QS:HP)U4Z1K
M;.]OJ'T\^E5_ID@KQ,]4.57+H0G]TZ&&*0.,MC>04=[R8.$7!TLSY=]5N5AY
M_>;XR%D/VOK [PX*AZ:,O\UB9J$=>1/UMZ2-CD$TY8>OCU0_(Y)ZIDSNM0Y:
M+O79A<P=RH1T&K&IWD+;Y/.N*#BWG';C=:"]@LRP\D1Y7WNG>-$'[/&H,MR1
M()MO1].[E>QHRS%O"NGB$BF_%WU89-6ZQ%9Z_P!!9L[HE.]2P_D>_*#]PZQ$
M[G-N59M52'2?L>8\8^#;Y/I-=LM?K!<(:?9E(U"^)(';FE*EX:/GLGB7ZF_9
MKW=XEIEU9/+[$[S-,JD0>Y6ZU<RFS.8>0/A_TRGVFN NBS210(='5CG=XU/=
M8@!MRY;S3;J9RI&I:2<L(C3?_P NXO(19X/4)D2QBK(&(N7OJ)!J%:NAR>GE
M=B"W2K84 36K1+WMZ,%)@ID>2-#^W:*\/=9%HWM$-.\.<I0P& P& P& P& P
M& P& P& P& P& P& P& P& P& P& P& P& P& P/YQ:7X*>>7CYXXAQ7%YA@
M-=KYVCR=O/7Z7R MXY<JZ5"=L5D[<:\9R+?95U:$CH5#"VRVBS5HB6$J7,_)
M/_*1D/QV)(B6=>6,SKV=3?"WFOE74BG?;3Y:='-7&TV;HX2!ST*//!Y/*Q'/
M@G+N>))G*!61L*.3K:+5UF59WE,EG7)[<)J(WIMAI*4K,93'1I5ZB/BOYN^0
M7DKS[MG#*[S)0'PPJE.Z-X\CKS:Y RP]'[X2Z4)M?4&*HX))L":K]:<BY^U0
M52;0E$%R)<R:F]:;2MW#6,XQ%3O+5VL7?U&[[Y*>4O-:H8Z_>"(&O]&BW&##
MZ4$!\LIDJS^:%'WSAKC1"*U16ZMT>B^(< A%57R%E&+,$(<R3]8M-S&"4R-?
M143XV9A6/&;U<;(5J:[]T.\4=1#G (+TRY\\Z3QP!=;%8:'Q3R\$5%!@T,B$
MYQ/<KIYWG#TIW2G=*6IYW2T-:G[42\(V\;+M=_&SU.NGBYLGIY+JME^S]T].
MSM3(JI=TH_*CLVT<P(4??E;R3EXRE75FB3:M[L$H=@&+"]6Y9 Z]\JI$J)'A
M2TU(G".W7_IVI\FG^TM>/78$>.86*;[Q/H%@$<FAD3(P"/@WLY!6'K]@*%2K
M[4%D;4YTY)22CWMN/L0UM,Z6ZM"=F(J]=G\X(3TVO/[@,3E7+J-2G;%0N ]"
MZ[TOEE\\9>T4_FEH&/\ <_%$GSBU @[G=S#Y83-?\C17VM-.K3\"4U;9OP%.
MI97#<CKRQG6=VR-^\7O5 Z&%NPOJ%HZ3T10>T>"O6X4^C]KJO&G[!;>2]!Y<
M0\C.6\7KU6N,.K[HI:NA#QD49M3=0)R3C[$64S)CML2F"<L.GFQRT\6]96W0
M[U/9C$Z_/DV--]Y^#)]8Y5:_P?7=SBGFY3Y[5 MU@L!\LQ7D6VU<O<AR%- E
M:<TZZ@; :;((=%X>/V=9O"WGGDOS%/;:QW^[W#H==W=>>E^-V>_VBL6RVOA2
MG!>4N]5@S9]<ACMQ1D'OB+0F!%DL-_ BJ3J-_N>X^M5C*IV<]?VF3]3/Y5?S
MAQ7]-_/L->U_9#M#QS^J'E?Y-Z/]S O#$[I(PA@,!@<*OVE+]3#YA?ZGC7Z>
MN8Y)=/:^^'7K@/\ 43Q3\DG./N.#96)W2WA# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!;]ID_4S^57\X<5_3?
MS[#I[7]D.T/'/ZH>5_DWH_W,"\,3NDC"& P&!PJ_:4OU,/F%_J>-?IZYCDET
M]K[X=>N _P!1/%/R2<X^XX-E8G=+>$8O9+Q2J8L,U<+?5ZHY8B306OMV2P"0
M2SIB0I"&!(9!27%43)/+<3I##'ONJVK6M)^G6"IEE& P,#B]3YC-N<CG,+HU
M#E]"AH<<ET.+;Z_(N<5#+&Y3JY%7:(+-L(:C)VXK:F-:2WKWM_1].%J=^C/,
M(H"!48)8W)*$(8Z/I<=OXTV2S&;^)+F1Q\5'ONK1KWI$Z8TRC7_TG7$IU]*M
M:V%%7[-7K7!=)U@V+L U@D5#NSP\Z.0A(*@R$@29'[DQ7'6=RA92(['?1I7M
M:>;4A7L4G>L"J49$(*10:B@])J=#)D80G<R/HE+'A9 N(8FQH6W/F'HHJ4<A
M-R'$IVEE<ME*]ZVXC6PN6 P&!0PR8XBY/:@3HDQP5.4,)-QI#3ZX!%$:-,7!
MF);4K<>6F)-9<VVOV*TAU*O9[%:P*M#C;J??;6AQ'M4GWD*TM/O(5M"]>\G>
M]>U"T[UO_P!F]>S ^\#X^(W\337OH^+M&W--^]KXFV];TG:](]OO>YI6]:]O
M\'MW@66PV>NU* V4M!P57QSQ$6'8FEYT>!&?+&Y\<4&&,.R7&TO3RI*6TQ'9
M3[7'G7$I3K>]ZU@6_5^HF[>KGVKK4MWU,%)15(U8P_VO2,6VIY!%5:^<^N=0
M5-(VK3WP?A[3K>_;[-8&6X'@Y*C,M2'G9##3,-*URW7'6T-14MM:?<5(<4K2
M&$ML*TM6U;UK2=^W?T8&-0+]12M8;NPRZ5,E3'M[2U;H%C#S*P[O4[ZKWIL_
M'F."E[T2_P!W^AW?^G_T?_G^C OL8J+FS"0Z&2@2R 9V,P7@QID=^8*?F16I
M\1DE&:<6]!=E07T/-I=2G:VEI6GVIWK>!7X# LL*R5TGL7H<>"D-G(,PF%U"
M*096S T<[#9($!>F'W/K"#!>(QT/.M>^VTI]O2MZVM/M"WU&]TB_P))6AW*J
MW89"G.C)A*HV$19($0DPVTZ\/DS TR;'8G,M/H4II2M.)2M.]Z]F]8-MV58#
M HR!"")@32I29&'#1L23/(3YKS<:'!@PV5R)<N5(>4AIB-&8;4M:U;TE*=;W
MO?LU@5FMZWK6];]NM_3K>OIUO6_X-ZW@6P.:$6$<P7 E!YH5*5(1&)"YD>?!
MD*B27H<I+,N*XZPZJ/+CN-+UI6_=<0I._9O6]8%SP*$F3'!1I P8GPQ8D3!E
MDRA,A)9AP!PZ PY*FSYTN0MMB+#B1FE..N+4E"$)VK>]:UO JF7F9++4B.ZV
M^P^TV\P\TM+C3S+J=+;=;<3O:5MN(5K>MZW[-ZW@?J7&U*6A*T*6WM.G$)5K
M:F]J3I2=+3K?M1M2=^W7M_AU@?>!0LDQTB?.%QYT1XD,:AO$8#4AI<N"R1T_
MN [+CI5MV.W,U%=VUM6M:7\-7L]OLW@5B%H=0EQM:'&UITI"T*TM"T[^G2DJ
M3O:5)WK_ ,=8'U@6T28$GH6B(0G +C]RB$'4X9+8G1-S1)"4)*1-2(SCC6Y(
MXI!>C/H]OO-/M+0K6E)WK0?A@T'KPY\N>*#PHJ*IA,DD4F1X$&.J5)9AQDO2
MY3C3#6Y$N0VTC6U:]YQ:4Z^G>M8%*]9ZW&-M5J0>#LV)]J"\R"=(Q$%W62:#
MKHYYL<IW4M34]NKDE,JTCV.:'R/=]OP7/="^X# 8'RM:&T*<<4E"$)4M:UJT
ME"$)UM2E*4K>M)2G6O;O>_HUK I(9(>0<GLP9T28Z*F_5I-N-(:?6/(?*1)_
MR4Q+:E;CRODI[#WPU^Q7PW4*]GL5K>PK-[UK6][WK6M:WO>][]FM:U].][WO
MZ-:UK QFJW6H7D>DM3+."M(M;<=Y!  4AE8:V9C.I$-Y$B$Z\TIF7'WIQI>M
M^ZXWO2D[VG>MX&3X%C V:NVF/-EUHV+/1!I@K7Y\H1.CD(\0X"F.#C0E]Z,X
MXVV0$D&5L2&M[]]EY"D*UI2=ZT%Y6XVW[OQ%H1[ZM(1[ZM)]Y>_;O2$^W>O>
M5O6M_1KZ<"B$EA9X6-.!",$N&,08A026&2F)PXF-GL-RH,^!-C+<CRX<R,ZE
MQIQM2D+0K6];WK>!9S5WIU;*"@E@M $*8.L2Y(863*PX4\G&@2AD&;)A19#R
M'I$>).-0V'%IUM*7I;*-[]YQ&MAE&!;-&1"C#E>24'J/,C&3+H74R/LJV(D2
MGX,<HY TY\T@>_-BN-(>VGX:G&U)UOVIWK N> P&!83UIK57;ANV0^' -D9#
M\2 LP2B#DS948?-+28T3<MUK4A]@6.D25H1[5)88<7O7NH5O07[ PRX='YYS
MQ UV_P!\IE&;,R'8@=RX6@'64%9;"$NOQ1JS4Z$F=(9:7I2T->^I*=ZWO7LW
M@J9V9BE25I2M"DK0M.E(6G>E)4E6O:E25:]NE)5K?MUO7\.!]8%M(F1 A8QL
MJ4'C7#1)H,(1/F1XBRA=^/)EL"QZ7W$;F$'HL)YQ++?O.*0TM6M>Q._8%RP,
M5,WJDUTV K-@N-5!62V/.QZM7S-A$##=E?9VC3S  5-EL3S+S6W$Z4F,VXI.
MU:]NOIU@78:;"F7"C0@N+*N@RCH0VT-GQ)S@<TQ&B37A!1$5UU0\HS#GL/*C
MO:0ZEIYM6T^ZM.]AC[_2.>13%BKTF^TN.?J 55DM@-^T@VC%7KJ66I"CUB&.
M3DS0@5,=Y#FY4E#3&D+2KWO9O6\%2I(?5^6D954@#^E4"=.OD-XA1H<.XUV5
M*N<".EY;\ZJ1V"*WK%#83'<VMV'IY"=(5[=Z]W?L%2O%4NU,O@^06H]NK%S%
MQ)\@5+)50^*L0^*4B):7*&R)@B7,CLSXR'T;<94K3B-+3O>M>W6"IC=D^ P&
M!S9*>>/6#UDZRQP/P6[?W_GO'.AW7E5CZ8#Z9XZT"":O7,I.QO1150J?2^J5
MFX&(M;.-/#D2G8D5F?-CN:C[4SI#RS7&.LQ$MV.*]<I_?>0<Q[=S]T@[2.LT
M6K]"JJB\%8PN@'; \0T/8+#5K<5 *1H\S3<AGWEZ;>2I.E*UK6]DF*FI2=A#
M T"OWFATICLO4N-^/WAWUGR3F<1D5$+U6W5_HW">8U:NW&[4X/T,-4!JNL]%
MJIFS$&*38QLZ9(B1%0H_S[3.G5O:=0T:C&*N9IL/XV=\K_DQR"O];KU=L]-2
M2+7*JV&E71@8Q:J3>N;W2P<ZZ!3SFPA,T#E3:U=*M.B?,P9DJ%+0TE]AU;3B
M%;),5-)VPA@:+=;\Q+Q6>V67@G!_%;J'DW=N>TBCWOJ<NJ7KC/-*U0Q_39]N
MA4 4\6Z]?*>[8SQYJB%)*V1K$EF'&9;V\ZE;R&\-1CI<S4)<\8O(L;Y*T.P6
M=%'MO+[;0NC7/D/4.9W=VO3;#0^DT*:S%L %XU4#-BJ-C'N1YD:9"(C)TF)+
MARVEZ4E?OMH),4V-PC@M^TR?J9_*K^<.*_IOY]AT]K^R':'CG]4/*_R;T?[F
M!>&)W21A# 8# X5?M*7ZF'S"_P!3QK]/7,<DNGM??#KUP'^HGBGY).<?<<&R
ML3NEO"-4/*^F="Z77:QSBL4"!<:!;RDF)V:<FQ@PEHBT2%L?/54JJT>0S$]_
MH,YE$,C/3)0^.%M/[C-JF.QGXQ8FM>K9P7*)2FI2R8O0EUHF3BQF=3F9_P V
M-BS7F!I3;C"&TL;*0D(?^ KVK8]_W%;WM.]X1<\#27N7&NI6/J1&_P!*;5+K
MDNK<9KMGKH.\3^>V^\5ZFVWM)JU5,=;Q?R4ZMH5)O(0BA:)L5!),!^"ZZRT^
MM:C43%:J5?(O(Y5-X$B5=%&+GS&I=0(V*'*Z+<15=M-^F5MR/Q\-?"M?0,.=
M"KM8(NMLD)DE*'9CD?YY;*WE^[H7%RU_IOC%Y/PSX:Y6 R2W9]1[M5QI)/7K
M:J?3.?G^K>/-^;KTMMP\91-^?&TVW1]+;F$Y474N*Q\TME6E1D6MXLSX3QGK
M7*^H<3Y/#/6.)RRE\P*WCIHU-GOQL-#NPBTWD-S^LB;"==?@DQ_0('2914M!
M;D?[L]2(.W6-(EZ4X)F)B^JW3?$;JD:[= M%5EE*\2CVKR2O-!.0NO7&,DM:
M.NV[QVMU2>(0T3'78P,:SSTS"GB)*7!"G$-J^6?;>3ML<H3)QGF7DC28WD$4
MMMRG6^ZV)JT;YY$M-F>>YF4.J/\ 0C%./0HHV5,M%#@N!C@823APTPF6&!R-
M1F''&?FWR3,379JG6^0^9<>^!*N8,7?VM0IMMJYUKKMS9JG,T2^K<](,IM,)
M<\T,Z21B@1=A0D),)&$Z@36HFW%QY#CT0U>.ZLY;R/RP-U>NVH]KH\JK2Y,*
M7>N5V#R"OX"\=*G-2NS-LV8;;GWQYKED,8FRU5;H*.]!8FH$*0O6TQ6?K DS
MCLD6N>.OETS)A%;IULN?L-:B\]D IHOJ%L%@9]@&&^,JNTXM7(S \48BD:]6
M;''0U/C.L2/K!Q2F&G)2]MBXE04SQ!ZZ$C0Z]JRW6M52N7>NMC!8+OO2XL,I
M4"/D9VV\]8)*;A&TRMR;MRJX@86D2G-S&'HSK3#D=32)+@F86J-XW^9LQV<S
M8^Q7/<AV@T( )(5SIDP6,:AC@M+K]QK9V3[[1K5G>*#"QZ/8H,31&4_*;:>F
MH1IR.L7BGWE' []1^[A^@V!XD?#CZ/V[FXHI/Z5:K#/!U$IVU%\Y8.*CCQ%U
M-CVFGR-P]RW]RB$)<-ME;KC?N+229BJ0Y6_&#OQLWSN1TLP5FQ:#T'CMRL;T
MSM%U/,WKH-(+W]^X];K<)$F&FF SH<[ 89K"4,P5^W;2HK2(##LHMPSCI7$^
M]E^D^2[]'*V:N .T5OG4:MV*M7:J5B*)(UH.(!GIDR5'K^NJ@[5]7Q)+4"4-
M);@:;=3M;27/>7HEQ4+#<_'/R"0_=)]7NW0I+)TKTIB*(@]KM'M55F3/+9_&
M <>-8BK$$2.AMU@LR;5!ECB\F 1F-)(?&E:<;$3#+@G!>M#N6^7E:2)J[5X[
MRN&>@O$[M:K=1"A6Q\+Y]0KP!98M#I0J @QK%7"L>*^[%<;>BR(C[S3ON.1T
MBXN/)?\ QGX;<Z[S;JO*NUUX=.Y[:R9&( "&#(JUV>SU"S"%LVHCUX^*@#VC
M'2K 5E24$7HBUCU0VXBHNVG-OM-B9UN$#UKQ;\EJB/J8X7;C#UG*P* 2L737
M.MV!IZN]!'="-D.O6^\UJ$P.']FE=$Y/H+71OSC+NA[(AIAO4%M"9*BW'[*]
MWA7F!=03<.TVH]5'PM0'B!S /NEJ8DF;G5N 6BGC;<2)U]D8^J 8[+.AF=QW
MEN;?1'9DS6MNZ7%2+QC9D7#(786?*J=$M,N]G88.N]W>Z1;G;AT1WFIDE9[W
MR\EQD"*H)\8,HH(K2J:P4&M.A].;<3&DO[6\F8IS"35+AQ[G/=J!,\;?K?DD
M5YGD%&ZOR:QOP.@59S4B'>K'R@J+NX=MWX#D@.Q&H\KX\-S3$]*U-Z2VO6][
M2)F-?-?>8>-E^XEXSEPE1FMVGO\ 8N8<UJ1Z79CWU:#931J]#K+-:K$^BP:"
MY$@UL))(Z$25KCSY4MQK<XA[O^E:$S$SY/SQIY7Y)4*[A9O4C1"S!=\_M 4]
M.L'1B]D9$2&NA$B7-1=,#LS4QY)!JBS6XUDF&(\N2J5#C[A$'&U2$."9CHP6
MG<F\P:8: 6=TB1LJZQ/#+OM;(]L,D(7<+-N)T\.8OH!)J(^+YK6TLVT3-U7D
MM1HJ]P=,ICI4-A/2BWBD3F?%?(&O<"[<'MEX,$^Z7J@P0%0.O]-M9L6 -C/'
M^FU"&^$F3_AL5=:NL1C))Z=%AMS);DG4I]2E[;;:),Q>FS#2_ _)&&0E%Q]Q
MMI\:>NEMLO0JHWVNXBYMHKK/D(9LU"JE*+/36&><:@<A*,1G4"W!C$I,!(Z2
MYMMSYE!;Q:TK\<?,CF/([JI-ROD>:#XE8(=%KG,NDEB+,0Z5"EX,BE$IJ835
MD*61RXEU'F+7 $[*[>TW\1]#;"HCY;QF4R+\?/+Z19HY"-T:Y5JG:B79ZA5,
M?U26>)\UER3=F(#P][L9^6^]T$3;!LV%&^84DM, ,H5'A*:^&W,PEXJ'HGB[
MY,2^?VJBB[#9[U6S=%N->&5PGY"WL&49OUVX30:DW>+!=I2B!HQ5 G1!-B>D
MA'ER8:_KWYQJ$ZIO4=(B8MDM(\9/)!ZQ?*=,ZC?)U9=Z<_-M,:M]/-U2NV3G
MC8_L;U6166JR4B6NJRZ^BPU@5,&Q7!4&0V-T[O4I;"9#@G*.C+Z#P+NE:HWD
MPW.+2D=?[-PSF\ 9T6+T<Y(5^& !X]P^8EIK6G]^Y5" V\!]$FRD"&VF2W+;
M=VGXK.T)),QIV1MT+B?D'3#_ $RS[ZAT=_EHHC2W0 6%T:X2&[-R*&3X_'-<
MO(SHDBP]$ WS7V>L"D62 TW(E)+N[F$M-2'4PRQ,?NMW(>6^51>N4"U3YM_;
M'O\ 1QAL92[OV"[;^J></=.ZXLDS?YDZ2"Z 3EC>5V(.X#TE:WU$8L1)&*ZR
MTXE F<=EJJ7BGY6U.M!J@ O5LIPBJ>/1'G=$A5[JDR6+"W@?1.K565)L4LU,
MF$9\*\6ZPA+$.)M19)0.J''8TN&B%\*2.6/7NS2?XW>3XRUW9P7TCHQNE1[!
M5W@%=3U\S":NW(X17F,HCS:792AJ5<*OT$=&KAK2#D9R&HIHB\B60VB<I,*%
MPJ9?)NWT?QZ\:N:( 6XU8D>0G0BO1ZM1>T6^ORYM'M(SR/NHT98>R"8@DT_%
MADS(-4F7*W&1,*LM(4ZIQ:-N4N+F?)C=P\>?,ZTTDUS6P6B'<X[]/D2IELE=
M3,UZ+:[7(HO"1L0'&@Q 4PC7OJR[46RSVRFF=:C.$6)<=KX\B2W&%XW:M<\<
M/+=;]L.U.YKI)>PQY(^L;-=,.66QU2H18?E8_7*18K>[&,DK%L6?ZC7Y3,M;
ML_ZL<<]K"I&A,?;PN/'[)PZWSWN%B\>*U1N1UPA1;'*)&63L&P=FN!NYU6*Z
M(MJ@)45TF/;T3CC[5U>%R9.YLZ8B.*4]\*)(D,LQ\)$Q=RCJ-QSR:;A,)N2+
M)>R['0H9SHI !W^T4Z+UKG;U?M$0!4*A#@3@;/,"'.[ 5%2)[,5L='L:!+BW
MIKFY;C&RW#Y@\A\N EG:LL4T7(*K]ODG[=$?[*;FPNWCGNQ"K%61]9KY;WP7
M+6*;R9,T5)AI^5B%)+S<=WX[3*)^"X8K*\5/)BX\YLHJ]WDS*MESKEAI)L;O
MMO0)53;I]F\9+S4IX=,6+L?#=>WW4H)FK()AMD51HOQDN(1[\9P7#,'.!^2<
MXE%,PK38JO KT>,1H513V2UOPP12.UXML0!MD;AR7!]NAC(%"NT934]<Z&_H
MLXI2%KFK6V+A;O&NL]3/7'N->N$KH98 YQX?0[%:#]]Z;(K%VZ]+N76&K39Z
M4'M<0'NA*F5N4-VXV"0TQ 87&CHVE,:,Z\)K286H%XK^2 2GCZF/OI\*.I?C
M>8I'/AP;L=WAQ!?5FO'[DO/JD0EN(<^.1%@;T%L4R,Y+5(:CN2&Y>F5.[1IH
M3E'JGKE'#>J<[[%,L3ESM9;G<HITZ%]3V?JMUO&F:B2$\J?YU$BB[5.)M1IX
MJU"[.^N0ES4QMLAMM3SC*VV623,3'F@4'XO^1%#$4JK4<V1'0!,AZ172,?LU
MS2+YF>F^1=WZ-=++9Z].=D?A9@7SEI\>+:'S52VH4J$\RE$=J8[,269B=930
M3\>[J]Q/Q9K9"0?N-[Y!TCC?2+](,=6N$@N=/AHDB-T DFW3R2)-A3'*')4U
MB#+VW >CL_ :::U\)O1+BY[-=D>)_E'4N;\[YY2^CVX96 =7Y3$M0ZO]2,/6
MANX#N06FFVLW3CMCGPHXD'6KTH*4C!].M!I6HVW=05;9W$DEY1=MENS\'Z39
MNJB>G4(Y+AGAO(@?.5G4W,U7),G;7=.8WFQ:V#&ZW7$*+4ZNE6UOZB^\MQU$
M?>OA*U[A(F*I#U3Y%Y95I$A^9#E7!8VHW$-R1BT=ZN\-^M6_XMDDP+UW=D <
M;A]!)7EHG"BO:%2%1!&AVG8,& J:_J.6X9/PCA'8ZG)Z8<[+9"<<6?YI:Z@#
M,0+<7.] J-<GVNQV(="9*-R399DG78)MYV(I@F3<BO;0TP^XEMO>B3,=$5\M
MYAYKVXAR?KEQOUC@OFJ_&M<VI,V8D!!5JUBB19H:-N53,(C2'J5T_GXVO,EH
MB!THJ(GN$G&68TIWYG19G&-(2IXX\.\D O1!%K[7;3GV3#MWTT)I(_J=P*#(
M5JL]7X()BH*C)!\WNP@AQVMW:4,C$29-J$@JV][B)+RD1B3,5HM0/QU\CR=M
MLF[_ -0OLVNF>VMFCK(7IQBM ;#RM-@ZP:$M5I->)LVVI$!E?/5T(0&Q71<&
M4U ][_>5-)E++<4BB5XR>8Q&=0YIJS3C-TJBE%4]'?[?9F1HZ"_XVO<M9JHZ
MD(@J'KM,7HDX@0E6!++$F7&(+>7(=<><BM")Q97;N6]SYH-<L]LNMZLU*(VP
M2>Z)5!W5^KRC]MD.=![F_%!U4O68A,[1AD*N6RGN*C#/J^!,9 :@/;UK^.\(
MF)TZLTJW/^^_@X\,;2<Y\WTZ[T[A=JJ/5JYTF^MQ2VC_ $.FT6.M5OL%D"F)
MY]I$P#(C&751'YZ_B;7N,ZO:V]$N+GLCFM>*_EO2()BN#NO'B,.O\RIE5HJ
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MCZ7>RLOGP"*%IH$4-XC,7: .@ER;W<>2=%Z4UT9AJ'NR0)O3%\WC5:,U\"9
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MY,OLR66I$=YJ1'?;0ZP^RXAUEYIQ.EMNM.HVI#C:T[UO2M;WK>M_1@>N P&
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M6QXKTVVSRM(YZ*AHLC=)#@@,>L^5F[66B6JESK3:(B+[ XX4:;C'F'WY<]N
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M+#L&%U6M<7^SLAMAF1IW3J=OH4]/4^G9;Q6NNU?SI?J%<(SKMT/9T+7[E9%
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M<<&RL3NEO"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MQR2Z>U]\.O7 ?ZB>*?DDYQ]QP;*Q.Z6\(8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MP'^HGBGY).<?<<&RL3NEO"& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M?,+_ %/&OT]<QR2Z>U]\.O7 ?ZB>*?DDYQ]QP;*Q.Z6\(8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# X+?M,GZF?
MRJ_G#BOZ;^?8=/:_LAVAXY_5#RO\F]'^Y@7AB=TD80P& P.%7[2E^IA\PO\
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M,!@,!@,#@M^TR?J9_*K^<.*_IOY]AT]K^R':'CG]4/*_R;T?[F!>&)W21A#
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MDB+CSMCM0\I+1T;R0K]7KA6%$YS(OTRBO"HBPAMDQNI,>=P R8BG6H"):&;
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M8ZJ7CTQY,TL](CM07Y:VF6Y3D-W:B\==6[7)^K,=$K1,F9A"JM8*[:.AU6R
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M3$&7PE;F3XA:)/9D*4_ BO(><<0I*O=TXLS*8,(8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!;]ID_4S^57\X<5_3?S
M[#I[7]D.T/'/ZH>5_DWH_P!S O#$[I(PA@,!@<*OVE+]3#YA?ZGC7Z>N8Y)=
M/:^^'7K@/]1/%/R2<X^XX-E8G=+>$:U>0'7N?\RF51BY<PL'2IOU#T/HT'ZB
MK]0-*J-<Y>/!OW>T./VXZ#3$D01=G:^"U!V]/F^U;3+:U;TE18BT*T[R_P#'
MNT'WG.:\IM-D)VGHXVM![!6:/3XC%Z,%)G21,RW)/33@M$=@5^#HRY*T6<AF
M%0G&7FHKK4I&]EXSU7,;Y?<1FP()EGF-H8'#1M9(WB6JOT/YCC]?-7C= I[W
M0AK-H<,!B'VCK*]/!8D>6:!MBU*GPXFVFDJ'&5H*^87 8U"D]1MW)3P*/6AM
M$ZB'%VP-RF);)M8N8&[7JM7ZIQI%V>9E%&!M>/RECV)&K$PXV^OY3W7OB+%2
MPX3Y8\Z@DNB@NG\XJ^Z))U:I('[+TN%+9M]@ ]J\H!P6NFX)B>F-/MMW$\=9
MFAV5,I^;/O3O>6TIUE.A4]$C^:':N?>.]'KL^71^3GCMM(,.RJQ?M@1,4AS+
MCXHAT*_/0G)3.V"9RL56)(C5R'O:F=6 K#1[$M.NJP8Q;%0O=VR72.WW +4>
M>2IE!X]V$S3+J/ADW)QRNUN12K.$CRI+)3<:0&LSYAJ9-5&;:=E[8C[TO6FT
MZP5I"Y5;RZY<,$29LCB-O!7T77278>J5X+5^>02=: #J!0K7;.L3Y+5TW#+1
M5 >HP6FV(LR=99'Q'X^X>UM.IT6<9[Z(](^9M12'AW8MS((2E?;-%$[%T^/4
MATRHUSE!*Y]*1#$SI4LXB^%IY#G5';)*88@D!:)$YE#ND+=^"@<99W%\R^)%
MJUMH9P;I18=JHW8L< 0Z!1GAX:G")'-(!5TBZJTIKY("=7T(+MY0]Z=$CLQ9
MBR"HR1<OX!.,]TH77R3YKR./2QPSF-H/0;E0JU;8[7,QO/"(475B]DI?.*K%
MD3&K@-#E6I1Z]#(430MR?$U$4X^ES41I3F"EC<\BN"'AK;9?EAJ7,#EZK!=J
MLNA5<^7$W H<ZQS.($@0!Q(K'(V &5XL8&>\.7)0ZU\LF&Y(:>U[HJ7[S;L?
M/>N6'H<*%P)":G/XQ4NN'K'N%S2US+U)L]FZ-6YU%,5FH%[(1+6L3(Y<M#C$
MC;[GSB5Q'4LOL)0X)B>Z/T^6?$GG!Q8;QPM:BS?/MV^NTNM4WE\JYUNN,1NB
M$;]N58'NA(K,*6+C<\;CSP:7XA*(1<9B.MOR%NM0AQEE',;YP#L'9GI,/FUV
MU9"/U/8:G;[O'&[K+TOBU5K[D(-2AD6T$Y@!ND#O()<AI#HZ)#=(DR#K+CK[
M2E:$W$>3'I-SU6/+V=RJI<DK3S'3+\.G=*Z3+B#C95X3*XM.LQ$3*;-6@00A
M-3Y=#$-1TPF)\*.W'><7$4^ZEQ(KZ;9Z_P!Z\9TV?NE<+TX"ROCX4SVF]&6@
M%$LHLYJHRBP6P62.Y6"1V8NZ@"$%^(XP39AETK<]S2/;MS2!4J<AV_D029JN
M6[Q].U=D78^?VF]I)UCE! 9S:W];M9"H<QL%I; V\QJ;9K<<@>S<P.V4D#4/
MM+GN1DJWM(J4*&_([QOO5IIG;NE\P[,&$5*KTBSPSURC5IZF4Y/0:5;[YSV4
M9JE?NQTM(L)VM1W]_"9ARVX,R3"1,2S(2VI@M3MHEJ;Y/<;*EBO/+CQ"S"S#
M00QT._UV[A.1Q@E5J]-K%%*A+G>#I&]N4M+)2+:1(X7M,R3*CRV%LOHC-Q=K
MT2IWB6.?WUZ!<),UR5S8F-YQ$J@ANS7RT0*?984'9?R&E\$N_/9U8$6EZ=*&
MZG5YR0LE%<G#EQM)>TQ*VVEATO'^5<GS'X]5(XYF+PGHP4M$I"^HPJX.JG-(
M9$5R&-4SMLC=%0Y%N[0B&(>!:+M-#VY/UTF6F1&5"0MY'QB<9GJE.^]EXS5;
M61KI;G;U@@$8?,RW2;A!K%2D5RO0^U6Q%#YO+NC9@D/L1W=FL%6::<U!@$UP
M8\)EZ9IEE#2M$B)8G(\E.8"J9QSM$;@]^44ZS6[+-H4"'5.;Q^@C>?AZB9ZH
M2(E)#USC0P04G61SLYJ D@J6]*D-LKC)DN;0DM3K%[,6+>5?C/\ ;-RN".7.
M7ZQFC%#LU<?I];Y>:?N5DM=EI]5%FM2)EH@/5NR5PK?AZICEBV)G0X[CCNO;
MII?L'&5$!\L>76D=%L'1_'L[7I]K"PH722DX3S6V":Q23';;5Q2EMW0Y'L"B
M-D%&K;6MNJ@P(I/Y%E[XKK>FT+<P<9Z2^:SY>>/UWB5DS5N"= L;[56O1ZO(
M$\PII&<,Y[6J94.A$"H%QD\M,N)9!]Y&QXX@2N4546=5%DPV76U87C/=1M^8
M-.DN]?E%.<-QJ:U5Y*JI>!H&D70"35,\?SGD#8Z7;-A.A*;MI-Z,$.R%-CG=
M!Y&V]1WYS4M_VJ)4ITYSU;D_3[^NIQ>4$ 90((ZO6:99;/4Z:R,L=8X]T)GD
M'3QE/D#"YDP+K@FT3HC&HLZ..;G0YC;C+;J-._#$Q,(S[3Y-4NL0^I509RAZ
M<3K1*U\]'G;A6JQ)YE:;]%HU=[-8*:N-!L2K5(C$JB5W/<D/CXP^3,@/-*?W
M(0VEP1$RMLWSJ\;) ,_UV14R\QCFSBF@MHGAZ-#+E:F1CW%\G8.<D#MF@S",
M9L51"$F:%CN-V%N'\NZ\.2U):4H<9V5AOS-\?*>ZQ"E\ZLT<IJRVVIQJV/J%
M47:V0',BH0D7M#U19-)L0L"R3M(\@(&OQFCI5N>S-@#WVW=.X.,RS+JG<^/4
MJ^D*W:Z;'%%*,Y6)<BVV&D5TE%D5SJ!N+ MDJF17CPVW$A*T%7&S9:!#E#XT
MM2V7]29/^ZN"(F8T8#OS-Y(+E669,\?NI!3A.JMW*Z)<JG+-$9_+Q7/F+PNY
MV(A"Z ^R6#!J5-VCZO<>>+)?2N&U#4OV)47C/=)5^[5SWB]TA\V&<Q(V25NM
M4PG6*CSJGTP?\HUH9W>YMRTF#]NK !B"*#<?*N1X^F8RXLM:--./N3M(CDB+
MU8!=NS<_K-JY (@<FK\K@5NY88[Y+,QZ/4I/Q#QJY<IH]):%U^98 <H"9>D]
M83-(SE#)CBFE):2I"OCJ2*_E[1>Z ;5Y-TNC >?TQX*U8#57W93E8BZNH@^(
M)^7<:[.@"+$Q]B' F77QUB/L.:3IQ]J6^ZZG3RT?!%:6KS/D=Q\M%?MFN"6J
MZM7L!>7A)5BJ\PFD>D\FY.\P[=K<A)JWPR"Z2"GR(6HH\MJ*2GNSHRHD%W6W
M%-"I69WRSX;N4[: _"KN>&58%TJ6.Z",I7.&(C7,^($:--O]J /%;<-LK=0K
MQ"[CY,6&B*U/G/-.JB0W'&?I'&5V*>6?&9DRECE\@NEE;M%]EL<1D,5:@S(5
M\L8?H['/K)<Z;LC:XZZPU6K6=;DR9Q= >6Y"E_.1DOHVYM(XR@XYY!>-LWL@
MJ_JYS8[/'H1&QUBRV95GI)CG7,:*,X7V"]M=!K(&N6@X+M \W4Z"=@?)P].S
M(J'9*U1FW7FTR2Q$U3?#@_8JEVZHDKA4:X?J\9FQR1A0?8A8T?,?*K$A3GU@
MU*"D"P4W'F"S<7:I467(2A_3L9U2)$=YILS,4FS"& P& P& P& P& P& P&
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MC)[;Z]2([GO;P7*NUXY\621V:11H;1[=B3:=V%HH?9L?UHB&@>AC5A:+(-:
M)'MICZ$Z?^JM,)TW\O[FM:P7*\'^)\NM-KW>;#3AARV(8@L0BYA4LK]5)&SQ
M)6,H..(29 H0IPD @/2=QF&MS5PF/F/BZ:;TD7.R'N5^&O(><0;@T2%Q;N1O
M,&2#.S#(H?!A-U253Q]#=J(D.,;:B#*^]5AK<5QA.U:VWK3:/AL-L,LEG*4\
MEN8<^.V./;R]2#$+-$'QQ48U)C>_.9'1!ER#1H;;OO:]UED5T(VPG7L^ALF_
MK_Z?T$N5N*<9Y8:#1*\5HP"<%@4.7S& />B;VS!H4Y0)R168>TK2Y%@;>K Y
MQ&T*2XT["96A25H3O0N5NJG ^.4>8$)53GU?#$JX]*DAB,=EYTA#ESI5^G3Y
MOSTE]^5)G3YW4K$_(?=6XZ^\9E.+4I;JMX+F5@)>+G B\<C$(<U#/PBAPK8I
M,#4LRR/:)V!L@S9M#H#!-J&(&6ULK)T8@Q$,02_QU_.,O[5O!<J&T^*W$[C9
MJK83M.@28=3B=);BU=I'RM<(3^J6*C6:UDR\.-\%PCN=/H<=+L1Q:A\EI]U#
M[#NOA^X.4LI@>/W&!EEEW"#SNO,V28>19U%/@/NNQ#NC$JQ/$!#+S[D4&LA8
MIKI&8B$B.W-GKW)D)<?_ (^"Y6@1XP<!!18\(5R^N1(L4B+)QF-)G/-LK" K
M'50XYO4B8[[*X,JMN*"F!7_Z,:%SWHB8^HZ]M8+E)M*H]9YX C5>H#WA8*$I
M:HD%XF6+?+)4E"$L,234XC,:B1VFTMLL:<TRPTA*&TI0G2=$99@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#@M^TR?J
M9_*K^<.*_IOY]AT]K^R':'CG]4/*_P F]'^Y@7AB=TD80P& P.%7[2E^IA\P
MO]3QK]/7,<DNGM??#KUP'^HGBGY).<?<<&RL3NEO"(8ZSPFE]C6-?LDRTB9D
M %:Z@_/J-@DU^:8HU\;$-W:D%WF$._,5^S?4$%3VT::F,.Q&W(TAAS6U;+$S
M#&+CXX5LMQ/?$*84)T6OZOM:NT.>,ER]DPZQ?;Q/:2T4)+:D1WQZWR,-^/ 5
MI2FX*7&_]&XVU\-0O6T;E/ 7@!R<T3-,7,J15!/,E9\RTNKGG3%F1T])RTD9
MZ8B)L<V17V(^X\B$Y#'.N2F5+BJW#A_+EY2EDMXV\W-6LO;YV[&J:;DLD9HY
MLZ^V'T8;Y58^+/&H\33?Q62$WG=D7">]COP5*C1WDMI>0I:R7+%:OX=\7IQ1
M9( .+0VOM/4KHR.U+@? C6JHS Q%@PV32+19'=FB )A\A%>G.P7WMN.)8;6Z
MO:ARE^Q?#_D34Z^%9JK:7+]):L4>VDIUAVPY.9LLZBSI^F((B&+$09"5<Y%I
M^89C(DO_  W')+C[[SKJB\I6:J>'E+K?4C5_=/V6<"<LE5N%;H*BTU-;'VJM
M,VY]FQ&V'7GU&B<<W=ITJ)[NX[#6]1].MO*B15LCE-,HN'B;R*[QBL<Q%L*-
MEC=UL;ST0Z^G;1F^6&EVDY(3%DM2ALN+LU01JT0I;$B"ME#K#S+S#[K2R7+P
MI?B)QB@P!0VN#S[$8.8^OHFG[#-?WLHJG= H[TAS6_=;]Q\+TXMM32$H92\Z
MVI"4Z9;3H<I7SCOC-R_A)0N2YW#GC63$&/$>&2UC)L>.\E@:T2(QB3@I-E5+
M//BFI,QMZ>]$5*VMUIEI3B_:)F9W0F0\#.;Z:YP'$E+!+ 4JZ\L./;N9XQ:C
M<.E<7E6@Y2.956>[)BZAU658+3+053/^?7/%RWXCVW$?+?+%Y2EKHWB?Q[JO
M16>EW8:8*&D"1P>1 T7=9$3(HD==0\#WDH:^M8"4"^A%F7F84N+%E[D(=D-.
MOQX[K1(F8BF,I\+>3K'3H)(YTLV^81:8M@+F+J_*+6$5;^?47FA8*3?3"9CH
M%HK7,@.V$QFH[C4L<E_2]K>D[>+RE?3OB1R0^;+FY/VLAKM18@0O0X;9I<43
M?X!"TQKHJL6V'MMS<VM1K''6\TPPN.YIJ5*C*<5%E2&7"<I4I/Q$YK,^P2QA
MWH-8?YR*YT' O [+&<1)A\I3>5479Z >$G!)R0"F]#(3&7'XZEHG)CR4[2]&
M86@<I6YGPLXZ/:FHKSUMJ+R[6<MP,C5"HP&9J,VULVZ/;QU>.10FBZPMF9O1
M-+\<@_/^6^,WN&J*J-&VR.4L@L/B=RBPU2B4QQ5O% Z'S!7%&$!;40A3;/R&
M3 KPXISVXD5Z?FFPAJ-5X?S#VEM$/:ESX4EO3[^G1RE<2'B[R0GI]$L866U)
M>MSSK"34M#"OMOV$-W,\UIG7^CU'=OH*.MMOV>ZU#TJ/K7PU;U@N6."?#[E0
M8U03D>;;IDKE^G!=#:-D@]A8KE%V0KQ6-S.%LX (2=TP80JT%R&I;JB\33/P
MVIR&EK;4.4ILYWSD)S$ .JM9F&U5T,&" @PHJ2V1CBH *&J&S\FXZTF3\Q.2
MKXDEQQ;BG7-:W_%_@PDS;/L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<%
MOVF3]3/Y5?SAQ7]-_/L.GM?V0[0\<_JAY7^3>C_<P+PQ.Z2,(8# 8'"K]I2_
M4P^87^IXU^GKF.273VOOAUZX#_43Q3\DG./N.#96)W2WA# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!;]ID_4S
M^57\X<5_3?S[#I[7]D.T/'/ZH>5_DWH_W,"\,3NDC"& P&!PJ_:4OU,/F%_J
M>-?IZYCDET]K[X=>N _U$\4_))SC[C@V5B=TMX1#)T2W9>L-AB12SL"H7.TD
MV( *X6NK1]D)-E=BNS)**P9$;FO_ "\=*$[>VY\-/MTGW?>5[2]+9!^"VL?R
MAT+\[G5_OUP6?@MK'\H="_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[
MG5_OUP6?@MK'\H="_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OU
MP6?@MK'\H="_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@M
MK'\H="_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H=
M"_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU
M?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]<%
MGX+:Q_*'0OSN=7^_7!:/NA4(2*13/JXYT>)LCT*K"IVVNN=5]L@=,?D)E1%[
M5<E;TT^E.M*]WV;^C^'!#/OP4U?^4^C_ )X^N_?QA#\%-7_E/H_YX^N_?Q@/
MP4U?^4^C_GCZ[]_& _!35_Y3Z/\ GCZ[]_&!^_@JJ_\ *?1OSQ==^_C \>0.
M254=EJ5.)$E0K1T,4Q+,$IY@DJ 'Z':10QF44*2)9&<J(.AM,I<?=<<VAO7O
M*WOZ<$I.P& P& P& P& P& P& P/)Y6T,NJ3OV*2TXI._HW[-Z1O>M^S>MZW
M[-ZP(+YO0 YOGE#-%3/1)A0Q3*N4)2U]9ZDVJ5/(!(,N9(4VQ<6F&]OR'E*]
MU"4H3[?8G6M>S6%EF?X+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\
MH="_.YU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.
MYU?[]<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]
M<%GX+:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]<%GX+
M:Q_*'0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]<%GX+:Q_*'
M0OSN=7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]<%GX+:Q_*'0OSN=
M7^_7!9^"VL?RAT+\[G5_OUP6?@MK'\H="_.YU?[]<%L&JG/ T\]TR-,-])?8
M#W>"-%M;[!UA"(4!SG- +N1FM-W5'M0LD4D/;VKWE>^[OZ?9[-:#-OP4U?\
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M&L^H(>$RBR?6 4(3 G<N'3QU@],?F0@O!E]F/0:YSAN4.D7_ .,WJP$2<?\
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M.E#Y<ZW2@T\H*K+<J:47[L2/(=::UK6D[]GT:,S4SILEW"& P& P& P& P&
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MJR!6ZAPDZQE:K'C-]16YH\/"#7I#T56DNMH3KVI]JD:42\?Q]66AO&;U-['
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+@,!@,!@,!@,#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>g288879g27k40.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g288879g27k40.jpg
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M(#PO>#IX;7!M971A/B \/WAP86-K970@96YD/2)R(C\^_^X #D%D;V)E &3
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M# 8# 8# 8# 8# 8# 8# X >Z5[>/2?65K]*RFI6&&.T<M+VLW3DZ-?6*8I6
M]9;J[JV&VQIJ<$IR,\2&/#@[,H,VX;WL&E&@D^7Q%YM'33::XSZJCZ!]H.>R
M9_\ <,>ZDI"BV19<TQ]KIVYH<$0XK&UT<;.7I' G2\C49Z9D"= %84\=/VGV
MG$$QX$67H0O_ &^$6;]LWU:LU+RE<W2=X]/,]6<[5JC;8Y_$!R2_Y;VNIF,6
M:K"K.-<]3N#2:301#%E+9]?GB02!K)&VLWRT\QG&E?%FUHDP@"^(-6R29O\
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MI80S\ITER6_4K[4G27#(U,(M*$.B/KVV;8A4/BL-<5"J',R)5'JGCL@B!\G
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MO)(,4\B7]Q7!.4^D0.0"D6SFJ4,R]D ]-"(0A#&L9$YP-^<8-9%F\Q)>V/\
M=[+.]I_I%HA-SM-.1QF1QB*^Y[1_5U.5C%YS7K4]V'SW4G*E>4&@8$#A9T%F
MU61RQHQ(&,;NT)).U+&<Y2TE".$2,TD\@<YGKWQ_N@3_ .U7T<Q)N>K&@M87
MFXQQE6=P);2YR=;QXD>;@C+GU?*(6^J[ A[S+Z*6<C(F>7EQ-:0^Q]H;$*MI
M(=][;W)3K:E,.K-YUEQX]?\ Y78O]M>^Z\E-<)JKI5%+(1(/9NGO #FYSZY8
M&^6'1EJB3/;Q"7"7RHR*Q8%H-.VYR)B?S9A0$&E%$^<2<"/P\8G*6=?_ &R@
M4R]H2\IQ6U_M<GJRGI--Y%['/-'#%/KW]]8G0R/]+5I&+(33-(WN*YI/%&&$
ME_<6,Q.^DZ#L[:?0PA#Z7TCG,STY9<^._JI>JC<>M*%DR/D*[[GZHOOVXI1!
MERFX&A^[8K>6QMKYTA6Z4C-'%Q1WG;TVI$\17NC,^IG%"QD1MR<5*K?J[$0.
MMZW.+UQ)?P?V%TVT2EMFW0BJ0T56M1-SQ:Q"^*3*"O;0ZO\ ?3'J$Q9**S[-
M2-L78%3',B7$@]F"F6*'51MO;$YGQ.@# 26<+^*_\(8# 8# 8# 8# 8# 8#
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M/ P)2DBD!NS2#=T]/LVY<>X:3956R']'9[ 0T)8JKL9T>*NF"-HI4N<J-$Q
MJZ'$3<)/7:MX3&DK3"5N]&M;8I(7.(4:,XL\1GC7L'VYS^6XK&<R0/A;JPR#
M49G" 47>/B:T=3[@9J.:06.'2?88@GD<Y?"AM9JK82W%F+.=4^S&XD:G0XU8
M#Y>C<=7E_2^L(T_6K(J(%/6(Z$L250C<)K8D&AB*5G0.*+5"4TMS6K5CFG:M
MGIRU "G/UD^@C.(,+T3'69\M3D7;$GBE"Q6\G\J"=&ML_MZGZO9TG+#)*MAA
MBZR)C&X9(&B:DRY]>GC4GA;G(-%?"*$K,N4+M%HU*) <;OTS7&9QV7S9W1%8
M-[C)ZOG%;3Y_6F1*6OS)')!5[@IB]M&0B/)Y7(XE"5[TC''Y3(&]J.T?\-O>
M@J $'C3;/TE4;+))?"KZ^[HI!!25)35YA$RJQ!.J7C=RNL$:*_=G9%2=8NX$
MQ IC.S(LT_+HI7)+F<<%&Y&DI]+4:90L+3A3I5@TPNMS4P?.\:'8I8\PPXFT
M'%V:+,=Z2*4LM43AU97VZVAG!(]U/''M*T#;7>9.$<V->G" S2/:4DT1B@O9
M0PZ'&O>[=R4$T12,R\:Z<.#>_L,WECJ@9ZWF;I(*\B57R,Z'6?)[/CZ1H,=8
M,SU[+DI[8YB6%A-TL3'@(+/TG.$6.-9'?9U)[L1?7!)\U5*VFR&"GW>7I8')
MCZV:[.F$9C<NA$-5SX"'ZNZ<IHSR]L^7&@.&D&H7)TYAQ1RE. T<;C+X\X6A
M#.J&1;<3E1CA!I1!;,M>LF5=8\2:M2Q.77%AR>#&NC ]*$@G!$0Y#8A#5$$C
M!I$M$<EV,W9.S1B].F6*[(Z3F//48BQ]:0AOLB<NJJ0S)VB:\]R3B)I.HF7<
MUN^2M@FPHTX^2(XR AK8B!Z]%3(GEO*-_HACP:S/?LR]C]J4;6CBWMK@JFDI
M,7U(3?8E5>0"53MO;Z5$L,1J[+<ET>;EB=+'&[R:--UXB5F$CT(@@[[K6A-;
M7[5]HT<EL%=7I:V8N)S-,*U@4BF;1!).Z5I&I3<K'#WZIVU[GJ-O-CZ8,]3S
MUI)1' -,(+4K22U(R/5*V,<:GC'T95LB(K=0UN;J<7;$^LRLX7H4?=P&KI;4
M9-C'S9$J)VE]5 0B+JIY] XW02U6R2]%;%LXOS$Q5#3/L-,I60MB@3-)(U+1
M= T'7L^B=L0"1Q.0):]N5W?T+7*6AO=-MVQI9 ",N!2%7H9OH*D"@E00 TH1
M>B\4;[-ZTF?/D_@4/C,IH&$HI#2M\6TI=;W/?R"94^5(^TXS1ZL(8-BE$?4%
M2*:CLT_R&%IGE6$24&B&]2(6P;+KK+,W/=;;+V+7!SG 8Q+6.=0V92ILJ0F8
M-:N'R%S8*@L&Z6QL5P2J;+F:)LTQ1Z=/;DZDH2$IP@"^(4I-':(^.1:/)QOC
MLPT,[XYOFA9#B4_RB+Q9PC-DRQ@GD[@LIAT$D[33>U^[7U'I0]MJ9N<%D!3M
M:E0M)\P!FI$JA0F^()3*#"A=;'Y4]ZT&UL+T^24NT(>>T$UNXIHO*ZDGS+-Y
M,P6]-6^N:YD</ARADV_R5KD<X=4S7L"8@:UO6J225Q"8PXD(QQJ24GU$7<]P
MW54Y=465!M5 W5NX_6.;,AK,F?\ [08N1)0H!(3@!.9W9J HT5M.8,T9FBS!
M[V#R^7"68F7^V5T+1T<ERN+6S%I(WFPAJE]C1F33.KG8Z(NRNK8F;,Y8IKB2
MN#8>C<)5&HIL]6#X;91QY!*GX09WPZCTRXN.C"-?==!N,:DDH//L)C3L3!6\
MJ:V:0U?.&F53Z-W'(-Q"IW>MHL>S;?)F78$P\&I 0E)VL N&6!021HTH0QQK
M-\U= K;XD_2A FU>S,M2W&P5PPLS_&':)S!G"?15/6"_-DP;'<P1ACNFE$Y6
M^B>2$*4Y ).(D1P-Z/,%F,-=^8NXS)W0C;T#<]G4,ZHI(PUN<CJJ@V.4R.S8
MC.++=S6:-UL]-!$]GCW)Y:^.YQ+<A2IVAL/,5DJ!C $HLST2[:]<3*\R^WZ3
M-<8A&@I;-W/IE8#[5J6LOLOF&[!99S&&*.RY_:91'@MHA,"-N@\J1/\ MR/,
MTU',AVEA*DPH0=B,\;^2+(?<.Y^=S&TA@;KED2J2$3=3!$K'2MAKSK(3U>^F
MQVTCX%Y&4);\173F6$+F9H18-Z.*^&VHV:7H1>-;-*)V.8U"18]--S19P9A"
M6Z55NB7.XHU'Y@BD[6F<8XH<'A:VK%#.R+D2\L]08)$>I+3^;04YAO@4(GG%
M:-5?TG8LJHOAYCJ2!4Y!+7ZAK1PL54VF-;YJF:QC\2B3/)K!7,\88%L>D+\6
M?*9<UMK<ETK0"_\ R0U9YN]IQ$'FK)FY[1LG7%_/4]Y>=KP.BR%EF<<CUM)9
M%#P.1SLS(K'I=^F4'F+*A=@$(ECC']S:#K"TJ@11"@U$( Q%EF;V$)+,;85]
MQ]U%-.N8W#+:C,8C#?0KM5L77CGQ:IQ5'V1;KNV-"V7(JJ2;/  JJ*W<]KF@
MYY7^J<].Y9@$184B/XU:-M9KT\KVEM]PN#6-$ZXE+7.6H^:NS5&V":'0E^W6
MRF6OJ9Q5L42,FX$NV@E]=RVLT! =B]#:G9:<1H5!Q)1A,=,J+:_<&Y^?8:S3
MQA2VT^1Z1)I,], VFGI\M<GJ#P9$SJI[9C<S$LPG117$+4OJ9"L=M%>@<XF!
M2H_BCAE@&7C6TKQ8;&W0$NQV=*^SN/K6IH>F,JO&97,':2MS]\&)G51]O:@F
M#<$RTA>4=ZWF"06GWLXP8"@B'HF.N%$-7:U"NT9F\H+>9(A(KN/,#_*F9VAL
MB:Y.B,D4_FE3I(VGCJU"4Z+Y<DM*OW6/*6XDL9Y#J0 K>MA/(&87C7TLWJ^"
MP$VT(V[ZE<"DD*J^U+&8I+/*PF1L$DK=4\?)>IBY1@Q"-K4SQ/$R5Z92I0(5
M*56XI=CVA,," PTHG&HS&^I5S8AZ!?)S%I=*&>L>@I+6K$34]>226NJ2%L58
M0"=&ODC0M8G [6T@Y M$,[6BAG:]%.028?L(3"X]/17K#W] "+9N5BE3@O6U
M5&EW/*V&6/%()*G2(1Z'7S7,9?HS)[,F24A2TLC1))2]"*2J#0$!1)1!-5A)
M3A$IP<;C[I"P=N1.+QJ1+[>^<'O3;:W5C?\ !5S!)1*AQFF.?;UEU:G67-$C
M&4\GLD<869N0!<' W8/BU@S=I2!>0TLH<?1M]+9XW1:'BFB9IDTW;S"VTUN;
MZ[8E<R>7HIV-(+0GM*)J\X%"(P"D)HE(S"TI1'B8,P(->;#+6J,=H1*<W/2M
M70F!6)((]<U5VE9"6R/JXO:V6)+:LFD3@C_#I6V.B=*Z,SZTR%^5(G8M0$DU
MK<$Y"<91FU6AE&N.);4TL7KJC*I2S]7.9*X,X:SLBMZMEI 8\]+E:226L@BK
MM$5B1(A1J#W&,B:)6!6M<R=#1MZ9 X&*!EA0*=EDDM>A?U?2[7-+.@B]\=4[
MQ4D3FLREZL4>=QL6FFMV"OY-/265[+3#0/KM$VFTF$:U&F$,\H;@$OR[& P(
M!BL0P]ET/)'FAF)I?WHY;T;$6N:5V,V+/J5*G:WUG=WA@1310I1E @[\^!CK
MDE2H'+T%1K@W*4ODT>4(&#C>OV9.O.M:/M1/$%$'DB]XU.;5L6G(Z1M@>$2M
M3+ZM;I2\RM0<E7)$YR6+Z8XF8N1.H]:0N"-:@-3F& 7)MF#C8Q"GLNE4EEO5
M8'F3D+C&;6C5'2F5AKR6F5W&;7F[/$GJ#0I[G!;8-C1N4Q(G322A,]02;XQ>
MG3G&E'*$X#1QN,HRT]XT?)&MN<HJVVS*C9#*99$82S,-3S)4^V"Y5Z>N1V0X
M0EK-;TYSS%Z\<F\:-W>/Z-J3KQDI J#%*A.4:7C6::^W^>'Q5%FYCE#L[.\\
M2PA9 &-+%GX#[.03:02.,#(C;,L1)7%0X0%ZB#F3+TIQ9*F(_!#$[ 2!V7L9
M.->]N[-H-V=J)9VV2N:M1T3'&N45^H*C;UM D;'\LT,=!-%FTFB82XR)T2J&
MU$F<=DG'NB4Y+H/K%B#HO&]?LQ+WW#1306(Q";/IAM*DG[X\D0&N)=-54<A-
M:3N05O*;$?DL?;5IZ*%;ET4<D[:IT$9[V!"H-;B511!PP#C468^\:X<II?3.
MXQB8MT#IEHIMV8K/;VA9)V"WOMN2(AP9NKA%'DJ]PD+K*7)X0I61.C"J-=QJ
M="+T#P\-CCTGJV&@MZUS/8')K$2.BJ-L4$6R9KL1/.6]3#WBNG:&)M+I2W39
MM>0IS&(UG;1 6#-'L28Y <4J)-,3&E&C)99T4/KI7GQ>7';A.JR>[E$H=FN&
MU YN5"OR2TK7^>Q]WE"0-8(W%D(F"Q@U%&1:Y+#56D"=N;B!GK/0*\!;+B]G
M^/'N!\Z,R%N7#66(X"/B%A3Q_;FFJIXN>:_BU02Y/!K><K(: ,@5\),K"2J0
MD.Z9<66K!_[B"CP[#L0XU<M/=%UO>"^0M<,W*4CC'V>*RKX*7P^00]2^02>?
M.M0>P8T4_H40WJ&RP<;< )%1>O/HQ&8 XLH>M!$2RQ>N$,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,#3*!<EFPJ'<[104Z+<MT/T):EZ&+M1W:74G
M+LI-T,G#&0I_G)_R@;/]NH=[5^=1Z_RS>O2+]?\ HC5VS;?6**F?MQ-\AE14
MWT]5;+WA2\=')7UAN*JGB;PIP@U_WHYW@4W)&EBL>&N**2PMP=5#?M4)6<B>
M$2DX!Z0K?HC)+-^F&Y4[H]#*W?FM6RKT,39^=;/U/VY@;V4&T#HUDTE:U.(8
MJW%DK$A4?2(2+*+5%&! H" M!HC1?])HPLSGO]VFT7]NMYK>=SJ?5K=!+2J2
M7+7MK\\QQ_@6GN-5&QQ"MK0K9YJ!])2REI<)C7SHS75)2&GX4]G5Q]$<@()&
M>!O!HXURSW61&N.9A'9S"+;':K&[6<&Y+4M2VU2F!+$L2E:2W('%*T=(W!F)
M-,MN<)^I\,KU@2-*I:O>MF[1'&K '&*=[*)=IV\8?Y2?($[Y^41Q#!+1B3M#
MWJJJ&K2[(_+Z]>52R3+*0KU!5FIM73RR6"S#A#G,8*UI$:I$O)>TJ<Y"0H)V
M$7Q(%(NV?Q>SC_BEDY3V0D3)JD>PQ:!H:N@TXC]7N,3ME3!$"MO- WV!*U$Z
MD3.]JE::/M7QWRQL:$Z]>@TL&4#8@$$C;;*LGKV]':17*\6F]VI'7,T<]O.<
M,CXY5NL=K7TW753MD5(BK5WL%TGBI*16M6(K!"-D;6EK;"S4[:G+4:$?HU4<
M7ETPF\QX:52AIK9*DM/Y(\U70%8U5%GD$/*<"BY[3ULT]<T&L%:VGOQ(%;(7
M+:=1@7,NC2S%2-286!:2+RF:)R7/0%)3^M9E?5C678D?GDKO:80R5*DL4A*N
M$QJ&IH=6L7KM-'F5(XRJ7.KDD.U&]KA*5:H1^SU9@?#182P );G$GA4[9PS'
M6;ERP>>VIZCK9(K'DLYD4CL]N@B!$YNILNNR0VZD+?$29R+6OAK*0_?+0&'K
MA;%HO9NM T+TM%Y?NR^]L<@2V?NU_L<=MENBU/\ 61D<'?45700;[- ?+81&
MZNENJNF9<I:FR+[L.L8@W-2G;FT//RU02-:EUZANR@B;=O6*NF_(IT$8.I+-
MD,EE-GNG2U<SAKON&0>OG!X>YW,-&%L'/3A5+,C<W19#5M.PE2"-%;'M00M2
MD)7->>G-1G*1EFV<3T;1<U5+/ZBY?@]?/<D;55WCASC(K$G+HU:>FIVOVP#G
M&:V3,'%F:W5FV[-*ZSY$N5?"$+DOG2;"04>5K0!A,VR[9\*,7<9V)(-V_/9!
M9]<)+JL^7\P35,LAU1NT>J9N=^5+'+LB(*Y'"S[)=)7,WV9J_,W/CL:_IEFV
M@A E3^D! #9I>7CPPT3X#=6Z^FFZY?9L<DRUDFE]2S3R572PJUI.@O=@D3'J
M&2BR'J</Y9,/JA"_%H8VWM;8@1 ;4"8!Q.S@".&7ETQ$/#[;9RM/4!TO?:.L
M]Q@= 0CEZ8H;*I*02&(2VJZP>'M1!7AF8$ULMBR.S4QCDSBE>P*%KFT.IBL(
M@I4P$X2C!R_U;'-O)AC<],+MJ<%# R=D3#JX*4,<]/1J:4UW-H$5 @#T\"T2
M)NU+]*-.&@[T/2?T_AP^?SA)R_TPH65^VZTO<B;);\WJR:.A@^@6&5,=R52[
MSB&N\%O#HF:] (D;:TLECPY>V2.'*YTN:CCC%2I"]HCQ>LE)V$KR3"\ZOH_D
M@GY;-6EOER1L;Y1UM2_33:C2QD!:2/M=/FT5M)7:5,4[%%#(7I:7T24M!HH"
M0"X.M)AZ(\#*G+_1D:QKN[:6D;3!&$^%32HY;=W0UI2J3JVM9'I1 XE93U*[
M09X<2G^MSB5+I4KMF=C(+<B421$1'FX8#D^EAI1VR6R_B]$ZY)A]L78[V_9S
M]+W8I-7#36->QN'3VSZL#$&%0\+Y%8AKDZ5S/8V;+#[$=P-&E):HO1!"=@2
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M;ZL3(]&ED;5GIFM<J.)3:.-"#U!!T'S"UKQ\=ZPC'/%OU+'G)6RO]HUTQO"
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MVA]AAC0WL*$+R-AU*VAUTTB=0MB;2C9'DV=H@OS^/D#X$FUG90XO:[]M@81
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M&2N41^4CA#BE>*];1RTL#(,R/-4CLF(1M_="]R- Z,1!B9A=U.PG*DYI) O
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M]K^<=>J!_(32GZ)*X_ YFRL7NMO"& P& P& P& P& P& P& P& P& P& P&
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M# 8'"K^)2_<P]A?U--?MZK')73VOYQUZH'\A-*?HDKC\#F;*Q>ZV\(8# 8#
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MJ!_(32GZ)*X_ YFRL7NMO"& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MA,H.T/28:<(B36;9X]XV>]O;L.R>Y&J\[Q^H4=A_*X;<?8!R)* "?=SFZX)
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M1P^(2#WS:9[=J>(1R5,<;C+%RA7IT9THT@9FUI3-L:>6Q*U& 2L!)8?  0Z
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M(Q "(<-LXQU?Y$_><]LJ<Q&:SZ+=61=UAE=E0H^8274*M5&T-)5BS5OKN%B
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M@?X?NY.CIHPUY-.9_<9=N?NM'Z>O*".-T$M7G^J9E"IBX31W=EA:)I/=&\E
M[J3#S0@!MR_Z^7PWLO'%VD\Q_7?7-]4IT?4SU9=!6M +EKTXJ3L94UK:4L\P
MC!CPS)C"79K \L:I8@$N;33 A/*T/SEBWK0M:RN.++BOX$.;Y#9/+7$]#M5'
MIW+X_P![7C^4<:Q10Q!":D:NM(1UY,:E:Y@NV1O_ +8X_G"X7,>E&O$P1[(#
MZ? &]ACTW%VZ_P#6_P"RV+U@,,H7V]/=MJ:"N;9"H73'O7<NUY%WA86B$WQ1
MJ@A'.C(VO[FE..3HC0-@&W2]448,L!VPCT,6M"V+#,N=Y;WXNAGN=7619GLU
M].J5ON34)WXZ17IOD[:FTZ;A%8P1BJ1 X756AK4QRAEKZ=3-G7J-*F]2Z /5
MJB!G$;V5X>F#S[)I,>Y.F.CL9RC<@;9YOZP K]Q^B/<9=(W&)$(^6TA!*T@"
M*L&UWKQ\^ C4C;*WF\X1K%;XH;%:PA2J.),V6$8 A$$&Q97/:8LZ8<!Y>H3A
M_A'^0SQ'DA*V]\M!]81@-%[W_P":K0'6O4V+R[WY_H_Z_P#7(Z=/FN.W_A;W
M0U937_[9?=3[-HMO5N_1?M[#]NZ^XS'6H\0%]E4FX<_21GZ>H]064/1AP+(J
M).H.0%["/?SEK1[!KS;\=$EG":WM<_\ AS\YZL&MO_'WVMNQ+7:E[WP-"O=W
M]P>QKI?G)I4/4/@#K:TE6*.:K(M!G2%+R$C'$7U<H,4*3R1DH3S-AWOS&!",
MW9UNL_EQC^B;CGOFX+>]U&T>63.J>5.K^=3>4Y!TM7DHYTC#02O@ASI>37#8
MM6TOF3%9]@MTB>F"%*@'+3M%MXE8U9)WPQ ? (CEMI)IRQ9<JVM^PZSYA_B"
MV>Z>OY-&ZYJNW/;X0U3RA<=G+D,?K.,6;'+47/MKU^GG+^:FC<1F<ACRT*K6
MCU"8Q6D/T2'8_6T 562WV\:]\N5?5<DA]V,O\31U%S>L;G_CZ6\K4A6JFPHE
ML(*SN+I* MAFK&DL(>48 LTL-CS8N @<79$(\I0I4A'ZIGJZ$*-SIPFW?/Z/
MZ<O;7K3IB T#!G"_NGV7H9AE514FNJUD:J)C%.F5:QE08DU:QK':/RB1'3\2
MQ.N1%!5J@)1@^!V/0/$\005RWLMZ3#AKW'<Z?VN.Q.A>N>+.Q.?[/F/0E_4)
M%>N_;%GAK#(+KFEA+VJ-1%F=*461UWW:$:DOU,D93D!$K;S6@)9PCMC/#Z*0
M,;UG/6:[2XD[L[2]5]767[B?OOK.:NOF'F9HCUP4;JPF!VYWA]Z'3DY9S F5
M-HBW213*-&PW;6D3GIQ!3@4A/V?ZF]ZV5H(Q;KQUS,W\6C$<M6:2_P!@CVH_
M;ZHJ*OMI7!WG)YVT.U:P9]C#3+GWFVE+XL"SKZ^6/4I=F>/,(7AJ;$31\:X*
M4Z'TUQX!CWX;#LUC_P#I=KVCUOUF2NA>;??LX'M&@)5R:Q6;S#:'?W+U"SB4
M5R_KHS7DX;2H5=T<C+S6TADT051]LL%L(7(4:-4,U 0J4:.+!L M[IWNN^<]
M<5=G,338L:[IYC2]P36,3Z6/GLQ2-S]N>9UK$2ZOB!4;/K-O/N>K)VR'N$G>
MIU:$7@^BE9+@)X"W_+]'*2V].8IT$F)MCC>/_MU6!_#\W:2KX\YYJM3[F% 3
MI,+F6VBF;V]VF"5>@NFOUZ)QD[R-Q<IZW3Q=8;V6Q-A"EQ.)4LR<(DSB#8O*
M D QCW)^[.//=S*5U?U:5_#(UU;"OL..*N5CMP8:3F //,.3N:4@WM,ID3D[
MZ!!,!211M/-?_P QYMM>MF W\%OP+_I-FLZ_+C'7_P .[5&W11G(OO6>YZY]
ME3V#4G)^AJZY=F/+%K7,^L\"B$NH&#5P:QSJ"P>=2U4V,/Q48GB4LQQ:RE03
MSC2/6],>BO/CRYV6^W./7&<N+EXN#$[\!>ZQTK7NBH]Q==_O+\QV!SB\')C(
M["Y*QQNV*S;+9MB&HEQ* DB#2^5(A'$+"RBTY_P9GEW_ $8O!72?RD_[<:[
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M1)7'X',V5B]UMX0P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M&!8G$1O6C=;#A<+3PA@<%OXF3]S/U5_>%*_MOK[#I[7]D=H:<_)#5?Z-X/\
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MR0CIY[X_W3)1S+;DAKR_@O,CM>U9%&N$X(P4P^/#;;$"99(XRJ2=9J)=%4$
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M:QEBYV;*'M";U39<5AEUV"^*+U) %+$(!"D51RV%,5?3=&:WIW-/(Y6M&@
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MA)3!2 .)"D,#\:;L\6SK]I%/4W5R2.TQ65=N8;:HA(]^W/&:?:7!DKVRA6#
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M+BTM3VHGD2^<)9)I*O=64U(46%3Z1!)468STQC-=6>NR'682_E.N8O&Y:^R
MGINKK5=EC;$I*IB,;@-:G/3Q*GV3SLMKW"X^84$)2=(A5+RW%P5*2@)B#=;&
M(%8U\_@T,AM43J9(JRACW!+W6] /J?H%E[M=IL58R2K9Q&7>MK1:T:!-)'\]
M)5TL;7RX%4265^5%SSSF./DFE^").!<0(UF3KX\,#"ZHL!PJFBZ^B$.O>%0
MF@_;3@LH9&MLM6NG!AD4;["7@Z2;1%*R69\8G!'&0JQ/RLG1?G8# GA.$A&0
M;D+C-SC.;_HZ:\R0EWKL[IN!%MDH:J^8+Z5!IMLD"E^<$*2"OE(4S(G-+"ES
M^H6*5$0+LYXD.B2R#1I4BO:A,5H 2?2+K-ZXOES/Y\I"X8U45 <N+ZMG#=4-
MVTM1-[VX>OC*M&@@$MJ:KHVWW52LHTJT4H8W^W[&C,,4 ;#BP'+BG.5"\N]I
MS-"-6S-OF,)$&^_M-7$<7*IRP8-,J9A7MJQLEY+KZ]'>3R6%*3JM#T>:OE3/
M)XS3=21J"L#F^,DF:'U"[O:\*4X9B4HO;>:$=.OIU68E@$NA]"5TPR>J; D3
MG>-\W<ZW5/[ 9>B+<6P5!')U;)]1(E-55G*X].%#0^,;BC;(\$I8TQUL3@(5
M*1B4"2"-0[WIZ(.T4[?\PH:PI_8S+T$.^J]]NOE=QJH!SK8K4^-72T5;+[=I
M,O96!L>CT[Q;Q3N@8$[UHP;DM/3FE)E(SRE1GQ$7,SB8QFL[9+4]Q^](0Y39
MJOI+?;W[ET43M4U2FV@DJAQYO=#W<ZMXV5(4BE+4SI7Q,&3I$RV,EFF.>I6G
M5KCD>A!.6:).L\8PSU*.3M4"RBK.F2*^(#+*QK.WY7[F$_M1)9WU!<RX_7KB
MM=G,#F_D*H18KLIN(E,Y0T4+TOV@B)"M,3I.E.*2F4O7TQ>S>/MJ$#N&E(#%
MDT1=)JQ23HWDQ3*8\6R.2HTZO?\ R#K9=-U3VU_#@7(&=MB&E9[D,X!?P:4L
MT9ODT 6]&=>E_*M!%]:7].5]-I;$@$]=#N..C>7Z-A<A7,"XX5BMS-?$0DMA
M])H!E@4&KXPX4NP1 I4[;WHA$Y"D280@Z*,WAK,G;S+_ /#+T2@E]A<Y\-\[
ML]2VPSSZG[<JBP[1ED]JR=UQ%ZB:::GBV52<A/*)W'H^BE<EGK6F,C*))'A.
M>SDCX<>>,I$$PW8O2V^&]W0$J9^A.#.BI#2XG"PFVS.9;X05]\B97G;A,E;A
M7LQ86DB/,ZM E=W(;XZ T6@],C>EP3"QD>H6:6(1F=-IGU:K23C)V72?ER1V
M/)K'N&3S"Y*Z3V\^IF@B"-T8JZJ^6^JD4/ABMK@*5M$P0K<VLU40YFKE1RAU
M6O6DAY^R!DI0EY=\?76(K5;A(:"Z A#[8$$OQRA\<K#N6I8.K:*LN2WG;3"V
M=LL[A2\2,<(_'9:Z%$+JC9$HV)0Z'E$JVA,68 \18?/A;UG3'C_1MWR$J#6$
M2C536"C-@5I7)+NHNC(G3!A1;DX5_6DFO9?-A,+NNC0'&*M"J(IK>8TJXL*K
M27YLN.3HQJ0$B,PSMUZ^&JG247L=?8_3!I<:OMSZ"<7ZJA\&RV#D6*=6<89R
MX?!D@@JWZ/",J^%)6FX2)(NGQ<I,2B>8R<03L*Q-M*G 68Q.V/+<+D*L7&'1
MBW9D_)9>78]B7YTBL7JIX[2I:/<1:NB+?+J9"Q-+\K,*8((FA*Y*>U$H222C
MD*H)VMF>IH>R;7QXPY9UA6_3A=2R1]?)%:Q5S!B=2,MWUPV55T<P/4IN 72U
M2/<DL<VR)A,))7<R,CK$TR9,29"@%-RN+.I>Q:);D:-.6;Z9Z=EJ1KF!F/L<
M=>_958,>:3/="L2V;#-:F6?1]A?*PDO,=\&PM^W-4Y1#,[05\>7HIL< MZX1
M05*O3<MT6,_1 XF>GY(%8]8]!JOJM '1TM"%T]'2>RH-5,C45WTO;SU YTCZ
MADC91DI^$IV7L\X^-8:.^6&P5Z?/F#1\&D/* <48H+VHIF?GT=(N8:J?V.W.
MI+(L0Z:/,V76JRPV,2.1JY$@C3A &^@N>C'AQKR&JG V+,4>DMFMSLL4#0%#
MW\Q">1L\6B?*$S;TDC3Q#!9\[6,PMKA%+T.Z;<.P9]]K<P<DUF!I9YX\=)E-
M]A:]2=69NGG"L5O/:AH;&5B2'?.D4Q],\24M:2O5X:ST^V/U7KS1SNC9O;/:
M:*55LM8W"14I,FUYK]X(<VES.D[ZA>0A2."9T4$+D"Q6L]#[D8RM!^C?T:PS
M;G;+3..<Y'OU4OD@C-=71&W*M_:GJ>.5*TI&ZUZZ=F7H^$N_1;LN2M;"<"/O
MJ^T8G-BT9B(!H#A@*<0C3A&F7A$<:SB^,96Y$X7T#(^P'63SN5RR'2%OMQGD
M\1'JH+[?&B:<[DT='RU-8)IZS2HKGJ'L3Q)53QIS1N;60[(Y2G JT XXQN.V
M.G'$5;$.59B&MJU*=F3H<]X</;,>9G-2'*<7!IP7=?M#; OJ:^/^OGI2HNZX
MQMW>$[21O9:I,7K8 $[VC3;3ENW7QW=>J!LQ%8$+3,ZMV6.5BUPT0**7*E6M
M+BVJH_9KM64+GKLPN1BI C0&O9+5,$2E82E$9I&8JT2;HLT(BPG.S#D*S--P
MV=.+.>I%'KEYPC5FT'?H+C+@-4=+/;A7]F(;MIE16K3(7MRDS@3>\E61(Z0E
MF&0%F:4FXXK<2$3A\-\(>0;Z3[]5WV_(ING]JFQUQD#EU02!F"J869FKP^:P
MF4.["W7PB9&B8URW3E<FL:O3+18 A=&=G>3RW)H"Y%)#1BT7HP1)_- U-./<
M_LM/%(%&.AX_R)(.GZ1VJCCR.YX&J4'M-#=%BO=9M!+AL]D1VGY)(#X4W.6U
M&DC6Z2 "X17G,4&G'%STS?Y8>346F+8ZM GV$=#J^@FOH:Z5?1$A1,URN-<R
MGC[1]I"#'HXY(MFU[*(F\TT./-D+CS ,<D12K28P"8A<0YJ,&9^6/U>>HH7U
MLQ1^!LTT;;@/OE!T+''T4ID+G()'#RJ06<HWTW<]QR3/K<D2Q9:JJZ0[0,UA
M"&4/2^<@.=CA&D.K6+8_;G[80^IJALQ?14N76!:UL0I>J@M!$VO 3^9^PI"H
M=KUC4N^LTN=K(3KIJ_OUK-,X/+6L,O' 5J)N7M(TB@2P"0*(&RVS/3_9U6Y4
MMINF]>Q6#NT1/JZUX35U:/\ 8E-J#WYT4UFBFY$@30YN6O;TD+4;4/"*(*E1
M3>L,T]($FRM.!!!I@-#,;3%SX<UX&Q=.16=7;:+T1-Y5<D&*[ >Y'32&N>A&
MDGHJ++'J4AH.'-%VNDN=*-2LC9' 1P^-_5M 0]H@%JT1:8M88Y>H:Z8QXZ(Q
M#(S;B+ZVH'J,W.Y<H;OV@9#/6.LJPZ)K;3Y7;G1]DMD^^I4!G\LE=^/D,:KX
M(AY\Q3MX4RAW0IEAPFT1)R[:P=/_ -EAV=1>WDWK>U:>A5RMQT4Y5YP6\I";
M4MO1%Q23J"KK_?DPHS%';3-('*:-:Y>@3*DKBE.5A;E1:,PH*5686>)>TOJV
M][;3W-'#:MLFC&R9R*5*C)QS\Z,,4(<'%*VH.@&9"SQ.TI V)?43%M%2VK&8
M^X+G$TO_ /&LA[D9ZA98C=[,ZX[5IY'ZQOYG/(K8UOO-5%.2+3YGHNMY"Z+Y
M>Y*K;KZ7=AU79DIL-4_Z/VKGK7!>:X]&V!\=E(U(2U(9 4H,UKXK6XUF=_7_
M (_Y>"L>68X9.:FK7[(K!CT.B7<W>$MLU !FL:,QMQC$Y9KH4U*XN$I%I$BD
ML"E$0D++HH2%<>WJ%>BDBK>U 3T^QF];]HZ4<;()JT<\0UCGY4L)?XZ_6C&4
MI<X&[GR@,0C=LSEBKSYFL?AF/3EH4 ;VS9"Q4,TY8FV6>(PS9GG%6-N_1L_A
M'!;^)D_<S]5?WA2O[;Z^PZ>U_9':&G/R0U7^C>#_ (,->&+W61A# 8# X5?Q
M*7[F'L+^IIK]O58Y*Z>U_..O5 _D)I3]$E<?@<S96+W6WA%+6QT-4%(/U3QJ
MSINQQ1YNR=ZKFO$;JY-Z$QXDFV)X?]A\JU6F$6W@(9_AQ*-:$#2Y6D3_ /R*
M2M"+);V\(O0?3];WPW;3MK]%62PD[E8B9TJH4T87>=-#57]DR.N3) X,28Q,
M[IFQU4,1:H(QI0 )"L*+V(6]Z$(68_!;4'LNN;.1.+E6T_A=@MS0Y',SJOA,
MH9)4B;'<@LLTYK<%3&N7$(W HHT Q$F""9H PB\/#>MX3%C%M]T4\[S45;-5
MK5NYV( 3N$<#;YQ&5LR ./GGI7XL493.9CT$QD4I32U8=D^9,,L6C-!V'?@7
M%QGP\K9>M)/;F^LC-<-7.SS%WAKCTE:6V?15<Y1]^?'\J*,K*](DKJ:I:W5W
ME)X&Q,G/" T]P'I, (CMZ!@Q4DW8< "9(R=SB(:.A\A8XE+2?K*S>K%Y7)RV
M(Z-QF1%_&^=ED$A*E#8)"B4Z*4JPN*790!Z/*\Y,5@B+LII29-"D]M5F>96Z
MTAML,!,[BY@H(X*EHVQ,AF.@NF]QE6H<BAI@%K?1&)0 1>M><.PZ+BH?:/4-
M$5!2PNA)C9,4!4!GR+Y=-FE]9W5C?OK(ZIFAG^KSFF7_ "YZTK4J?-K:<X>O
M1+,,_P#:6+>A);<>4Q.NJG$\EC$+46Q6I,PFS<@=X;%39S&"Y%+&IU*..:W.
M-LHG33B^-[F2F-&F.3%FEGA+'L&Q:"+P&*SLXL* UBQ"D]D3:)0"-@5$(12"
M:2-HB[*%:IT8).CVZ/:Q$B^*/"2/8"_/YQ: +>M>&M^!)+>R,KKXH]L>V&-.
M-R56@D4J$Q@C#"LL&)IGF1#DQ!:F-A8VPYV M==R%.: :'T #^+",.RO/YM>
M)<5YR;.H93)2J:36!4BB7F&KT1-5D2F'FR$9[,#;DYHBX26N$XB/:RR]J#RM
M)O,2$&S!:UH.]Z&+W>-XZ JA.ELY-&;"K:7S&IXY(9!+X.WV9!D#RP@CI)VU
MI,K-<GLE)"4Q*TO2=0L=1)4J(P7B>,&M;\!BLW]ME.:F&Z[';%:@L$(7/9D%
M%.XO];RMLJ$;F\A''-.GS<(FAM*&H4ZV3_0D $8/P '8M#%[L31?0%2])0D^
MPJ:F3/-8JFE$NAREP:5Z%;I,^0N1N<9=4Z@*)4JT0!2H;-JD@A[U\4WJ"%(-
M>D<#>Q99TJJ:L[(K"V:-)MF.O<&W*TU2M-K2FIA6K!2I%!T;LTA<B6V8NKDX
MM2"+$%F[V0)>Y@1)0BUL0]@UA;KBX\+/;!T.Z7N^KVN10IXZ"CT'*C3VS$S1
M.[S6)P56X-KT:FW"]O2H<3;WE>:WGK#RD24:_P B+X@9H2DN@$ZX^R2.MR5$
MPR)ZB#Y:==,TLC<=/ETBC+K-8VWO[!%$Q 52F2O30K<B5[6PITH]&C5GEEIP
ME[T+8]!WXX,7NIFRK8I[EU80<G119N5VQ>$(#:1FY8V,1D;<+1:G1C16M,].
M9RCX)J4H*O$E+$9I(0J^7F:+,T(DW"R6_P"$KA]B<Q5=5M??4^RJ?BE0NJD<
M;K-Q36!&2H>]K1KEPC66*/BIZ,1/:X+@6IT,D@\XT)@#-;UK8!:T2YMZ]T>C
M?8-'3ARES=!9U#9%]FUQJZ8LU2=.8<QD0Y\;X2Y3=<Y;^:O1(WI"0B;#BM%I
M="/,&E7#"#9;>K$6.-3"CNDZ5Z,A$4G]2S^.R9CFC=('9@(3N[7MY4H(HZ(&
M>2J#&<E:>L) Q.#PA LWL/\ VVUZ;U?+L\K0A99<5AFKJ#G&6VVNJ!JLVOWR
M?Q.LX]>&BDTBC;@E2067%R-$@DK2Z%.!P-Z^1MQRI283X:):5Z<\8_AU98A#
M%QGPM6"32M[(:S)O6<KA4[9G(SY8;+H.]L<E;5QS.,X/R\U]8E*U,I,:S%9F
MO2$;O9.S1?1KS;\1<SI7SG%I5E60685D6)!H &1+OE<?%-98Q18+XY:V2':!
MIV]KT.G%6$2@O6RR?./6S ^.ONM>(DM[/$HN:H$DW2UFJM2N4UCKE9B!% #Y
MM&BIHK7%-I+R8B3Q<;F%[.6 :% %6R@D;'\,/1OAY-^;"8O?PK1YZDK)/=5:
MT;%Y%$9S+II+)O$I4AC4WC[@]5@OA4 D$Y.U+8V@-7.B0Y<)AVBT2?I*,HXW
MS;\?+L&S7&XSX?[,.H:VKN[QT[8K]%*_3#K"/6&VS6:35@C#2[KI#-7Z&IX@
MWI7LU#I0[ -9/B-" >/8PG:#HO7AYMDQ;,Q;BFS*X13EOK!9/X6DLEV;3'EJ
MKY3*6,B;.324!688YH(L:N"^+&\!2 \6SBR!%Z"09OQ\ "WHF+W\(:9TCSN2
MU?/3;YIHMD^L:6'_ #@=G0H+5];5K6F>TD8^8;>])/K I95A2P"/S_$"2FA-
MT#TQ:%LN*C48Z>K)YMFS*8?I+$(9.X/9+97<:CC_ #:/I9-91CC4M<VKMXBT
M85'(GA02G)GPD.RB0*A",;S#/-K0O( 8N,^%S-<XA;Y]6ODLNC+O]<V-5)X?
M\L?FM?\ 6J-(=-(ELACGPJHWYVQH]/R'U5:;U2"_C2/,+7K%^8F*Q)EK5>3.
M15@;8\$*LD#<8[CK\R7, )J!J*2:7FN0HL)PT]A0EH-Z/$;LCR:)WY][\OTX
M7%[^%?W->_/M?4[*K$M6:P%558:LD-CKRU[I'7MNFE:-Z!M&Y.#$U*59B29L
M[J"1-Z0G1&CDZL]T2$:WL2HG0Q);<3NAD3['I:2V<]5T;-8(QI!1ZFWVMY,Y
MV#%R$EM_;&EE*AH;H.A-4D"=52$4;"5K24U7M28K $&@BUK0B\;A>.[9JS4^
M^RG=E0+5GZ2;7[KG<OC^IU\%I!MUVK^J?S#Y]\/IKU\3Y_0\OP_])_[/NL,X
MO?PA171U.KEFCV6RZO?8@@8IH]2R;-EIP%2T0_ZF$05<K3NZ<M]&LV3MIGB5
M6I4@#M.VDF)]JA%_&I/5+BOVGZ=YM51A5-D_0%*G0U#)$\-72L%HPG<=12Y6
MVDO26++'GYW\O32)2S*"U@$0S J1)!A.T#T]Z%@XWMBOPY=!0!EFT_CKZ],$
M<BE5Q.(2"PK)DLE:H_$HX\3]<I+B$3.7N@TZ(;HO:$?QQXA*"]$%+6\.@F"6
M@\@QT96$7-&IQ/)9!&TQ&:H98O!["B[TW.Z%Y8Y_6L_3.)+-,XXO0BV0>D)D
M<?<D!Y8!':+"2G/]3R+"=:&%$2KO.AF=XE+%')7&Y8Y5OT'6W/ULA*EK&UI:
M[=+$;FITU*'96:<J*$PQ\AV]!4,SX<OY@D5I=F -3&ZT6:W]%_K+ZHUNA#/9
M;A<E5H:YD*_Y4P3U98$32PU[=/66)]MK3)CW8ME<%X3VY0 1)1PS B3FZWK7
MIC\"8O;R^[W>-+1J1DP^16]6#!+5)>SD\8>I[%6N0G%!:1/VS2V9:ZD.(RM,
M8=K/-HOP^%ULW_X_NL&*D<2L""3Z,E32#32)S*'G_'>C*HM(6A_CAFVPXU.Y
M: ]-2M4VBVWJ$Y@#]>IXDC ((_#>MZPF*I:"]B\R6%62RXV.ZZX2UJWSF45R
MLES],XRR,J>71.1O$:6-)SBN=BT19[F<R&+&\(C-#7-II*HH.RC0BPMULZ>5
M[#EL4+B_UX,DT?!"_DH9)];QO+<&+_5T:33@!^^?[4Z:ODHT M'Z5>KZ&R=^
M?S>7Z<(A"&^J-<UT/;&VY:K<'&PAN9<!0(K!B:I9-S&5R6,SN"))B'8PZ1B:
MWAN4)%&D83O14D&%"\!@$'1<5^VN]:1>WUWB[+<56N\EC[6[/;['VR?Q1>],
MK,P*AH7UV=6M*[&K6]M9%I8BEAYH %I3->4S8=_1@Q5)D*N*E=D1>Y V)4CO
M.I1+W=C@#VMN9*^-*ZPT;8DAK^GKN,KYDMAZ:?IVIS*:UAC.A+= E+?AS1>"
MD0#"_NQA<;W:%"OH;#ATCL&I'@$$:S%MK1=[E4/<"X>RE!+4'*I^S+UQH&%L
M*#Y!C&X%E%!UL.][UXZPF*_#GT/03)%6.=/-WU&TPJ3IUZN-RYRL>'H8U($K
M2L3-SJI9'Q2\%-CJ0UN"PHA2(@TP)!Q@0&;"(6M8,7T8MMZ5I)XO 7.K78,;
M<+9^S=JM<F-(WEJ4GJX:]+%:5O6HM$+AG*U!R=)\9Z18!;TWFE*?_B- +8Q<
M9\)P_6A6,;E<?K^3V%!6&;S$&OJM"GV5,+9*). P:@@/R*/+UQ+H\!--2F@#
MZ!)FA"+&'7CL(M:)BL'"[1HM:\ JBO+#JE6_15H-)+KB&2N)'NL=8HZI PGD
ME1)D7"5-+4PJR@HQ@"G+*2&:"5O0-^ <+B]T#A74E:65=PJ?K:01.PD9%7.M
MC.$YA$WC\I9FU8TS1MAQ\16IV,U>%.Z[&X_$[$-0'80 \OI[\?-@XV3-9UKZ
M:HUWM>U:42V1%06%2L1CTYLAG5/K.E^K4:D0'PT#BN,.7A$02R)V(1KH(P(
M-Q2I*(X0=*"_$8N,^$S@\MJ:T2]6/6\DKVPBTY*V*:G4*=HY*M$$%GHW)PC7
MUE9#UVR20J/AU!R/UM:T/TS! \?+O"=9T>HVTJS(9VV1'V)!B8^\Q9UG+0^&
MRQA+9W2%,2=N5/<P;W,:\*)9%V=*\)#%3@6,21.!42(PP.C ;$7%5%*>QN98
MBCJES<+JKE:SW58^ZIKU[9)G&'=E>9D6V.3HL0Z=$CN-$60V@;=$*C-#%I.K
M5)B1ZT8H*T(<;5P,UFUO(Y;(H#'K A3[.H@64;+(8SREC<Y7&"CME:*,D$>1
M+CG9G 9L\O6MJ"2];V,/_P#=KQ&+W\)$^OS'%F9SD4F>6J.Q]E1G.+P^OKBD
M:6=J0)@;,4+G)S7G)T2%(0#7B,PT80!U].]ZPBN1W_1);!%969=%4%QB=.IS
M'"I$.PHD!CESTG4F(U+1&G43MI"^.B964(HU.F&::68'81!T+6]87%2V;6#
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M0UN[N,MM)J;9:)]&E+'(0D%(Q+@C]1.7Q;^"\B^5.B*YJ[GA'2#/ (G8=3<
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ML6_TM;(*I7+K^YSMYI@D/L:N3K)F3165$6W3<D5.DA?X=,:O06(R.]A(71J
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M9-/YW6EADN[<](>H+9H.'25N@LE2UX:XQ0)[W$(6[38X"IBW.WB()3%.M!-
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M0EUZ-#C7E-TS95/T'MOK,UME+65.:R<*8CTGM5UW-U3;-G*OJN=E;802UHV
MAR4J1K5.M&:**++RZY\Y;SL56B9;RLRY-O85(+"K:GZ^#'OE_I":157(+B?!
MNNW/XPS2T+WJUM%Z)] KX?X'8O.9ZO@69STPJ&8\_6-9=X5;84\G]?:A%'V*
M\6/6K9#JP=V&U!'NT*D4+'$I19CG8L@0FQ$Y+)33G,AM9FX3T)*E+.V4448
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MC3%IVY1]6GGDCDTY&4GBJ0MO0@<TYFSUQK6$L>M#C_C_ )69T=>#T=2E!63
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MVUN:Z(LVSVV.M4[L&IH#-)&EBCFK=6(2Z31AL>MK$1RYD8#TGS "W1XTGH#
MB,,$0 ]2$O1YAG:26R+^PC@M_$R?N9^JO[PI7]M]?8=/:_LCM#3GY(:K_1O!
M_P &&O#%[K(PA@,!@<*OXE+]S#V%_4TU^WJL<E=/:_G'7J@?R$TI^B2N/P.9
MLK%[K;PBJ9K2U>V--8/.)PR$RA97;7,6Z,,;V4D<XJE53@#"F=Y H85J4]*L
MD:9L8MHD:H>]B2HUZTL&M?$CWA<V=D!9>3Z>C5E$V?&VMQCSHFL4=K)8ZR+$
M[9"DLY54VOHAT>DD:1HBDJ4;W7ZLHM8 L00'K$2=1O7J!,V8,W&'BCO(=11<
MZ4'M893YY?!;3KMW^)?Q'A^KMPVC,[?F&DNOA0_#K]R^=K_A#OI^'2^F5X"\
MGFV.50ERX-IQ>>WEIY':[+'23:(<GR%LDY$ABLSD_-IT2'4LOE:036<XK'QE
M305H3*P)U25O=2&]/I:E/$24,!>58\7M\46:E?6E4[VBKC3C#^@8%'XF=-MA
MCL BG3JL;E;S=#T2=K(.V>].AFU"58ZFNBUNWOTDQQ:;Q)P<ZV<L"IXG9:FL
MU<ETY[-J:QV>THG\O7[1AU*6-@DD;0[<PZ*,^/;?ELI5><C?E\QGD%YON?#9
M)<*0C'$-"1!(@;V9G?--S?T!+.CRFY>^&N2$R:R^%3&NUD=.3+B#RMULTPN;
MJVYM8@Z C0I2R"R]: 7Y1%Y7]'P0\6U^CKA-59M@W0YQ.,.,%=:E^9SE*I?*
M-6UFL/5P8ZL)&%A*>RQL91VD8A/A[V-<VEZ1K!*$HC2C!RZY3ARYNCSVLJ-[
M?9Y9[S+:?%-B&R9KWYDV_P L9+&3EIIG&)L4FC2=@<&%X+1HMZ C0H#TFV]/
M\,:3Y1Z&3*&M7$M)L]<3&K489?\ 5:<PJF8$^:-D@C'+Y#1$:9(I!-(UWP>M
MIENFI@3_ !IOE%\4;YA> ?-X:'*]U"R?C^8R?I*(R!H;5T%IN']&ING' D-Q
M*WV,R2=DQ5Y2.#C'ZC)@C8KC\EF,I>?7==+9 J8TV@J5Z5&)S6B.*-<NGWPV
MGMSF.%VY)A3,^5677TI7P955\H?*OEXHHNFE:JW!6Z_4R1F#0.6OA6]Q<EAS
M>X(=(GMJ&O5;1+4_Q)WG,RXZ)37-'UG3CW(7J#-PHZ"51ZL83\D"M\&!K8:G
MCJJ*05ECC<9K7P!2%D4;)V#0S!&^0.__ $P6V]U:ROD&#V!)G:16)/KAGB0\
MJQPQ.(2.:IMQ"M%=IQ&1P"4NL(;&EC:E>W4J$R]T:VXYW4NWRI&O/ DT5Z@M
M[+RL[/\ 9QQO4<\)9M.2J:-KA&8!6=?Q=Z9)"6E=(ZGIZQ8[:U=25N$J;EJ$
MR4QZ<15$KT<I(4)5(2MDGIS21C (3:QZ:\Y!J>N)0CFB!3-)))RG.X'MT=9I
M)1R(R2O-Z%5Z58J]^3'HR4)P7$-9-FDR5.4F0H2_4*3D%DB"6 EVM8ICY+K:
M)P5%4*BPK2=:Y(?*M4UW Y5.$*]#!2*7G;-9\'BL'5FLR>2+&9L<8HC(&6Y+
M'57MI1A3:. 4#Z!R\^6=F/)];RZ2O\Z*=YU$K">++9;;;9[$) G;Y)$)DS56
MTTN8;&?F#4ZL_P D?JZ:0H7-L<$C@WKMF"-,)V: D10Y7LB!?!U Z8W9B4I9
MHX!?H2\1%\>5TT=S9,ZNK[:@KO<;+52,L13L&T16MY7LEV*-+VD5%%!(*+))
M** 7E7C2\)UDF6R>3F6%=RVT918D,M<ZXE<[1[L%GGL&@3C5K0[Q_2>.IX8V
M-RJN7A6S+FC3.-D6(U1WJ(]F&#,V.5^V%NIN?6)(Y/<E(G%EAG;_ %#%Z97V
M$*0MHY;IBB+[+Y*T2 @T;")E+EWSB;KC35'P6TQ@?3!\/HL'EV3/^&1J^A()
M54'E<%:Q/LB26!))G,;#?)8YA7R"<2JP31F2U\>E#8E9VU(H="Q!*T2W)4*0
M@DL 22B_#QV+<W*C]<)5F3&8Q&6ZQ+Q9=,%3I:&=G]BGR5GDD\I-J6N*J-UO
M-G-!'B K4413O"Q*U.Z(M!)4*98HT6Y>HI4&&%Y5:]D\T5Q8\3J2(!-DT 14
M/*6"95 NK1\W%G""OL6A$FKR/";0[3+VM>TML3EJQ+\M7IE;<H*'H"@@TO6P
M;)+9<H EXJK5D)AZR&3.VX'-8H781*^SHO,4>I]/B;9E1,[L@%B+WUA?&:2C
MD\T3EN83=H"3FH\/D;!H2-B)V7E6P<QK6-SITK)X?=N0EM2SO[18F)*N$G!N
M1_4::U[YG4.RS-N"'<?GR_Q*WL/BH],SQ^X\-DSA12SCFNP/*24Q&7VG6TS3
M2*X7LV8P65($3XY-UZST5F6##W4#TP/K.OBJB9^18W@&DVM:!E^*-21LT_9H
MY?X>^3\CUO()*YSEM?["A-A.%EN-IIY[#)(F021G>WZKX13\F9VW;HT/+.9$
MY/"J\:P+$"M(J+VN3@6E;*5%)S21ROY,M%>4Z;BO-VN42VAY?:<W'G^,'-LE
MD;N[2)4W2-X<WY<I/EPE),AV^)W=U,4)G()X5Z=0 LX)VC@:,P<KGEY1EGXW
MK='(FN;2666G8U@-4MKF5)YY/I>0Z2(1%3HI@D@42V%L9F9C3Q%F.G[PK-3I
MT1)Z]P7F*EAZ@_>AZ+RO;P\TFXAI&6_7CYL&8?\ \PD]YI9!\+)!$>)70SG6
M3M8?P/\ V8_A!;5U*T_ [^Z^$#Z^ONO5^Y'*IR?S)62DIZ*,U(O(_="QOIM?
MY7H0=_:;%5<36M6R=_#?T4=]:&(O51?3HS7J:\^O/]!,W]'KI;GV/4.2H9H5
M,K(501.C,;(?6<ED:-[A5<,XW(]R+9H268S$2,AK0B/^'1E.#BX:0(0%I4WI
M)RP%Z%N4);.-ZK:;/2V<B>;$+$VW')>@&>"?6X8*]:K@FD.D$&F$T*92D!3D
MY*9 QRE=L:5>N6-Z-2H&<B(3#%O>R\KC"=5YSI6U?5".B#$2FP*I"8YIT4.M
M EEFK2WQI<X;<$<("E7LQ9+K%& SP A+<0K50"@AT8>;L(=Z);;<^4)A?&%!
MU?,;(GU11)'3\JM1;61\J<ZP:(K#Q?+:N6H%;?&6LIMC@2FZ-2D"'9#XE#K?
MQY1QF]"+-V$P)>5\KD359%DMMOUU%?,]361UO%:L<=[7B^4_5:'2:9RQG^&;
M]%A]!ST[3Q?ZI^A[V85Z8?#7D\=DSTP@-9\X1RNYVOLYRG5IVI/U$6-@C1)K
M5E21^4Q*#JW=$_.47BS>RLL;9&]*]/+4B4."LQ*>Z. V])I2J- F)" 6],>%
M&0GBU*9:]U6%9,EE:MAFO4C1T!'JT99FJW7#ZXPROZG8Z]D\TCAK42L+DD5E
M,"VM+1(UI;6I/0H%*PE4<07LHO+I)/1L.90436O;7)7U^FLFD#1!KHKA*[OK
MZ0H5BB5Y2Z+2^4-I_P (W(B#-LA\+;4+.9Y-#1-R?10MFBV(S9,H\T<MP&-F
M0Y5%GZ?1AS@M/5[13 [LTC(+<BZ\KB4,DH;&Y48K:UA*E8]&,843FHV7H:EO
M4'EA],0]&!'*K)K6,3J-E3DR?3L<Y626RIA)XV +8E:D$*@J]62EAD#;"DY8
M3U9;$Q("AJE2@9AJIR4*3-;"4(HHL5K+'.#8#':N#3'VLWL]5LT'P]Q@$<>I
M/"S-5:_U[8+79T%DD(=&ZO6UX&[Q:6,J4PC3PH=DIQ!6BE))X-BULO+KGIE[
MU7"E7.$=<X>Z3BXW:(RZQE-JVG''*:HE:*WIHI=(6]"6SE6./?.$J(AS@3>,
MA&Q*F5*02$:8L 4H_0T.5^S/NW&U;N#G)'MME=GQ5[=[B'?49=XS)V]&X5E:
M#G&'"'S![@1RY@<=%MEA1]V5D/;2[:=FA5I2/9:4G?AX#E4L5\R0%U:+::WY
MWFTA4W?2D<H>QWYW?R3'UZA\9:K$:$CD6J2-R1*AE*PBT'4:E642$ S1%;"4
M#16@[)F_XJ=LE1Q&/V(=9[?IT^LZBL(E49FSU^S6[ZHPM\DDA9=!1>D'6G3Y
MA*E7K*/-_2%^0/EUY?'8STQX85UH6!O$BNF4+-/7S2^JUBU4SWTG39:;<5AZ
M6PTC/IE)]#?RMS]&SG/U3];'ZF_1WY=>G](RA;7R14C0SJF-(&4? J[*HFUC
MO5?A&'?6KG9@JR-UWL)OPNO*V:;:>9_CR/#_ +LSUQ>8'J^ 1FL6]\=UPX/R
MN91Z4V=7M@*+!G]AD3Z#2I*AD2!9:3'$6"?QL@AY97V.*X=(TL#9SS$*Q J]
M!<W)U1 RE!19@1ROY+4LZE8E;<':(3+%DDT*-O$7E$6F+0]&-DZB\TAJ@I5'
MIHRR HD6B9"D4%B];9A)J5:2>>G4D')CSB1B7"!P#E&M*^F3+8Z5RF\DL1N=
M+(?GF;2Z2?-GN:2"T6F QZ0O$J"0A0-9AJ"-5@R-K6F0)D#>V($("4Z< /HP
M6V_@M:IZQC%,UU%:OAFG'47AS<)K9].RW;BX_"B5*%F_BUNRR=J#/65"^Z\N
MOH\-?^F"W-RKB$<OUA7[3SLS1_4C^#Y?9':/UA\<]"5&Z;WJ(FPE;]8S-IB_
MG1_R0[?D'O1?E.^[\/\ TP<KU^ZI9%[?M)/T:.BB1_MB)M+M!;+JZ:?5"=C9
MUE@UM:LTDE@2.&2M=ML5*=-Z*3R]R-;E3<)O<T1*T\@"K9!QQ9A>57(W\[QR
M.Q^>,D&F5B5\LL&31"6.THBSPRBD*%TA==UU5K86T?6&./[&2W*XA6#:4K3G
MH5!9QHCS/ .S->4F6OKS[;'/3E!U5:MCM;,/@K_!&&OK!CD1L%4UI;2:HN]O
M$E87.=JU#>N=%4A1ODA6FFJD![?M>G/^"6!4("B$I1>5SE8"?D2!0J;#MR)'
M6!()!%+ MJ\:_JYPGP6NN4%N6]'9DU6"Y)2 M U.MSD^;N0Q"=3W-,TGKC#$
M)*8O8BA#E>R(<A\IS3F^-5?'2YBWLT39V"XY#8M<Q_2EY12"V[>L%CES,=N8
M/A 'A=#Z1B")1%H^2$I&(YNV0(T  )B"2QMMRJRI3R#5L\=[I?9XYSR8NUV1
MACA#@M=9-I(? (?%GUPEL88*N&P-[,**%L,T<AO)"L?Q3D-P+)$<I-+3D%%D
MS7DA?'-:P^9!L53)[-FT^-M-DN-UELVE:9R<'N<1ZFY;0[6H6HFQF9F)"T)Z
M[F*DC3>WI$2(*DLH\)83-&;,+=K^3]N7'U>#5M;W%9=:-;S%GE-VR1).()*D
M:&2#2]"STRR[1B*X+RQOK"YQ%VF.DZQ*G4(33VPU$0-(>28$8QDY+MGT#63>
M+$1EOL.PJ[4$*F]2&5P%R84LI, @", T9ZN31R4-AZ5Q"/\ [CS)-F"WK0@#
M +6MX2*V@U$JZODE=HJ^F#FRU+%&&U%DSB+@<?(Y1;%K6-(XT^E6//)P_"<'
MQT<&\XI^4J/ T!BQ>\A&(6B4I1.%SG\4=E_)[1*+T6]"(+DO"%S==$([ A(8
ML^P4Z,H8>P.YK\>PL;=+J\E:V.(Y4[F!4/>V]4F&ZF)TVSQ"^$2^B,],8C_0
M\>54"TAV>4YSPLK[07"XDM::D^C*H;[H<V ^-K+:1Q(]O-,#+C$*HT_10U0V
M@#J:-S"BTY"VKV.5QA X5PA&()4L[I-IO[ID^#6!$9C%W3XJ<PM-*T+A/G8;
MU+K!;YVR5PSS-19CXN5*Q*'I>N7*3-K3AB\3/3&67EUSB932-<WS.M8M!(-6
M5^6 FBT:G=:KG%#+6JNEFD%35ZF4:/J:!HX= H4TQIGE>TJ!"L-,(4FDM@#@
MIA$FB 8$9SWB6W1S3"+N?H]*'Q_GL3D+!#Y_7 GBOY*".+WFN;1%&39Y"710
M:WN0R6Q]50UK.TK0[1.Z,Y&$2581YC/.27",-_&E,-4&E]=MY,J31J:BI,3L
M2&1G#6$!H!AK^.5Z6W+34YAR8!+96C9I9YO.)6/1HM[ULS?@.5SEY&SC"K6B
MSH=92.16>$BN[2L"YH!6XYH/=7P^Q+58)PP6(]-4:"W@5GD24-C/"O2-8L5(
MVY:N-,;RD@3#0#+RN,/O9_&M4VO.)+.'YWL-I,G)55:L*-1:6"9(S/5=(R@^
M7U<OD9 $![R$V+O"@?B0A6HT3B1O12XA4 (=:$VLB6&\^PIA:8PH8&Y[=G2L
M[BMSHR%M2F1A0@<K2M<%PJI$@<G$Q$<67'URNZGDM,4(O846AIQ?=Z(\!$S4
M8XRYZ!S52*>$*4+8W222S>PK0F#>RNK@^L[,_6++721)H@R/+HG1KG*.UQ&E
M+?&6HP9"</RMF3A 226$!0"[7E<H R^W?0#2Q[BZM;9LBC+?5<@I2$L#Y/5W
MR^LJU?)?#)XF8X%MG2M"MM=(S+*^9UC6]JC5C\E,0$Z$M,"46$ YU$G+B43+
M<-<S&..TEL+4@N)FM7H:?W%-DSZ\/*"N:)M"FX7%F"&MD4;8[LM]2V;HI42E
M+;&XE,B-.&4<I/%ZI>71/T/ M' 8%L3?W.SYO%D]6/\ 2D!8IA/5[DFI^LY(
MI9E3A'ZR6I4[>\-:XHR,-($SPO4N3XE3M24@I8$@O98B<KW9F/<45>SR)?,W
MB5VI.YL\6-5%IOLNFLO2KW5XE=+M;PR041R5J9&9A;FA(U/1A1Z% C1IC]AT
M;L&CA&F&CE4[.YBK$XIR)'J1>1UZ&9>G57@]"UO[3F%8P+D&RM_#_<1WUXVF
M\Z+Z="#Y]>?7F^@F;^CSP[EJK8,@K-N8]23X:IZ?GM'Q/XQ[$I,U!['<8*Z2
M/3F/:8'Q[SM57;=\.IWY=DA]77EWZGT#-8&!\A0"K9!%GRMIA:<)3,43K"'R
M&,LTK1&1BRV^GXNDA<&7SYN=6-R/4/R.+-Z9 K6M9S4<Y)4I!2O9Q:<@)9>5
MO=G(_P K51'&ZI&I$1(#T%+N=GNL/(7/9A^CC[=0RINF!3X()!0W),:EF*T*
M<.ME[(WL&];WY/I)RJPZ;JQHI.LX?5,=?)0_QN",R2-QE5,'!$[/B&--184;
M PF.*)M:M+$<>:"2428PXL:H:<@&SS3CMC-&+<W*S<(X+?Q,G[F?JK^\*5_;
M?7V'3VO[([0TY^2&J_T;P?\ !AKPQ>ZR,(8# 8'"K^)2_<P]A?U--?MZK')7
M3VOYQUZH'\A-*?HDKC\#F;*Q>ZV\(U1Z!LZQ&:R>?Z1K-WCD*?+Q=+'-66/*
MH^=+$<?:*QB ).LC\<C 'F.IG><2HQ86)+\2K]!*U-[DIV0>(D =&I)BV^&N
M7.O270UYW>TP)>]5<S1&O(E8BJT'5AAKRX&VE)JYZ1N;GPE?7:M;,1IX=#I6
MGKD#N;L_YPH0+ #0%F'@\RK"V23+]=(](WU!;$ZN*K^85"PQ/E/EZLND-Q28
M19R>I)9"Q]67V=(8HM=TLO8]1:-NK94A")"XITBM02ZJ_-L!I90DYXDF)GS7
MG<.J[M&;++?0+("WUG#.O(5RJ;0SK%W/=FO*62V' :K62A1-2Y,'Y5/S7F=@
MD3:S%LIZ0V,D% &(9RK2Q.)K.WG"FG^[NG98.G(-*+=W4%]1KKRC&2[JV:ZM
M);VQMAMD,$]5LK2PR%-8K\VV74DL6P]?\K=?B"E:SX(PMP2(UB<U(47$Z^F$
MW;^Q;ZCZ-KMR1N%<3^ /G3O7W/8*9@<2<T\_0-E J.DW")OB67#ECF%;-S45
M$$DO+:8TA2A2.7Q!0BS"/!03C.WG$1J=]@=1UK7L D8Y11MAR+H#G=)>$" R
MPF0-L8K!\W8W/,;VUNBA/.W9PG=6N[1?($Z5VWMN7_,6\ ]:&!>$A$)K+Z]T
MNL?K/H.J7.7TPM.8[ L4'1E/U!&+)B%9#T>EB]L4S*;B5+E%5*["3M[Q*604
M"<6=N\'U*E4&."$TTHP9)Q*H<9>J%2KK/MIGB=I2!P9*YKI\H#E5SZ"D<,G=
M?N?SFSW1BN"_(C'DQQ3-9#H56$8M*N*G0NQA>CW=R8UCF$O^G"286:,:])ZW
M_A+K-ZRZ.J*2R&DW8Z-3ZPG2UZ!AL8GT'K%3YV!FNJ 7).WLC5:.5B$)9,[1
M\ZCU[>SFFO:(!XWE'M24>-*8!:)K+U\/P9T7VH\B$PJ2(!3DJAG,-NWC)T4Y
MK)>\.\K>*YN"30JOA_5QKM :>$1>U8,QD/+@DVXN#DT"6A3%&"&$1@1C7]5L
M\IV%:UG])7C*Y%82A56K[0?)%@P^HS&H&T4 6VE')^^K@-K[IQWM4<$36,M6
M?I&3MP\2=CT#X8&A#;$D]<UJI<ZN]W*];69QVVWOR%C]Q'BEGJEADT55'1^L
M$3Y5\4D[L8F2M\F3*GH@MO?#S-HPF( +G,OUS#BM'F>6+,8_*K$D'8W1"%TC
M%&M:5(]6B==W1-;.]GPVIQR\MSCU%QN#2MI5(*H665%4Z622A)9C>6OT%\.*
M*3M+B<F(#LXGX2IQG?QAX'3LOK)@A5[6?,HC"H:=4,3Y<BXZ4^JJI_E37=?2
M,?J1.^JI/)$L_(;#XE4\FGXU(6U(,L]T2!,).<4@B@G;''7.(G\+OOKN93^'
M<_/J=IIR3R93<TI8+DLRJ$Z-QL&N:L9*0,1I([4#;:SDB;)BKF%P+$B\9[P(
MK;1%SU:=*':X T8Q,902B)I/.D>M^8[BF;O"PHV;EWI;88HUQ A[CP9E">@8
M;34FL6LI6\.A[LQ,UC_*27-L4! <J+8C0HQJ% %!AVQ>FMD]78G#!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#@M_$R?N9^JO[PI7]M]?8=/:_LCM#
M3GY(:K_1O!_P8:\,7NLC"& P&!PJ_B4OW,/87]337[>JQR5T]K^<=>J!_(32
MGZ)*X_ YFRL7NMO"(+8=8UY;3 "+69"XW.H^4XI7A,UR9J2.J9$\(0G 1.[?
M\26,QN=4A:DT!:D@19X &C#H6@C%K99;.S_(K5];P8YO40N!Q&)FM,2;(&UB
MCD?:V7Y="F5:M<FF*(0MZ9.!*P-K@Y*#R4H-!)+-/&/0="%O>QFWNIA[Y(J*
M97K*[TL6*Q.Q'9ZC%1Q^.-4LB#0ZZA:FJ'JQ'U.ZM;FM^*.4;>G&=DG#3B*
M20H:DYVO.;H BARN,192RB*7<+((N%=5<"66DF] 1$^41=H.E(#TK88R)%OS
M8:7:H;DC8SAH250A;4DHAB3@&$D6P;&;C'A&T/+'.#;%'B#H*0K-+%)!(&65
MO3(5$FC21SDL:4IE<;?%>]IMG&N<</1E;;SO/YT(2PA(V .O#!F]T;I/DJH:
M7=G69(HG$WNT':;7)+S[0-B+0W3#1%PV?++$7,^G(KXI5X-:22%- E6C0G+4
M2 G1G@#02@"[6_@E3'R_SG&2I,1'J.JUE(F1K:;)R6V$L"0EYTSO@9.TIU91
M*()?P+9)0?,$Z<.@D$KM[/"#1HA"V,WU2B54M4<Y22]#,:UA4G2S\Z/*IH2]
MQUL<-299$0D@BBYW$H3C&K<(S\.7MO/WOUD0RPB)$ 0=;T,UY4E$4PA87&+I
M*N@Q,>>((16#NSAC;9M"ZUVG5/JXF%N1 TX@KHX%=*'([X4WSE;.7GCWK8C1
M[V,UZY=2U1SXB5)IK6T*E1,X(C*:7!?8ZV.0I"7"E2M=#MN9BE.88H.B:Y><
M>VF;WZB$\S9A(@#^ZP9K_6:F*FCJ,EO8ZYAS6C3PE16Y1"-A;R@Z@2Q8H<5D
M0%O1'F,8%C@J-/.3"WLLTXP0Q:V(6][&:]#/4E81Z4-LU88%%6:6M$';JS;9
M$ULJ)"[)*^:%'Q31#2U:8HLW<=:%'B-*EWO92;8Q^GH/G'YAFO(X4I43K-S;
M)<JVABV?*!Q@U1+E$?;C'Y2HA*E4KB"M2X"(]=0MC!ZTW:$\>Q')=&;"6((=
M^&#-[>&.EG/M'SIH<F&85/ I&TN\Q.L)Q1ND9:U(5$\4( -*F9>H)/ZY4G4M
M(/A#%P!!4F)=B)$/98A!V,V,V74-5ELTKCH:YA6X_.FEN89HQF1IH-9Y6QM,
M=2Q!L9Y"VFI!HW=L019$2W%$'@&4!&4$G6O)K6L&:A"CEGG)7!F^M%=*5PJ@
MC2]J)*UQE3%VU0WMTA5IC42M\1:.)&>E=5;>>8E-/ ,)IJ08B!;V4+8-C-[I
MN=4-6*$1+:97<,TW)J\<ZD2("8ZUIT:.KWDMO*=*^1)4Z8HE'#UQ32E"8WE!
M EV%.7KR>  ^ S4Z;T")J0(FMM2D(6YM2)D"!$F+"4F1HD9($Z5*G*#K02R$
MY!80 #KZ-!UK6$>O 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'!;^)D
M_<S]5?WA2O[;Z^PZ>U_9':&G/R0U7^C>#_@PUX8O=9&$,!@,#A5_$I?N8>PO
MZFFOV]5CDKI[7\XZ]4#^0FE/T25Q^!S-E8O=;>$,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<%OXF3]S/U5_>%*
M_MOK[#I[7]D=H:<_)#5?Z-X/^##7AB]UD80P& P.%7\2E^YA["_J::_;U6.2
MNGM?SCKU0/Y":4_1)7'X',V5B]UMX1ICV=W-5/"<)265=$+O-YKWX)X<I'-J
MGJ"469&*^;F8]G2B76([Q\H:2'I7-4]E%HAJQ!TJ& W0/'TQ8:UUNW2=WAIG
MOBGKHM*"THCA]YUM:=B5//[LCL)NFGY35[]]G-<SF-U\]/CD@D91)[<%Q?I6
MC$V@,#XKT@A'E^( ;P76R9\(A#/= Y(G"ZJD;=*I.UDW!(.O(Y%G:1Q!S9&5
M$IX=5JT?02^3.2K^@C[.P;0FF(E)_@!P)!L9?T8.-6/RAV]4?9B%S?J<BUYI
M(62R,<IBMA691=E57 K0B4D.<"66559)IRP,R&;,BX+<(X(TV_5"F-).$7HH
M\H8QMK=>^$&ZO]R;G/C6Q8Y6-NMUS.<B?JKF5X+3JKIF=6PW0ZHJ]=VMEF]A
MS8<&;'A<P1B+JWE.)8HVG,T229Z@M>76]X)I=IF*CG/O-<15]-9#&GEXMQRA
MT-8J)E$WOB)4G8<QY^@T8Z6CS3**6D<SM&-,[FTQEBFS0]$#(5K %$%BV+1@
M@^7>%X;83N\O=6Y"H"Q+%KB7.]JR952*%@=.AYA55'VI:U;<XMLH1 =&17>,
M]@D7>H]!-JF8P*\PDTTQ2D0;^)4%E$?=X2:;7JL27^X7RM7]CF5Q-["U%Q*.
M8'WL*-3UU0F%U9.Z'B8"U,PD\#GY!A['*%\3:U*=>O;TX]K"FY60J"6,@T(\
M'&V=/5B*^]QOFV>3*K((O4SVKWVZ>8EW7=;?;'"'*N6Z14RS*2@R58%Q>C I
MFZ61%I5IG5V9%6R7)O:%9*LXH)(A"".-QG[M@.;N@X%U32D#Z!JPB4@K:S6Y
M4^P=;,(VOB3N_1H#FM;VN3D,3KH#FF8I,0BTN;#3P%"6-QY*@(= -!O9+++B
M]VN%I^YARW33%V8_3]WF[43P@ZUBT7TW$P5Y6O):BY6I@=JT/@K8F"-1.4<M
M*DA!*8Q'XZ$I :5OP$4+P+QO3[L#.O=5Y!K^$1FPW:23)RB\JXSE/>R)9'8,
M\/)J'G&(BA9*^1/2<CRC:WU:OGB%*C;#/^Z4J@GEAUXD#\!QOZX6_9/<="51
M,:W@LO<I00_VM0MQ=(Q$M!%7%P2'5A14>C$GGZMP5D_T;>\IFJ7(Q)40_P"E
M5C$,(/I!O!-;>OC+60CWB.8"^8+ ['DE>=6P+GB 0VLY\&P9_P VV!%&Z?1>
MVY(TQB&N%6:<DP-S_2I6^HU!P4.Q[(1* '[^X%KQ+PN>/3+;2"]E4+9=L5C3
MD&DRV22>X>:-=;5^YMS0K-B;Y2@Y)&(L0^@D7AI&0YJ7.7HMEHAZT?LD8A[U
MKR"UAFZV3/WPK+K'W&>?.-)Y"JXMEJN9[DLWKNP[<3D5)3<XMP,>K"J%#"GL
M2=2PB#-SLY,T<B@9(E-5G_#F>F0+8]Z\ [PLUNTS%,VC[S/$E4/XT#LZW!+(
M@AHZJNE)+;]94A8ED5'"**ND;IJO+-FTPB3,Y?5F+O!;,H,&>H3A^'++WLW0
M? 7@6>WM5AW;[I?)5&S9V@#FYVI9K_$*\C]NVB*@Z3M"\6FF*IE2$;K&[!MQ
MXKB-/S?"6!\92AKTH#QB6G-P!*PI]I_ S9)I:Q-W>[)Q_1BJJOFCM9UDL-PT
M4^].1:8T54LVNB*I.?XN<QE2*VI"M@+:\+6B&LA4C1G*E.TX_0(-\XPA\HO
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M:B-/*083#AA#LU267_[AZ\2\;)FI9USW9SGPZ&DE/1<H=8@UW[;K+2D(?$C
MX/#*BF+ZF4+$BB6KT01%QB-$)THQ*'%1_P!NG#KQ'O0?'>AKK=NS 6'[BW*-
M2G]4%V9/ET,3\=N]3QZXEKK&7T\LR27?&6V4UC&8 C:D;B[V)))4E>$R9,@:
MDRA68N-T0$O8O'P$UMQCRS/-?=E$]0S&<5?#RK.KZXZY9&*5S"E+YJ>=TC;#
M;"I0:<GC<Z3PVP69G7/,,>52<9!;BAVI3DJ0^@?LH[>B]BZV3/A]^G.XJ2Y3
MD5;P2<H[2G5I6XGECE7E0T94\YNFT9''X$F;E<WE94/@30[+T,7BQ+NETJ7*
MO1)]10 LO9AF_)@FMO7PDD)ZZJ"?71+Z!91S!)9<%HNL>B),SR"'/4>"VUW;
M:N3H8EI0)V(3*$\G"KB"TM<UFE%JT(P:":$(M^&B8N,M<1^[+QZ;3_.ENL;Q
M9TT.ZR;I [\]T_7U0SR?7Y9#9$EBE%*7-MJ6(M+Q)&]FC@TNQ+7!<%,WI@#!
MYS]"&$.S7#;-GHO6I>U*=N.VFBCF!NLZ-6@[<\LW38XA9%92NNGIDK5\L)]K
M!*3)6N5H6USC\N*ED=4EFM2D@M2!/H!^O$HP MF;K9,^,K YFZ.K+K:D83T'
M3JMY75Q8'UD^KJJ0,JN.NYOU4ES_  EW^+9UW_=(_(^QM4$OS?\ R%:"/7T"
MU@LNMQ>Z]\(X+?Q,G[F?JK^\*5_;?7V'3VO[([0TY^2&J_T;P?\ !AKPQ>ZR
M,(8# 8'"K^)2_<P]A?U--?MZK')73VOYQUZH'\A-*?HDKC\#F;*Q>ZV\(YQ>
M[K35G=">VYUM3%,Q%;/;0L"M266&Q!N5M*!<_.@93'5XD:98^.#4TD#TD1FC
M\3U!0/ &]>/CX:V:TLFTM[-9N@^&[+Z!]R[G6R'!TORKJ6@O UD5[(;<H6X5
MM02)):3C;]:O+-73F]15Z32Y<UN\?0KEQA $XV\9B$L1ANC %AW&IM)I9YRT
M2Y5X"Z/K!SX&0VES]-Y? :5L'WN3;A:G^2PR1O[U >CG-P+I@N1+54N".2/%
M[,/B$)NS1&;4*A"<!)=B%O1K;:67KUZ-N/:9K#HZH;KMF#1F"=@U/[;S)3D(
M14I4?<SU GVS*PNTB2+RWR#TDKCDMF\O*Y_CL""0G**>W%066N"6% ,9 1C%
M6=[+/'+[)1W#P/9O7WN+TZ\'2:ZJIYN,X0Z(I>W+4I220"./;NLL&S:U4?8P
MXK98QRU\;VF>15&O.4*VIO3JR@(M!+7IAB\I@UVFNOC.7._J3VJ>A2+)[DDW
M/U>6*OI6 %>UVCI'DY+.8PBH_MJG>9(:RL%G4O8+4X/*-_7KH<TL)132>YN;
M4F,<0Z];2PHT0@QJ;S$SWZ_DV=!'^L>4%7N?U#'^&[<Z4#WI;]EWWSO8T&65
M:&#"6] U3&H4[59TLYRZ?,+G6">I'UG$48I^$=$*UF'OX00C0Z)%4_;MBYQA
MKOT;[3?5G0M!\6<))FEC9(Q[=/&K',VKHF4(HV_L-]=BH(<TQ:(\],S>N<3)
M(#GW6F$\<U-6I$A+JD4-Z<(!B3#T&86;ZRW;UOZ-R/<9YBMCW&N"N1WF3<OR
M^!](-5T\_N%BU2W2Z/LDPJ>O9O*6RM.PHBFF#%+BVIUKM\I]S>B5)"9P/VZM
M&DPO1$H"$D)-+-=KUZ8_^'4WG2[FFQICT'4,/I^35S7O*$]BM$1F5.2%*S0^
MP%K?6\6D[TFK1F+)(4$Q*NRI C9=J/+\,<L).+(WY2!97.S&+YKDCVEP]T)8
MWNDU!*ZZK4<DY)Z1+Y<D'9<K&[Q].SQJ0\)69/+7K=*]L*YT2O;X78Q;ZULV
MOA$RD( (OZ78 :UATUVDTZ_RG;\VBL ]MKM<CD#W3J_G%*NRF=1?D)_]O7@Y
ME^L<+6*K:I&,VA>%H,TF:C?K%IO8T\RW/H^@"2ZG(30A8P>J$(0A\(U=]>4L
MO3.:VCL#VT+P@U_T+,*\5],7='B_;B[DJ><N%W7PJM5'7=KV/6%9LE=0&()I
MO(PJ(T5,W=$O(&%N+&W[V@*^(-+"65O9F;3%SCO%$UQR-U&N]J-[Y4+YN[N0
MW8QQOV]4KO&>E[HJ^P:B6N5-7U53M931S:S(KJF"."Q./QYA<%RA&>E:2E+2
ME2DE!,-* 1A>4YYS,=6XO&'$72',WNQ3TQ3!A&\-5SR[<\1Y8LI,YLHD\=9[
MYZ&KJ\E//2QF$\'24@JII,GD*9D.$DVEU'?@R/6T(H)>JSMM+I_]L]5L]X<+
M6IUO[@_,3RADUSU30+9R#UI5=OW!2<AKZ/R4@^S9)3X&ZKCUDS8I>Y(4%@L3
M2X[-5M;8%8G"BULI:D,V'8YY-=I-+ZYCGCVG[2]^OUB=;-O+46L2-4Y7?MX<
M6TSS[5#1/(ZT5)U8EY_FECJYGRM<"5:O!+GMB?*[^';?B#5S(68K>MF'+% !
M*"]&IO,2[=\W\ONVOA .FN+;[[GGS1P/=-]0_O)LI6XZ9;JI,J-4=6<_8>?(
MO4SQS%?A$BGT410&,0ITCY/P+RBTY,86Y2I"7_2%Z)'4O':3KV:Q5-[./0Q#
MW[>="V?-+4KBLZQ]M'HNC>D+6YVET":O"7W%<,(F;ISRB>I@P2E[!$'-C<7)
M$!Q:6Q,ITE9R]DKDNQZ".+=YUL[Y6[&N0K#YL]SNP9/">=^YQ<SE0WV_ZSH=
MWY:NF"PVFPQOGZ#*82^-7142D=RPR2V%"X>F4)"QD'MSF:>B"O" !@C_  ,)
M=LZ3MGJJFG_;QZVK'I:K.C9%!;)L6!-OO#=@V++>:)+,8<MK*%53<[U-D5.]
MS5O&$KDA]"908YU"K5 6+7!QVV.9HDS:G5 WO9;MK9C_ .OU%Y<6T?;[W[;%
MB^V=TWPQ>4>$.NNL##IY*G*EU%32U\EUR6%8]9-\1=HM;[U.T4M$HEK:O;E2
MAG0E(ES>(S9Y8BRMC)M9SY2SPZ4>U#SU(.8_;\YGK*?1%QAUR'5XV3?H%&_N
MB9_EKK?T]#]:;<?YG)4KB\%R.3N<Q<E.U"OXM5H0  + 9LHL&M5C>YVN.SGC
M+:'O.(>\'T'T"LH_NN05+9W_ (4):_F_+ERP""5"[*JR8GAJGNNBH6\7!"'R
M<PR.*W@CS)-M;CL:+2\!)0]G:"9&LSA)TSU5.+D_LXGW$"?>$#SKHU^4]%G\
MZ*N3RRZ\^T!/Q&&+?9(DZOT]"E 64?0NW4H3V-'\P^+^H9NF?0O5T(K"\M>'
M#[?JEO*O,%[PGK'N%CGU2=Y0QJZ*ZT[0E,!LV)7'  \4)*XN2)J6F&V+,Z=3
MW(GDCC-S#TXQIU7U:-5DJMH!#V#10A%4VVF)C'23\5K\,M?1M><3Q#VK+?XY
MN.M[%A//UD\Y Z*CJ6O))R0_-[? Y4SQ2V"YTU3T$S1AL$1B8U0V'1[3L0ZK
M1Z.*T7YS@S[)MB[<Y?+7KF6H^O[(7>RW04[X^MVBP^V6<M=>D+9L=PKH55/J
MRON<)90,/;*2>HO.9"]65NPG21 <M'Z;D13:C!OU]^?Q#HMLDVLLO)=5G<B=
M(OL!_B'V=IJIU6.78*<@OFE*)TC&@6P,/&$+K46FKU7P);67J<MA[<+3IM#X
MF%[%_P#%O1FQ-IG7KV_Y:XRCGOI=VX-KN"PWF'W"I!8E*]:^WO<$@@/3MU5-
M93[)6"E)E'7ZS$_/!ZB^)*P1N)1]'$S/(VKES,$TU4GV47O^D](LLY=;,8K8
ME-*>BZCZ<ZD]U^Y.1IW7[5**>YLXIYWY49Y%!I;T+;ZYXO?>PV+99E>/4PK^
M%FD/U@%$I2!NR\3<QHU1RDTH.@Z%4Z6327[NQ76]&-_3O+'0W/+P2G&GNFE[
M%K?7JB\Q*1QED3<VAK7A,&$OP&UNRDE06/>@^ RM"^CPPYRXLK^4)[X3]T!]
MY#8.E-\_.R3W"YY=5CU1/H)N8P$3U'N<;&X19.%R9BJD.I.*/'HHVY5^W30"
M4E88KT:J^Y+]70O".W+27&?V_P#G+:GM[VX.ASTO;==<_4T]S&!.'L[<E<B4
M4H;7:(MY4OGM+W?+G!?!VXEYD+8:A<&R%F)%@SE@4R,83M! <(S0@Z)KMKTM
MO_9LQTE)>H+AL;VW.BXY[?76")-R%TE9+G957.ZWF\FRG:)RGEZ70%MF40)2
M] JX<X,FI9*RT@P*G=&MT(@P7H;!Y1"OG+,Q)9F=78![=97<G+\N<-UE-*ZF
M=A4[-$Z>JIV9%03F//KW&'A AC4@-B\EDT1 ["5F@ (25T5)=>?7]-X>.]&.
MVS^1ZA/;K[N2\X3"%$\PW^QOK?[-MZ\CS4CJ*UZGGXW"]I(P1W5>5OQ0UL5F
M2Y75E9.[VW*=R "\UG:%R4E"6(D)R4LP4=KMKG.9_+ZR_H9]JF(3BO:=<H1/
M*R[DKIYC[)5R);KLVW8?:Z-P=T,,"ROB*CQ16U[/W%8&S+VC?G1'Z;0[^(($
M64+[O1=<M^M\?DTR]WSC'K&T[QA$]XXAYSX7UKSY+?;N[#?$3RP,(ZXHB;V-
M#IDT749\U=&Q4\K(*R*)>W:+2A4+/2> A+!L/T:C>FVLF-O%S%G2VK[3X2]P
MA]Z<K;ENUND>;[5XLI;F)N9>?4\'?+.HR4<\267*XFP#ATUF<&"LK.>QJ4E!
M$O0JC-(7-O#\44 D0#LJ9FVN+<7+6)VX*ZP_^I"WJU5U,$CH7HOW &3LA=0,
M8DD7< U'&)WVY6]Q.4#^L)CL@B:Y= Z[8C5SIM$I&G&N^)+3;/WY-F1>4YY\
M28_1:_N!T%=[K[F5<=$1VF.XY]4#7Q$HJ93)N&+D@E/SDBROM^,G)$8F2Z4V
MW5JUXA)\93[//2@&H3F*A)][#L0-^0FMG#'3.?*O[4KOM^-7#[Q4+J?AB;VT
M'W"=50QTY9,GF]+1.AXVSJ>4(W3DU>[76O-B&SPHN&/2A2(;<V1YR-<AI!%E
M#T$8#-U9Q_;F]O\ EV2J*NYMQYP=7%51EK<+QL?FOEJ+0=@9&D\A,NM6<596
M")E;&EJ4/:MK3H@R]_9@$)QJSR $%GAV:,&@B%HQ;RVSXM<"N5O;X]R?DRQ_
M;TZ0EC74%LOA4^N1EZ_B-:L3TQW*5$.\WDVU+FD5LS.66:M@EH-]$6^A:S2"
MF5O0GZ(2B^& J+WO6XZ7;3:6>/'Y-G_;FJ"_J9[,<XO0%/=B<[^W%NK[)<)[
M178;U7KM"Z[OUUGK>ZPYNXV(8IO/9NTP-<D7/2IV3G+MQ\(#B]I]!/$$LNL[
M677KB[?;_=LW[AT5O-JZ_P#;2Z3J?G6SNC(MSG)>KS[,C=3.%:HI6UI[7HY+
M7T/4DE6=/J\95"=4_*M^KL*W8BB23![#O?E"(FMG&ZVXSAS_ (CPGV4OLFI.
MD9_2:*%2V[_>QB/;MDTO%)I$I23SG0\6YCG5+,[I-9*B<$$?DLY>58$2Q_\
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MM=RV3S/[4W%$VY!F//T=XDZ'J;H>_.@;:G%1_"'CHR;2Z;,,(HB-5W/)[,I
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MK8/3P73&N9ZHQ#?>'MBX7CE^,TER17SS(^B.&:_[?<2+6ZU:Z@9H2P3J?+X
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M(98[-[=;G5U<J)@J[YK&P;H/;AR\AM-I.LZGJ@$ZL5[D8@1YP&_K6&=.+=$
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MN_5$(G$046!8<?G4!>8V4H(2.B0YJ5EJR-:/*" 8=[)==;G'2RIE[+_:UO\
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M6M"WA+O;TDDZK8X.XBG/#T$BU0_^6UJWI2]<UJQ5G5U:V# *4CJ2"-D>/)^
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MC=C-V,P1FW-SV6KA# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M<W#^6%*"$ACCY%BDD7P):I444([_ ./1A@0[WXBUK8>\UX:2%K<VGNC<2XO
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M#8=ZWX>&\&&+36E62WU_@[&@BOX5*)<I^&E\?/\ AT0#"B1K#_2<!>DE <>
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M$3'YP-:.PO\ R W(]^Z5'?-\%Z6OLT^7[FFR?_EWZ_R_S_\ \?RX=)QN\_\
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MWO6MX'WE4+ATZ;BV>;Q.-3%I*5 7%-<J8FN0MQ2THLTDM86B=TJQ,!462H,
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MNMO"& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MOYQUZH'\A-*?HDKC\#F;*Q>ZV\(8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MS[B)<)[LMCG5C]O67)><*)9&:.TP^F3R>5O2,.L&2WEU:JF5:.ZF?(+'>9"
M'RYIW'&\E 4<<1H)P]##%_;KC,SE9%M=TW39O\/K*.^8DXFT[?4GXG3VVC>H
ML41Z<4L';:D*<7J,DO29R) U*7,DY2A H+4>5(<7H6Q[UYMU)K)[G'QERDGG
M;79U>\^=V,S;T1UZQ'059[:;U4S1T1&*@8NX61#?5WMD)N^201'&(8AADDIF
MP4AOR>+*UY2Q24]E*$YFT^@ZV=*W-=;9TGG\']+/%NIJ#G-X5C7]=/$N52.;
MJ&(GOU# 6>X$RXA.F1,[>Y)ZH:FAA)KTU:C"<B& L:P11YPA#^D 0URV[^/R
M?SU-_:/4U<\3>X01?_2'8]:>Z+5?&%G7!):3N*OJEBE019<PRHUO37AQB\0V
MM@-$QJYD5*D;26<:_/ M:/ -6G"<+U-'3C+M,8X6MJYGTAT+>MS=;H7KHOJ"
ME^>^!JZY19'F$\455"IYTE=-EWU4#%:LBMF3J)57MEN)=<1!&^ (*0-+:E3G
M%HUBM2=Y"=EX2223I+;ZJJ4>Y!<<2[:YTNJ)7Q-K.]N9'P7Q?-[T0V%'(Y'G
MY9&^JK,L^IV7KV0M[/&6DV.R&)36.QY5*4B4M.WIV1<M-*3$@(\=%X3C9?Y9
MOZ>&M\.['Z[M1M]L]AD]Z=XRA+<?/O?TXLY/Q(T4V\7?-Y-4W5Q,%K>0+")[
M%549W%HE$%0D)HTX"1BT--] Q"$/(MUUF<8Z6=_P;[2HSK6V>N_<2A->]Z]
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M2LD3>G- CTB4C3Z+]/?A@F^TN9WQABN@?:9Y0Z0L>S[&F:J[XOJ_6N',O24
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M. ^M\3_S1'?\;;?[3@/K?$_\T1W_ !MM_M. ^M\3_P T1W_&VW^TX#ZWQ/\
MS1'?\;;?[3@/K?$_\T1W_&VW^TX#ZWQ/_-$=_P ;;?[3@/K?$_\ -$=_QMM_
MM. ^M\3_ ,T1W_&VW^TX#ZWQ/_-$=_QMM_M. ^M\3_S1'?\ &VW^TX#ZWQ/_
M #1'?\;;?[3@/K?$_P#-$=_QMM_M. ^M\3_S1'?\;;?[3@/K?$_\T1W_ !MM
M_M. ^M\3_P T1W_&VW^TX#ZWQ/\ S1'?\;;?[3@/K?$_\T1W_&VW^TX#ZWQ/
M_-$=_P ;;?[3@/K?$_\ -$=_QMM_M. ^M\3_ ,T1W_&VW^TX#ZWQ/_-$=_QM
MM_M. ^M\3_S1'?\ &VW^TX#ZWQ/_ #1'?\;;?[3@/K?$_P#-$=_QMM_M. ^M
M\3_S1'?\;;?[3@/K?$_\T1W_ !MM_M. ^M\3_P T1W_&VW^TX#ZWQ/\ S1'?
M\;;?[3@/K?$_\T1W_&VW^TX#ZWQ/_-$=_P ;;?[3@/K?$_\ -$=_QMM_M. ^
MM\3_ ,T1W_&VW^TX#ZWQ/_-$=_QMM_M. ^M\3_S1'?\ &VW^TX#ZWQ/_ #1'
M?\;;?[3@/K?$_P#-$=_QMM_M. ^M\3_S1'?\;;?[3@/K?$_\T1W_ !MM_M.
M^M\3_P T1W_&VW^TX#ZWQ/\ S1'?\;;?[3@/K?$_\T1W_&VW^TX#ZWQ/_-$=
M_P ;;?[3@/K?$_\ -$=_QMM_M. ^M\3_ ,T1W_&VW^TX#ZWQ/_-$=_QMM_M.
M ^M\3_S1'?\ &VW^TX#ZWQ/_ #1'?\;;?[3@/K?$_P#-$=_QMM_M. ^M\3_S
M1'?\;;?[3@/K?$_\T1W_ !MM_M. ^M\3_P T1W_&VW^TX#ZWQ/\ S1'?\;;?
M[3@/K?$_\T1W_&VW^TX#ZWQ/_-$=_P ;;?[3@/K?$_\ -$=_QMM_M. ^M\3_
M ,T1W_&VW^TX#ZWQ/_-$=_QMM_M. ^M\3_S1'?\ &VW^TX#ZWQ/_ #1'?\;;
M?[3@/K?$_P#-$=_QMM_M. ^M\3_S1'?\;;?[3@/K?$_\T1W_ !MM_M. ^M\3
M_P T1W_&VW^TX#ZWQ/\ S1'?\;;?[3@/K?$_\T1W_&VW^TX#ZWQ/_-$=_P ;
M;?[3@/K?$_\ -$=_QMM_M. ^M\3_ ,T1W_&VW^TX#ZWQ/_-$=_QMM_M. ^M\
M3_S1'?\ &VW^TX#ZWQ/_ #1'?\;;?[3@/K?$_P#-$=_QMM_M.!_.S_$N7I6+
MI[>SUR/&96S2_HWJVS:8KZF*BBKDB?9O)7(BTHL^J7/3 W'*'!.Q$%M/PWQ0
MP!*&L4DDA%L8_#4=?:G[N7B/Z&:]8UD9@,'C;CLK;A'HA&F-?L@?J$[6-+*B
M0*MDC^CSE>NG%Y=_^NLKDE^ P& P/P:46<682<6 TDT RC2C0!,+,+,#L(RS
M "UL(P##O>MZWK>MZW@</+9_AS/:2MV=OUAN'-Z^#/<G6J'-\;ZFLVQ:TBBQ
MS5'#/4KD\/C$C1QMH&<89O>RD*9,GUO>]Z+UO>][.D]W>=,JV_E@O:+_ #36
M[_R+N+\:<+\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_
M %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!0_E@O
M:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXOQIP?-O\ 4/Y8+VB_S36[
M_P B[B_&G!\V_P!0_E@O:+_--;O_ "+N+\:<'S;_ %#^6"]HO\TUN_\ (NXO
MQIP?-O\ 4/Y8+VB_S36[_P B[B_&G!\V_P!1MKR%[)WMN<06*5;]%\_)@VNA
M+.)8[$L.6R^SY-%BE!(TQ^XF?-GEX1QI6<G-&6)6C(*6;*,&7ZOIC$'9G;W-
M]IBWHZM88,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
I,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
